var title_f6_62_7136="Dual resistance";
var content_f6_62_7136=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F51461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F51461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Dual resistance to adamantanes and oseltamivir among seasonal H1N1 influenza A viruses, 2008 to 2010",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 524px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Summary of genotypes of dual-resistant seasonal H1N1 influenza A viruses detected by full genome analysis, 2008-2010. Clade 2B genes are indicated by blue rectangles, and clade 2C genes are indicated by green rectangles. Oseltamivir resistance is indicated by a red solid outline. Adamantane resistance in the clade 2B M gene is indicated by a red dashed outline. Adamantane resistance in the clade 2C M gene is indicated by a red dotted outline. Reassortant genotypes are indicated by the bracket.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Sheu TG, Fry AM, Garten RJ, et al. Dual Resistance to Adamantanes and Oseltamivir Among Seasonal Influenza A(H1N1) Viruses: 2008-2010. J Infect Dis 2011; 203:13, by permission of Oxford University Press. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7136=[""].join("\n");
var outline_f6_62_7136=null;
var title_f6_62_7137="Incising the fascia during vasectomy";
var content_f6_62_7137=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F68870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F68870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Incising the fascia during vasectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The perivasal tissue is incised and separated from the vas deferens.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Clenney, TL, Higgins, JC. Vasectomy Techniques. American Family Physician 1999; 60:137. Copyright &copy;1999 Timothy Clenney, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7137=[""].join("\n");
var outline_f6_62_7137=null;
var title_f6_62_7138="Fasciola hepatica adult";
var content_f6_62_7138=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F65725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F65725&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Fasciola hepatica adult",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A, B) Adults of",
"    <em>",
"     F. hepatica",
"    </em>",
"    , observed with endoscopic retrograde cholangiopancreatography (ERCP) imaging in the common bile duct of a human patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Fascioliasis. Available at:",
"     <a href=\"file://www.dpd.cdc.gov/dpdx/html/fascioliasis.htm\" target=\"_blank\">",
"      file://www.dpd.cdc.gov/dpdx/html/fascioliasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7138=[""].join("\n");
var outline_f6_62_7138=null;
var title_f6_62_7139="Photoaging arm";
var content_f6_62_7139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Photoaging",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDzKGUz3KLn5RzjFdHahdpRzzjvXLW2XjV1P7xeCPWtWPzGkVsncByvvXO3Y9dK6NeCBlmDn68mugtlXywUVdx7k8CucsSWkByWzxj0rcjVFt3LseBxxxmhDlruXrm9ihjES4d2GCR2rKudQEEXlsSinoR0p+nQtLMZZXJxyN3c1RubUX14kcT7iG+fHbBqW9ClFJ2NiwuzCUkeP7xCoAefxq1JMGj2yZbJxgdKIxFbqyPECT1J7VYYR7S0LZQdAB1PeqTsgdr3FsLRAwlY/KM5+lWp7hJZI2tVZxHxzxn3psUMpjR3VDCq/dB5NWWCq4C7Qq8bRxkVnJ9iW7spzB5SCyklR06UmxGTlVAxzjnNW7RfPuHLcDtjvWdqEy2UMiZwSTWc5DjfYoavJFBE/lAh8cY5/Osy2eO+hBK7MevTPtVk2rXnztnYTnmtW106C0twT8/94ntWaN21FGelkyIRL80RPAWkez2szRhTkYYHv71pXToEAEgGBlc1mSRmdvOjdtyDkDvQjN66mFqFp5rMUHC5DYrC1my+0W21sEhcgj0FdmYlgSSaTb86kjPY1zE9hPcysyHgcqM9q3hKzMqi5lY4cqY8g461SZhJcVua5bNGpkC4wcNiuctjunNerTmpJM8ycOV2NiIDGT1qcZIxUca5UVMvAOa1Mxpz2pVJzQpyfSnAYJpgSIueakUciiMfLT0GOtNCFHB5FOAHagDFLn0NMQ1uQcVWc444/Gp3O7gcGqu1ULYHLHJ+tK40NPXikAPYDAprEipYgdgz1NLqMsQr7/hVpBwPSqydRiraDoKohkqDr6U/bkc01Qcc08EnpQIQjt6U08DnvTyKaRnr2pNARsOTUD8tUzEge9Qk/MaQIaTyacM9qRBzzTgeT6VSKI5W4qq/c1Ylz6CqrA0ygUjNWBwvNQovzc1aYbYjnmgZZ8NRh9RY+lelacmFArz3wimbmU+9ej6evygGtVsc9Tc2rFQw4HNbMA45696yrEYIA61swAcZzk1DM2XbYdAavQgLhf0qvBwvvVyMLnJrNsCzEMYHQirUYA9881XixuyasxD5Sff8qhisKPvGpkGCM0iDdhu3epB06c1LJHjOCKcu0JkD60xS+DtAJPTNSR/dwcdKQhVGeTxmlxjB/WhMgdBmnquBSJsNUDOMU7HPoKU5PBFAHPvSAYU+YnGPT3op596KYj4e064Mcign5TjmuiQESqYu/U5rj4M/MAc7CCK6K2kZVUseCMiuGorH08GdFYL87MpIzxx3NaVzdMmyEKfLJ5OOprGtJtnkKU4znOa3C6rDvcgk9vSsjTqI9xsbbCPnA4K9s+oq9psCJMGX+Ig59TVGCAsDKigy9Bg1f0iUxxt8wLBjkHt60t9ynoiS5RhOrTEOeyD0qeybaSVJDHjBHrU0aZQs+DJjcCfSqxkjjhduQx+6T+lXcSfNoaTzbN8eScd0PGaqMbhp4ool+V3y746gdRTtJtnfDS5IALZ9cVpfZhdyQ3MhdYoCSUHGV71mveJaUWJqN1DFCqWqbOOpHzH3rm0gR5mknLSsThI++al1XVIb3VEs9KOJn5II+6vrW3o+h7PnO6WbOWYms2rspNQjruJZWOI0ZhtkHZu1PljiH7ksSWHIParlyzrcKMfIeoJ6Vn38w+VoUDle/rSkrCjdswLuBUmkMhyqHKsf5VTt52kuMQ5VTyW7MK2iJrs7SqZxtOe49Kz7jTZLWPcGAA9KSV3c6U9LPckntfMjwwymOtU7q3t47VZrZh1x16HvUkd28EpLfPEw+fA6CqyWsMTSTvl7WQ5wOi076mMoW3MDWtMiZGG/KS849DXnDW/2W8kRux4r16+sEeUNEwCyDMfoT6GuD1zTSDK6qVkjPI9RXZhqlnZnDXhfVGfbHI69KsH61Tt2xj0NXM5XNeimcIi9cGpFAPFNUDBJqZFGQaoB8fQCpQopFp4HPFMQhUgZpBgg1JjNRkAE81QiJz7VVkOG61Yl6HFVXPNSyhnJPripE6CoshT/ADqVeoA70IC3H2NXIRnnvVWAZxnpV2IHGBVEkwX1pWIjxk4BIA47mhV4qQrkdKTJIyDTD9akIx0qNxmlcCFwPxqI9ecVMcDiomGO1AIQcGnEccjimL9MVIc4FUiiu/K8dagKkNjtVlxtHvUeDk0ygiUc5p03CEe1ORc4NMuemPagDa8HLyx45Nei6cvyjArzzwYvDH3r0jTs4HStFsYVNzaswOO5rXgGAOKy7VQAPbmteHmMcc9j6VDMy9bjsatx9cdqrQLkcde9XQBkYrNgTRcPVmPkHA71DEuRjtVmMfLzUsRIBhRz0OcVOBnaOAKZtHBHpTxjjHBqBChcMMd6eoGTSfwgjqO9SbQQCOKQB2BAzTlGDluppV+UY4NKR09qBDRww3dacBjr1NGNxHr1pSMsM0hWGscYGKKUYJooJPgTTJn3oG/iGa6S2zsUtkA+tclZyGOaIsehIrp7C6V8JIQMjrXNVjc+hpSOjsI3cw7vmUdfYVuMQ/lrCAyjtXPWNzGIgAwEgGFGeprb0qPy0a4Zsu3GK5zoL9ijQXG9nz3VD2NaEPlgkyI3mHPzAdqpqokKyOdrdeBVqMySthD+7xtwRSfYdySGWQrGrAhm6Be4FD2gvAitwEOTg+naiMmOVS+NkfA9qvRxBZg3mFY25wBzmo9QvbYsRSwx24tYwQ79z2qrqN9La2Rt0kIeTI2g9fepyYo98jqEVehPeuejZ73UmnGWUHYv09qAik2aPh3S106I3bKJJ5D88nfPpXVWtw1pav5aktITg+lZcaD7HtjCiQnLEt90fSrstyRZwxKMTYwSP4h64pbIlrm3MV0urmeQJy5PPPAHrTpbV4YxvJLjPPat2xWMBmulKZ+6AMVBqUaTy5iYk57e1TJaGind2MePiEqpIJ5BI5zULs0kGJtwx39avyo0bmTJ3Y5z0PtTbm23OmflD8YzwKzvpYu63MKGNnumESjbt7n17YpZrcL+5dVCHg7ehrRNikMhaJi23jIPNVL14QzMdwcj5iOx9aSbW4N8zMe4Uww3dvKhVVO6Nj/T0rlJZHmiljlIyeCx6muquT9t2K7gBQc46msXWLQq4S3XK8bWrWErGcoI4ae3MNw4X7o4qSJugNbd/pzRQssi/OAWyK51GxJg9jXrUanMjy6tPlZoAH/61Tp2BGaggO4HAqzGex5roRiSKo4p44XNIOad1UZpogOtQycCpG4+lROfSqYyrITiq8hqWVsk49agbrnOakoTPGKmi5YVAOTVqIEADFC3AuxDHNXIhz978KqQZCcdauwKDz3qiCYfWk5Oc07AB570FRmkwIyOeaY5AxgVMwG0j9agcc8UhDWAx15qI089+KjJoBAop+CB60i89e1P6iqQyCbpxUY7cVK425OetMwOOKZSHDBFV7oZBNWQCBVW5zg02NHR+Cv9Wf8Aer0Sx+6K848EMPnHfNekaeMhatbGFTc6C16D3FadsMjnisu06DFa1vzjA5qGQXrf5M89avxDJGOlUolz1Bq9D2x2NZMRZj5BxU6EgD3qCMAYLVZjAyv1qWBMoAVcc885p+0F89RTfUelSIQw4HSpEOByp9KcOR2oX5hxilwR0x9KQDgMD3NLgE+/rQuGA7YpdvOaQrCYAcc9KcD1x2oByduOTSj0HX1oFYbyQc9e1FOABznPtRQI/PRs+WCB8ynrWnph80ggg5HftWXFICDxkcZq9YP5crKCAp5BrNq6PbpuzOrtVLPGRhl7iu1sEWSCMKoBA5JrkNKbbDn5Tn8634ZpQvlH5U6hh2rkasde50WUWMDGcnGRSCULIGTLEjAArPSVo5BuXdEB2PerGmESXWIlBXpjGcH1qLj5bamtYAM58xAy7SCatSSxRDMhCg8DHaqEks+xo3TCqcbhVK5jmv1it0J8tByfc1m2xpXJrm5e5mkhgTdFtwG7VoaJaCzhVmAJAzVHTImF0bdRwuV+lbly8NrbiMtmXuDTQTf2UQ7SNzKuJG6471chaS3mSSUbsAZDelV4EdYjKTjuBuxmq32qS5DyIdzZC+1DXYSu9y/rl8+ovElqwhG7JOegHaltpI4rhxEFK4G4noPpVfUtPa2SNuskuDkd/oKREiSAhEJck7sn9ahK71NNOWyJ57yI5BQYJ4DdKnjiguIuHBQe/SsWRFVR1IGTyeDSG6SOAFpfKV8gMB0qZe6XyaaBeNHaiYxZLH5eOmKr6WsU5kj3owboO+alMEVxsAJZVOd2etSJZqI82w+ccqR/Os79h9LFPUbW2jzsQLL/AA7e5rIuY5J13BfJwcfT6iuoj8rcyy/60ckHt9KztUG6ZxbKN7jaapEdTkr+JZAjDAYfK2OhrjNXtPKkEkanyycZr0WfTo4IREQ32nls5yp/CsLU7RZ7TgL0I46Zrro1eV3OevTU1ocpZt8wNaSLg1kRq0UzKeoNa0LAgc9q9WLvqeVLTQlxuGRRu+XFHTgc0rAbasgifk4qvIccVZfgZFVJjgZ70+g0VpD04zVdz83tT5jioN2TUlkyj0q3EAdtU4Rk4rQgGdoPWmhFuHGADV6NcVXjQYxVlQTjHSqIHHnnv6UY4FOGc4x+NK1JgRnuKideevNTEHnNRsOgpCIGB5zUZ9TUrqcnio2BoBApGakHHJPFRpTgAapFCOQTg1CBg1LJjtTABTGObO0VQusAn0q87fLxWdeE8+lNjRveBpR5si4716hYcAfSvIPAtxm/lXINeu6a3ygVUXdGVRanQ2RwATWvanODWNYtgfpWzB0GD+VQzM0oee9W4D8+O5qlCPbgVcTqMY4qGItoPlw3arMfQY61Xixk881aTgD1FQxEg+vX+dSQ/KSPWo/lDH86kHLBgeCKkCThcDH5Cng88CmquVyCRjtT8nb2pAKAeg/ClA7E0nPB/wAilUZPPSkIUDawpc7c0ig7cHrmjkN60CFA4P60U1mIaigVj89GiaG42nODUs3ylM9CMVo6xbbkDgZb2rNb95bnGMqelZ7nsPQ6/wAPPvhTf645rqLCWORsODgZAI6VwGh3bo8e3lWH5GulhnJi+XIbqQK5qmmp2U3dHQ3hZlRYycHnr1rW0BRFGxAw54P4VzGmbmbGWK56/wBK3ru++xWgW2QGQnHNYeZq1pY15rpVQpEflRfXNWtOlFtGJGjDGQcZNc9pkT3FtEz8SF9zAdx6V0UiF9qEYROAO9JNsUkth0K7zLOAEz0z6+tQzsLq7H2oYDdx3NaOn+UyMrqQq/d96qajtaUSBhiJScD1oeuwJpMx/E15LDElpaMWJIHHJA9Kh8NT3FkbhblDtV85Bzk1rabZpcWks8/Ej5cnuBS2US3KswPyDjnuKm73LTSVjbhvPtDwybuFXjd2HpVEmO5mcYYMXyzdBtq1aQrKvluQBjOAe1NuL5YSY9uR/d9arpqKKtsZmsIpVhAxjiU8E9//AK1Nh0czCGXzd+BkIB8tSwW0+oySAglXb5uOo9q6R4INPhWO1DH5OV/u+1ZN33NHUcfdRzN1zdERgJt6gd6ACoO1+c9u1Wbq3USyPKDkjgD1rNuFmjQsxCu3FQ1Y0XvKxoK+Y28tQZX6H1qrFCjwuc4mzlgOc/jU1pJPLFEsKYKcM2P1qpfu9tKsdsgkkZvn2jANK5k462KUk7z3QjVVbaMgk8+mKyNRs2jd1ikAB6nqK1W050V7hpNsoOeOq1UvICsRYPvWUYGK0WmpMonA6vbFHaRlw4POKhtXz2xXR6ha7oyrY4XAFcwgMUgVs16eGqXVmeZiaXLqjTVeAaY3C80kUgIANOk6e1dqZxkDHAx2qnKatSHtVS47d6roUkU5c81F3xU0nPNVnOMHPNSMtW4IPFadtnA5rKt2yQc1sWuGApollyDOauIASOSPUVDCABVhFHJNUSL64pMc5pxGDxyO4pox1PFJgMYkkio2xUrcHimMMUgIWHHB4qJqnx2AqJgOlAiIfWpIz0FRntTkODkVSGh7qB16VEB+846VOQpxmkAwDk0xle4+7isbUW2o3ete6OAfpXP6q/8AD3NJlot+BHKawT2avbdMbcorw3w8Ps2owP2Ne16LJuVcdxV09jKojrLPBXpzWtbnkcdKxLI9Dnitm1+cHHWpkZGtD1HIq4nDDnrVGA8DPUCrtueMN1rN6AXI+W9qnU/Mqk1Vj5BBq0uCBjtUsRPgZAp68fe/Co88Ljk1MMD5upPWpAehyOKep29efSo1wFYetPzjAByKQiQ9PY0L79KaDnApwGeOhpAOGNuV60AgZ45phAGPenD+HIoEHU880U4EMTjvRQI+FomEsZVwDkdawZ0+z3BH8B9Kt6bckttZvmHUVZ1W3E0e9O/86zPZfvK5U0yRUdkPBzkGtm2umEhgYktjqK5aN9k0bdh8prrNKAnZXYD7uDWdRaGlGXQ6vTJTDBEMFgD+VWH3SX48z94o557Vj6RLKJCqAsAfmFbmjTGS5kLxrknuK42di01OhsIxFtVSQSKsQ3EguZSQCcYP9KrrGhuFw5Qehpmx4XYocgtzn0FKWhC1L91Kj2z7WKSKMlR1rO0gSmKR5SWB4pbCV7i4dRjaTjd3NaOoTLZabOsKBXUHGO/0qd9S9vdM8ySXJ+zQI32huFAPUVc0+N4bby5FKnOSTzUGmxNG8d3KxSQoME+pp8NwTcMbk7kLYyO+KFoU9dEa4kVtrHKKFxx3NQKnmszxoS3T8aq6jO0yxRwDG/t6D1rWsj9nhAzjYAQT/FSbFsjV0iHZbkyEiYdUxj86eyrK8m0NuC53etRMZLpRPNKqpj5j0J9qfe6hAkYCgCU8BR2FS+xlZt3MfUQsaHnc7HsM4qvaWcciB7k5x/qy3X61ftrRZFZ5DtHUDOaSOZJpGjkQiQ5CZ6AegqHc3TtoiG8uILOw+aQLI/H1qnYw2zRfO5Mh7HqfeoXsZJbx2kGY4vuK38VaG2GNklj+eQ9eOnsaQP3dEYd+WieRXUqqH5cjO8VnSLJ9lVox8ofIUjnFdTNAbiUs/wB/GQp6VQuIo9qGNQy9WA7GmmHkcnqkKPEJI/vEdK5TVbVhvbGCvOfWu4v7IeXJJGzEPk8VzksIktXkf0KnPqK6KU+V3RjVgpRsc3A/ABOatMwxnNUXUwSYIwOoqdHDLya9mDujx5RsxHIIP86qyZPXtVhz1FVZR1zViRWkOaquc8VZmYBe2aos2X4pDL1nywrctFyBxWTZRE89637RTgZqkTItxp6GrGOMHg1Gq/NxjHenoCoznOadyRoGTikz83NOBycdzTcHoakBGPqKYCOd1OOTwcUhwKAI2qORQee5qY89KjcdKAK7DjgUi8U5uc4pqj1NUhkoAwSaQ5IoB/CkdsA0Aildk8+lc7eHzLrHYGty/kAQmsa3XzHZiO9TI0SLUXyPCR2Ir17w7L+6hfIIx0NeTGP94gFei+Fpx9nRW6g1pDciqtD0SzYbgcnb/Ktu1bB46Vzli3A4zW9akhQOp9KbOc2bYjJU556VdX5RisuBiMdyK0UccZ71k0Bfh65B461ZQ5I28d/rVGM4wc49as7s89x0qWBZjIJwRyanBwvtVQHLAk1PuBI5qGhEyvkjv604MQDx0qHeABxg08kgnHpSAlLcAgc04k8etQqcLk9TR5gxg5pWAlzjqakHQc1VJBPHFCyBRjIIosIskgD0oqq06nv+tFAj4DcFW8yP7w6j1rTtLhZoijHB9Ko/hmmbWifzEPPerlC+p6NOdtCO+j8uZsd63NBvQIemSOCKyp3W4j3D8RSaPL5dwVPSsJK6sbxdmd7poMkhdeFwSe2a0dMklSZpICvzfKMjoaxtKuVWJtzYGKv6dJHIVVZAshcjae9ccktjtg7nZW26W2Mk20so3Hb61j2uqi8uGt5c7S2M9MVcgnMFk5QYfBH1qt4bsVZ2klTMjPk57/Ss5di42SbZ0VnYtaxqQAuM5Pr6VmNLLdX7LOeOnTg1uXVxF5aRhyXHO30rldXvnhvYjCS208jHWlKyVghd3Z1E8pFoqhAyg7cAd/WqzLHHCPMB3MeB3qC0lnwss6kR9R9al1VitpG6HL53fX2pNjStoiWxvIIpmM4JwMKMdatiYtKFKBsgDOfyrPnkgjt/N2K0w2qQe3vVvS43e5aaUZROStRe+hVkk2bGVWI27gEDspzj6ml0y2SeQG7/AHW3jcx4p+lqkW+XaW3tkA96tX/lTSbIeQwycDoRU26mbdtCG9uorRlhSP7/ADnGdwqNFikjMgBB6kjt7ZrRjsbRI1lmLM7AKGJ4zVPUAUikhh+91AUdBRYqLWyKsjhmDkBYwQOO9SCJdhc4cOchcdqdZWjhA9x94DhcdvWld3ikIVgyAccdallPsZd5LGWOxjuHGM8gVEAlwzCMH93yeMA5p81nAZJLkNgAcKR1NFrLEjO0vDjsOmKlbg1ZaGdfCKJGUowVAXUD1rnL6JYNGd5IykzZJX61ueI5ZWj2xgIrnn1wK5/UJPtVq/mykHcFCjvWsSOV2OP1W1kaBHIBYDjHesiObYecV22qQSzqscagIvfv+Nc9c6I21ZA2CThuOhr0KFZRXLI4q1Ft3RQaQE5z1qGU8Go7xJbWZo5hhh+tVnnITJruUk1dHG1Z2ZFdyY6GiyiMjgkcZqCCJ7mXJ+7W/Y25jQHFPcTLdlAAua1LcYUEjmq9uu0DHercYxxVmbJI85O4cU8nHb8qYxOFGPxpdxIpAIXwckflStyox1pjHJ5oJO3rQKwAZz2pDxyCKUH5egprdeBQFgwccVGeuDTi2ARTCPQ80BYjZe9RsPmqTio5GGenIouMUE856VHIRtyT2oZwB15qncSYGB0qrjSKWpPhGqvZgAgGmXU3myhRjA61NE6lvpUddTRbFuEbrxVzkV2Hh+QwXGw9M9642wkX7eM+tdUswimjccD1pwfvjmrwPTNNfIFb9u5JGO1cXo98hRTnPFbo1a3t4y8siqvck1tLQ41G51ds+W569q0oz2PUetcPD4q07CsbhODx2qyfGenKQBOGc/wjJrJtW3HyS7Hcod6gdxzVhHHqM15vceO0t3wlnMw9ap3/AI8vHjX7BAqg9Wc9Kzc49y1Qm3sesCQbevPSpRKpAwQO3FeDXvifWpuWudgHQIcUtp4w1OKIGO7zt4YSVk6sTX6pOx715wABLDikkvYY48yyogA5JIFeAXHiTWJpCZ72VI3/ALp6VWnu7wlkkvA5f++xNL2sRrCPqz3ebxLpkP372EY9TWNf+P8ASrbJikac9AEFeMG9Ma7ZlQkng4zTUnAkRgJJM/eCjgUnWLjhF1Z6JefE+eRmW0tFTBwGds1i3fjjW52AW6jjb0UdK5wussmyOJxGeTuFJJp4cMFikWTPXoKh1TaOHhHobM3irWii773GfTgmiub+wXVuS8o3kjgE5NFR7Rmio0+x5ZzgClPIxiilGTXecBUkRonJUfJ3xSW0ircBwR9KtyLlTnoazJAY5OMYzWc49jWEjrbeTbBuzlG4+hrpNGtwVWYY4Gea5LQrhJLdopPmDdCOxrrvDrqEMcxIVTnNcVSJ305aG5JMJcAbio4471fsUa3ZJA+QDkgjpVCziLzGaIr5RBPvmr9m7BpAR8o6gntWFu5re+xdieC7vBIwZSvXjGadPapcM4giTKkcnjNQyskkRlgXc44464q1aurQ7myDt5U8bqhopPqOil3sqOAgHUE/yqve+bPMY7dd0aHLD1p12y3UCLACJUHJxTortbS2KMpV2OAT3xUvsNaalLYHuvLG7bjMm/se1b6SyQW7PGFA+6TjPFc+LgG7acDaAmCcZFa9lOs8y5k2wYAA9aLJFu/U2I45I7cTQlwD1OcnNX7aDELJnkjv1Hfj3rKlujYz+aSWtwuVAq7aTy39oZ2k8pc5APU47UmrPQjXd7Fhg1tGNrebHL93nv6ge1OijMtw5fJ2qFJHf6VUEyzBC7c52qF7egrSmm+zKoiwxxj61NtRvT1InufMDROP3aLnap5JqmqO779uD0Qe1TxW0n2kSyZj3DJJHf0FF1KZciI7di8KOlTbuNeRiXD7bg27jPdV9feqeoqd4jyA/DMw7Cr9/ciOOM8G6bIxjoPWsaRJLwllKsN3zDpwPWpNUtDOWWW7vNjZUMOM/wCe9SXsCSXFtEkQRlyx96uXFskksDtEBcLiNQvHHrTruxlfUo2EmySJcnA4Ip3E0Z01qrXHkqoEuCVbsaqm322LrIqiRiRj1rVmt55dQJTAixhs9Qfao2hSXzCMjAHNVF6kNJnIa3pkN1DGxUZZeCOoNcDqWmXFvMQykxBsbhXqy23DZbc0bHGR0FY+rQCW1n3LhmwFPr7120azTt0OOtRT2OOsIlRcY7Vq27KAMjiqi2QIUx7lA4J9TVuz0+SSBmfdgHAwa7PrEUjkeHk2Wo5UBqwsq8c4rNNm6DaHIkZsAHt71IbOVW+WTcQOQKf1iAnhpo0DKuAc0glTHXms9LecsF5Yk44PSprqzuLWMFm3Mf4RQsRATw00Wg/U0u73FV0tLtlB2jnnrVaUzQzeW6sHq1Wg+pLozXQv7h+NNaQfjVNFnkfAOzPdqS4gli2+ZIoDdwaTrwXUFQm+hM86gnBxUJuWBwBmrFvppZleORZG/uCpJra78xVkVYz1VVGcj1rKWJXQ1jhX1KZDf8tGVB7nmhLeSViUY7f72081qmxnuQWJhLoOFxjNNtS1m/l3dvIz5yMtgVi8RJ7M3jhomHLaXJyUGQPXiof7LvpwSgGB37Cu2SAtAZDZuI+xDZpLchC0cqqNw+Tdz/Kl9ZkP6rFHER+HZ4yZJmOT/s1YtNHUNukSTHuMA11k95KJTb7VJHcjAx9amawvbm3+WSKUAc4PQe1L20n1KVGK3RzsOgDf5tqnPVhnOK04rNV3GeFxt4Xmt3S7eSy2efc7IumTH0rWu18tPLjeKdG6nbg49Kn20uo+RLRI5meEJaL5ZmWQnoO4qGV2Nm4mBdl4Ac9PetjzlcbROkRTjy5BUdzaQyR7ZY9snXepwDT9rLuCpR7GXp1vDLamOcMyt3A6GrQsVhQqIy6rzlThsUSWl0u3zGZI84BA61pW1uXgwXDEHGSeaSmypQS1RQghiLNKGnIxgKaiFwJfMTyZggOAxHBPvVi8tbuFHEdynPQHtToUuY4lM0u8vywNPmJsQ3AcLGsgcEnOFHUegp0bC4lwtsxCcgFcGrUxZbiN0WIsBxgn8acJpWuQjQukh6AkAfgaOa4WMv5nvXBMiqP4NtXQspAkWREcDO1l6irc8ReXzDAdwGNymmQyxrLi4DFMYAPBpcwJXJISJIv36De3AyAVxVZvPtkAgCsjcZA4X2q9ItmGYceWw5B60+K3tAnyMUBPBVs1LmCRRU3Ui9PlXrtFSRvMWLeaq4GOaljjufOKjUGCN1AQcj0NSPY3BkcqI344J/nSuXp1Fe2luYQjE7TjJFFPt/tNtajeq8cEButFUpLqCj2PDcZ5JpRgcetJj3pRXqnjgFyuDVK8ixyKvL6802VQw6UDTK2hz+TcFWPykZFdpp92qxkE53+navPpg0Um5eCDXTaJKk0asWOcYrkqxO6hK+h31heNBbbQ3yryAetaSXMd1AWX5ZQMcd65eGR2tRJt3AdCK09OlL427cN6VyO9zq0WpuW2+02PEpMTj5vb1rZMkE8MbI6qY+BkVl2MpR2JwQBjBqZlW6ULAoVuuzoBUND3Y3TboR6i5lb5VP5+9XtQkiv49sQRucnntWPJMwujDMoRXGAwHWkmBsbuGOJiEJG4EdKF5FOOt+o+dIJp1hJaPts9auW8Rt2T7RlUBBWsSS1knvpv3zhw/wAhHYVslikaR3jb3xw3WpNEzfsQLsSCQErjaAB71IXzI0cUjmQNtz6+2O1ZVheyJINn3R1rTePFvNdhtnoBxg1LHazNQxRwWpQIHlI+/wD3RjpTdNhkjmSV2BJAKoe3rUtlPANLdpn3s6gkd/wqLSg/miRcshG07j0FQ0JNtM1b2QyT7pCwIH7sr0/Gsy/DGXekipF/6FU2oxpC0ZmmYxyAkFTnHtism7klvCGRNsR+UZNJ+Y4K+qKiJDLfOyKzL3b+lWYIUSdkQbFHIU/xGtLTrJLK2LyhVYg4BHIp0cayky4VxglQDjFS0U5XMq8iVZUcRlpCMHA6UyACSM3JkyOmeuT6Vakd2ldgH2kYVccCqlgxtWktcAKRnbnk56mpWgWurFCKJjfm9ik3K/ytHjpTLpDb3hMikh17CtaziiilVd2DjK571XvZiuoI7pkHK8jFNEta6GLcoFBVANzYbmuO1adbqcW0WAFIDEdznpXca1Lbxx+Yrjjt6eorlrbSi9p5u1Q7P5hGeeTXRTfKrmduYSHTFittrRZmkT5cHOPrSxWcqQIu0tjjAree1beCpzhQDVi3ChUIT94DypHFDmOMbI5i/sx9vg8uIOYlJkIOPpRe2EJC+Uz72GTxW5bRrJqN0dmccYFSwWwa9ZNjBgdxyannuVy23MjRbWKdgu0OyNlhjBGPWrklmlzeM0aqUTgbuK1b6KHS9tzFGVdxsfbyWosxE8KMJQpYZOV5zRzNahy31Och0+eS9bYu0Keh7f41HdWZi1wLLs3FOTjINdcBCAyhgrgfLngmsqe2zDJeMqyHJXJ7Gjm0Fa7MW906G4DEsYZiRtVVwSKotot2rsvlq57buTXTWkX20722MuAuAOVxWhIv2fBx1IA3c5pqbFKCOVgsJ7Rg8tgQuMblzx7mqTqrakUkkcqoyFBxj8a72/SfyVRSjh+cj+Gq32Jbi7iDIi7T852/ep89nYUY9Wc/FAUi86GTaW6bhkfiaWWRZmSKbBc8nAyMe1dza6fGqeXEu1D2ZeKz7vS4Fm2hRubnAHBpOXcF2MCJp0Ci1RkROxHFaKvbT2we6RUccAYwQfWpIBqFnGzQxLLBnGxuq/SnPe/ah5dwlurdcPxmha6gY6W5lmdpIXltz3H8qhnt1gmVLNJ4kJ5AyAB9K2VMMCbLWU2/fb99c+1S295tlZ7mWKUY+/t24/Oldob11KUthJLFj7Q0yEcK7421lRLNYzsok37SerZxXSTWcM8TOW/e9UZOP/rVgXLLZyeU8oZUOS8aZLE+tXzdyUhwuJZGIEMbh+rKmao3f2W3uIyrO4PWIk5z7CtqznQQOYZUB6AkbT+VRX9iZcXc0YynR4+T+VHOO1mQxP8AaLNA88sch6K4+7+FVL77eEUWUpLD/Z25/GtC0ijuCzyMXcdAOCKuxaevkvNHPKHIyEfnBqotMTujLs7nbZjzrX970dnBP41aeKKS1DGTYW5PHFLE14ITHIIAxz/F1+tZtpq+b1bLUrGTccgFTwaadyeXqi06IiqoYucjBqybaSdf30hfHCketMuIYHi+VZLcg8Hmr2nQNBaEMy3BzkAZyKXMO1kVrVLlMwo52+jckVK0FzlPtlqXK/xrzx9K0CtvJFv2tFKBnDDrS6ZcyXatyrFeMelSpLqQ7vVGDMLfzzHKWXP3RtqaGCCIja4z6mtq7tGcGWWBW28DBrPgkWWRY8SBgeRjOaaaHq0V7mFIykltdKJM9Bz+lWrSW73NmaABh3UinXNoJGkdkUEfd2Lz/wDrq3PoSW15DBPqMjoBi4KLnyyeoHrgYp3I5rqzI5oLlYZIZYY5M4Oc7GIPsaKh1u0vrO+kWeVbkKqbJixJdCPlP5UUm0ty436HhGOcg0UY6DPIoHB5r2zxRRk8/pSkY60DOM0p5wTQMoXkW4Zo0a5MF2EY/I1W5lDrzWTOvlyZHGOaznG6NacrM9O0y6WG2O5TtAq2YN8X2q0kK8ZKdM1zPh7U1uLXa5+YDafet+zJ2uqsTgcLmvPldOx6UHzq5o+fK0YIJ2jBZh1FdDZTB9u1vmYZwK560l2qcKSQPmWtaMB4PtVoQGQcrUculy27FnXCGtwkaZdSGyB92mWTBj5t4odtvftVa2uBLcb5DzjAHrW5bmGSJmkUYAwMVKViuljm7yU21y/kuSkuCG9PatDS5A0jNIoOF+bJ61CbAszZbCA/L34NQ3cEtqnmb9ykYBH9aGmy009Dftg8sy7QFQZIrSsJhcQzx3QxEMgse/tXH+HdTZfkuTlifkPYiuqkdbmHbxGo5yBWcine9jS2KyxWlvhQQOR1FXGhltVzAV8voxY8HHeqmk58reBlk5yxxkVaa9E6LbzZESg7AOM+tRoT1sV7qeDagnkJXqWPf6e1TRKJr6NGRRCo3ZX9KzbeIX101xL8sUQ2gZ7dq3maGztIyyBDMwWM5yGA7mpsW7LQNV3TJst2USLgknkAelYF41xHAzxud2cH0xW0kLSvISCqMcfX8PSqn2VZryOMAFFb52PGMVMtRwaSsSGVTZRhSGfAU4PSmhLdb6GQcSLkEHuPWpL3T47RSQUDMRhu4qheYhZri6U7UXIwetJgknsSX0gS7QxJyx4+tUtWLyXUTbQDGMsKsfaQhW6mGQ3CADj61Q1CXNs8pZlLNz6EUILWaOb8WS/aVjjVcEjAPuasWlm8tnbXEbMGjxuQ9xSvCt1eRyyJ+6y+3A6ADAqfS12wK0cny9CD3Ga1b0sNRsiyyuGjSYNGSd3B6itBIAwYr95h1xmo57cvieXhlxsGODSaZeyKGW4CrIh/h9PpU3JtpoZumhnv5IxkOh5PTP1rSNlvvHl85ldsAZ6Cp4k2al86bRKMhh3rUFu253XaUQZye/FLfYcnqY9zAZJ1glcFV5zSTWcMQymM9/emWFy86SmeIghuCB27VqTeU1r5ceTKRnntQyWnoY17EswRcKV42HGCG+tNt42aV02sApwCRwMd6ktoEJMIeYXL9Fz096uWZSxEkd4rl/7+OD70XKtpZGSYmSSaWN8S8AoOAw9a07VFnsGd237MBfqa0fsVvdbZDGAx4DLWdqcAs2jEDvhz91++OlPZ3ZN+b3epZXSlZdw3EKMgA9KhW1JLeXcMJFGSSKsySXS2O6J1yeqkY/KkghaQmRTskI+6eRii4K9tSNZZkUM6yf7bBeo9qfbsLpmFrJuZe5PT61pJcSeQsbBcqOgPWsu6gkWX7SLcw+pRuD9aL21JSM5xd2l7smBPmEDIORWpdabai1yUTePmOapT6vbynYzpkDJJ9ap3E0ilAA0oY7XGemaSlbYpwb30KUmmJeXitDGFABGUY5qzLpk1vFtklDIecMu4VuWyi2VTJHknoV7VYzFM42kNtH8XHPpTTYnf7Jx19YzzW4+z2zBlOVeJ8KfqKt6dA+n7PtMG8SYLYHQ1tLHdQzN5UChXOSAeKv7YZbJkMQLYxgmrjZkyk0rHOawmnzbPJiWOU474wfWohLLCNrOZFB/gUHI+taOl6ZavHNkCRgSQDyQKil0uUZELyFTzjsDS21B22KJs7aV/PSWaGVeSoalkt5dqjdI0Q5wXGamvopBGYRKscjcYdec06xglSFlmO4oOp701MXK7DVgEkahYwFFVryEOoMCpvjPJPUfSpDHJM7OMqqcFc7efWry2GxHwGbdzkcgU+fQexBpjJcgxlcN0yRkUl1a3mnMu2ESRsfvKcfpV+xtyYw8MiLIeuF9KfLc3jy+VPEpAOQwPJqG9BW97QWCEXEavtOMY246VnSWEVtcuIpTG7DkjjNblvdRqyqY3Ozof8ayfE93HFbiRX8sk8Oq9PSm1pclL3rFdfPt0dZJ2l3dCTiohbSx73hZRKRnk54qXw/LDeRZaQGYjhWPI960xpYmkQiXew4J/pR8SRb916mNp324SMpmQnGdrLXYQwy3yme80G4a4bBLRyhFl/wBojqKxVgdZwsiKhB+XceOK09T0pJNee/i1qCMz4JjZ2wpxjA9qqBlOzZnavb3M2rSS6gjQ/IAIBwFGOMfhRU2pteIxUyWt1GBw6ZAP/wCqirHGLaPm3PbtQcUo64Ao6HmvbPEE/GjOKVs5phPXNAxWbg5rN1AAg46ntVyWT5TUSRb/AJm/Ckyk7FTTLhrO4DKTg/er0rRrmBo1lY7lcdh0rzS5jw2K1ND1GSL9zvwM8Y9a5asL6o6qNS2h6rFFvHmx8mlklmSN7iBcOOJU9R/jWRpN4wEaMdm/o2cjPpXRW6b2lUEBivU1zO51pmfFfwzoGVTvB5XHStN7hlVgCVjYZ4rJNuLZ3mjjAw2GHYj1FWJ2UhsOFiYAn2PrUtXNL2ehtIzfZFiXDZGc9xUZJeALJhSBuGOQap21y1s6+ZnGeTnI+tbjiFrBpU24PAwO9ZpuLsPTc5SyeKQMhbh2K46FT6111kXtlVW+dRjJFciYorK5jdzl3cqyY7Gut01WVA+/MbcjP8qlqyNE7mxJcKSJzhSAMYHBx7VPCovG805RuhxWdbje8/mP8qj06VetLxFshNHiNlfaCe9Z2V9QemxUvLS40i+jtQ+YJPmHvWvegXE9tFPERjbtYdKzbaVr/U50mZRtX5T39610lS4RYVlBFrgSP174yKmxTe1+hbmne3WXcgwOhHQe1VbVHnts7SrbsnFWII/MhuRvaaNm2o4GMU+xuTbxyR3K7HH3G3dR60WZOy0KN5LnzIJo2KheCe49aa0VsFiPL7h5YU8dqgvbmd5ZCVPX73bFXLPZcJJkAqoVSSPvEcnmpLasiFbciSG2mjxBkDPqO1Yvix4j5dpDHmJmOSe2B2rcmuG+1WwUgxR53DsB2/GsfWIQdQtpJc+a+Tjtt7U+4Ru5K5X021USwwq6lFjx/wDWqppiwMJwyMVSVlJ9Bmt22tljvkKhSyLzjpUWgwCb7Q21QJZHypHbNCHfdl+GBJYVMLBwOPUD2qteWMEF5I3lqGZRz60ljbHTt/kMXV3wyt2HtVi2sM3QkeXfGpyVPJNCdyGrPRlee7inP2VY9k8eGUetQapqXkxpbbHWZjhkI7etWtVsIDOLhw/nZJQp3A7VLrWlSXdjbXIXMyLu98elAe6rXKdun+jjcDweR9aktFRJ8tH2496mKq0dnIBh+hHb8amv0cESWuwB1A5HemS5MkjsbYq8nDSHlSeMe2ar2D+b5i3KK6MwUDHSpZN8628U3yydyv8AEaPIa1cSIpOepHIpX2F5MSaFreRI45VVM7lHf6UzVtOl1K2KSFVKjKnvT5/Klcs5KYHPoDTohcSO2+6LRIOGFDdy1oVoJ4VtUguRucYBAHpVm606LHmRnaSM4zWfd3IFxF5irlj/AK1Rwa0GRvk2EnjcyZovoNx1uY8aOFYRyMW9z/Ko2uLq1DRN5jwsPmB5xmtqCHyHw8JEh5UkdKgYR3EpWViHY9umal7lXTObFnYpFtigcMSSCece9WrKyjgmV3Y888ty3sRXQyWKyKY9n7xTnNYmr2DWjLIs539lHJFFralKV9C8Jt33wu4HAyOKiaKR5h5Z4J4J4GabY2zuY2mZkDDcSauyTnckS4aMHB9/etpSXLoJ9kQ26SXErhwVaE4IJ+9SXFnIkpZWbafmKHgY9BQ9qS758yNs4Rg2cj3pLme5RnjkBccDJrNO+5HLd6FXZBaTmZFmBbg4ORVr+0dv8DMW4NU4hLkCQ4jzkgmn3MDRPHcRscA8iqs4xuOdNdSW8s0luA7ZIwCAD3qc2oiWNkGSeTk9KlM7OmZI1Kv0cdjTgpRfkzIcZpxRk1oVrq2aQr86rD2AHU/WpbKGUysiyBlxgCrFvCXVVm3BDkgAZAqQ2wEmUkwFGQM4zS1Qn2KE0CRELkqqEk/XvRaxJPKXfLhRnrzViTLBZCMZyCCOKhlQ2yh4SPmBADdBSlvcBx3JOSEGwevemXcSX0DReWASM428GrLLJMI3lCgY/CsyO+LPKuQNhwNopyaCMW9uhkwQW9ldYjXDD7pz0NbqO0FuHTO5jg/41mSjzoGdUy+7g5rajubcWqgK3m4wyletKJU+9h+mSrDJI5itp3cDHmjdj6Vag1Qy+YWsLDCnGPL5rI0233XbyRKVBP3SKsyW0MTPLIzBuuBVxbRnOMbkOqOkspcQpF0AWMYUe+KKZqVxHb7GiufM3Y4MZXr70VXtGi0nY+bjk49aD196D1pCea908AaxNNkbAGaVmAJyarPl3AHIpAhADKx7gVbQYXHamRptUDjNSEhRntQUVriPKn0rPTMUuelbDAEcGsy6jwxPH4VMlcqLOy0DUYbiIW90cd1bNdGt1LZhVaQyQ5B8wdV+teZaVP5bgP8AdHFdxpkoi2NI3mW7DG4dV+tcdSNjtpVLrU7RTbTwEx8pIPmwf1rntVgmsSjIWeMEZB7in28Msbf6C2+M54B6/StrT7mC/tXim+/HwyN1FYNNHQn3EsbuAWsZkUPBMNufQ+lW1ujbvHbsPOg2nYc4OfQ1ifZnst0kI8y2D/MpH3T61rPLHfSxTW6gSxDLD1xUvUpGZrDJdHeFZWjPGeoIrpNOuY4LEK0u6TAO09TXPeISkjxXcBKRSOFkT6GtbUxH9gt5EQKyEfOB1FKSLTTNZblhI4VeJB8o9a1WjiNlFEdqjr71Q0sJ5fmlh5gGQSKZqBuJIm5QDaSG9aw3LT1sie2V0vENuQyNuLEU7Qzd282pWqgPGW3j1Iqr4T+0rtSXA2r/ABHnvWnFPs1WRI1by3GHZRQ1bcp9UzUtb/bpwiWNgS2cnoKVCE1Jnv1MkB6NjjpxioFdLadbWYgFxw39cVqEs0UShAEQ7j6H60mS2l8zNkm2eeW4hf5FB7f/AF6qR3pg+RySQcbRWld2/mNmQgQs2cDgD3qld6eZLlIlG0N8wkJyT9aE7LY1i47Mdp0f2i5llZSqnBwew9aj1KH7RqKbHBMWccdalJmgV7eL7xwWyc4/GpLi0ntoVvYU3sw49x0NQ9dQWjuV4TILR2hUiQg5yPvVF4e5iJlOwl9xI75rctljGkysMDGSVz0rCtrG4WNZ4ACjqQ0R69e1JIFqmmbUpS2uImc7YzwS3erblRcBkVCyrnA44rAa6laB7W+UkqchsdR2rRuC5W3LQ7VZNu4f1ptkcnciu5N1yjIn7lMkkepq1cySRW6SxPvCjcqg8j61mW8LwZjifdkdT/LNW/tYaFYimx+je2KaQ5R7CSTwXDpMgMbDqmO9GoXAWNbhF3BW6epqS/EUlttyvmMMDA7+9Y1kzpbvBOxG04Kn+dHN0J5E9Swt8k155khZcdM9DVwXiXOFJKW+75gOtLeWtk6RRh9ikABhyAagi09lYRebvy2Q69BTaYvdNSO0QQOYwJEb0OTj1plvAbRWufuRkEY96dJvtnE1su1+BtPRx6irMoS6t5QSAAvK0kIz7WKG6j2zxjdncF7VFqFpJBHmNgsqnhfarkVhJDBE8YDyL1wetT3RW8kBkjZfLUDnsaVr6jUrPyIbecSohnUMRwSTVIwwLI7rhVU5wc1ZubG4slKqySI/IP8ASqcEskUkjYDngEAZFO/ctK+sSVEdJUYSne7DqO1SzmPYfMQM5OCMZq08sc8cIWIrt/LNJJZ/uvNiPOeQegp2uhS6XGusfkIfLAiIwyd81QkgimcGGMLIOQoNX42kmjUOgLID949KWCyJnW4QEMBz71NriWhy+qX01rOFZtmc8kZH0q7ZXbmEPOiyqRgNjFS63ZLdIykBSDnPrT7ZFlt/s8Ui4A+YY5GKqMX1NtHEqtJ+9dnjPk9CwHU1bWSOW1/dFetPkghCLFPkRMOo4ziq8AsrO6YrIGRznbjpTk2zNvmGKZCDCwyw5B7VTje5ikJwMKfQ5xW4L2whkTZktnAJFJebVLvuGD3I7UkrCUtbNBBL9qtlIOG6U2zgdt6yruBPAzzVnSnR4CFAAUH0qWaOKWLdHII5VG0ehqtXqZvRtELxoYhEwJ28YIp4sYmtehBIp6CRIwJ9hY9D61Eu+3lGSGR+mO1BnYSVEEPlA72xtBYVkyWoywijIPQgVsrFGs2ZnyrHAU9ailtWE5ZflXHI9aLXKjLlZgx20wkCBSC/txWq0TBOADIBj1qaMGNlCxscdzWtDFEbcnZzgknFCjqKc9djJ0uOZXUSrjPB4rdurFbZ7mdLVGKhYoFZdwcn+LHeqcDHA8vGSejHFad2FW3k2mV5bdlBIbA56ha1irIwlJtnNazpw/tMrEkaoVVnQrwhI5A/Gip9XtXjvV8l22thwXPQEZ5oqG9TaN7LU+Ts1Gx2mnFutV5ZMDB5Ne6eINmfkgdakhj2rnuaZDHkhm61OuBSGKMDr1oz7UE8ilYccUwGjp0qG6jDJx1qwuB1FMcHbxRYaZlqfKlB7d66HSb1oQIyf3L9Ce1YV3HjORS6fMwJj6j0rGcbm8JWOysLyayvQSzeQx6N0rrntMxm9gZvNxncOR+Ncfp0vypE37yKReCex9K3NPuZNPX90zSQ4w8RPT6VySXc64yubek6wkivBIi+Z0YY+971ZdE0y6iubZz9mfAdSPun/Cs7S4rLUUn2/JICXRhwyn0+lPs7tmIstQUg9jj7w9azasrmysy3qEEV3B5sBxmTBHbnvWb9unlgfTrpf38Dg4z94VaeRdNulhBX7Kzhhk9PapfEMCMkWpWcZ8xGG4/3lo3Q9mdJpR82yV485X5WHfFW7Z41nkSdtqKuR6NXLwa4tvcLPaxkgD51Hf1rSe8ju1llVQpdfuk9KykuV2NIljTrvbcSiED5Gz+FbVu5DGfOGfuPWsKEQJaJJnDMu1u20+tbdvKYooi6D5x1HIrNlNrdErKlxJC7gmVW5b1rRkvBJZus5aMdABxk/wCFZVuyRxPtdjhiUHYn3qpFJc6hAgKFijnI9/rUuzRSV/Q6O0bz08h9wQ9m649qUK2Q7ZKLlEz1pkbFVty23IX5j6H2pLu7hihkDFi6DKj+99afQXXQh2A+ZdSzfcyHXHermlagNQtzFyrqPl9DTNFZLixkWQES9x71mRabPZ38l7ayEoo5QtwDnpUtF6STT3RsXY8m08q4j2S5yQo+96Yq5ZlZrVCTsK9R0xVOe5fUBDcxEO3p6Cprd0udkEpRTHwRnBI9qlaEtXWplajBLDqDCZhLbzD5ZB2NaOjQtfM6MWO0FSh/mKzNbaRE8qMbl353DnaPSptJ1e1F4A8pRygUgd6BtNxujRvIRvKAeXMi9QP6VUECrGzyA72XdkevrV6T57wCZXUEYVwcce9RStCsxLkgRkKox19K1pyT0YJ6WMqyuhBNG8ihmUnGRn86bPNDHqQeXPzHDAjjmp5biP7bJhFCuQyjt9Ku31pFqtjGFUbk7D7wPpUzV3oEnrqVzps0UsjRT/LwVB6UOk0U4ddpbHzDoKtWc6whVuMgD5SauXKnb5yoCSpOPWpcWtjPmfUoLdpLGVuMggYU/wAI+tPWF5bkLauGXgFh3qraSTrKyvGWhbgMT09RV29RbKJZLcOr9QB0xSsmFmnoTRhrCYyGVjCgJbd2NZt9q0EdwTkENz8tN1PWGW0WOQDzHG35z/OsK2KGIOqoBvwyNTV0tDSEb6yN8sbqCNzPMGUkqO2PWrdrJAttsACyA8t/eIqlby+Xboz7FUnAJ6/hUwtXumYgbUI4A4zRFj0WhcjuLdyHOUYtsKgd6tSiaKKRwAV6kVituVdrAKy9CKtiX7QqLKwAB6561TkS0LiZrd5GIBHJ7cUsWrQqNijLAYA7H3qdZovsc1tMD5Y4HGTzWAulxW1x58Z3Bjtwepz/ACpNvdDST+Iszu1wks5OAD+JpLSOOO5jkBwrZJUHj61OltII3UoVOdoA5zVX7O0d5HGxwh5I+nvVX0KurWNPUdk6ptEZZTnee3tWHerE10EcbVx0WtS4splPmoRhjnbjinnS5m2T+U2wcMR3pNqxMZRS3KsEMbbVVd6j+IdT9KzNduPtatbpwqjHXrz0PvXUWloijci4XOenT6VmXmhMt4Z4XUxyNuKk4IPtSYozipamKPOsoYzh/l5JQ8Ae9XrOR7uEuwcrnlh0z61oXVmbWEmdPlX723mjQYCskhhjzCQWxjrVLsynNctyRxJFbxMreYqnkntVuGcTkRbEJx19BTbwCCLGTGgO5kPOfpUa3EQLS4C4GdpP3qdjC3Mrkt0kULQsPnC8Ffaoo7tVuXVsZx0HJqcrG0IZQMSfKCx5B9Kk1PTLZURrfAaNcb88+/1pxjfYmy6kMEYkcEhQvXnjNTHeRIsTNsHZaoCYQRL5zH0BIqzKStsESRskclau2hMo2ZXhurcYiycjP4mt6JrnayzachkfB3eYBvx0yM1y9rZsESSRt7Bs5PpW/f29vfTfalvo0hGMqxIZPYUlcicUnYoa9HfTeY80W3f8oIwQOOh9KKs3/lyW9/JubNxtSP1bbj5z6UVMo9jWldrQ+N5WwOtRRLvYFhQmZGyRxVlVA6dK9w8MAMdKXvR79qBTQXDGRn0pc+1N6U6mAhNGaTvSngnFIZXuEDis87oZdyjpWqxGKo3af3alq5cWbWkSt5SzRncAfmQ9veuraVJ7VJYzncOcdTXnGlX72V0Mf6tjhhXawK+8PagNG3zbM8VyzidVOWhejkmspEkiUxknh8ZB+tdFbzQ6hYsCfLu0+Zc9j7Vj2d7DKpgmGxuhU9qidGhuhbyHDj5opQeoPasrHQmbzTC5hMV1bgzqoZT/AHgPSrMcznTWFv8APC6kqgPKn0rn5nnwttcS7Y2PySg8oafY3lzpV+Y7hl8iU4EgPGf6UraaFrzJLq4W0EV1bkkMQJEx0PritmyKXNn5UJwXIcDd1HtUerWkab32ByVEgdP1rKW5SwMU8R2ozAoR0HqKzav7xSdtDqZyFuY4QD8w3MPUCt+znDCMBvlToGFcbeSuyRzwMxkRsjd0HqK1tJ1GO+tB5Y2Tq2GHes5LsWjUvrgC481UwuecdK0dHzC4VxiCYbgxqneyRsQoU+VjGcdD701WkhWJJC3lYGCD0qLF3ujduGEF0AjeYoHHHFNtIBcTNLIB842lmHSmmTBh8xAwK8bTnmhnlilZmO1OoGOKSdhKWhFZyz2mqbJflyNuT7d81f1PZOzGHd5xO1gp4x61SuJlbZO2wxOdrZ7HsRV/7PHPBGQxjk/hOc5qAvszN0RUjeVY5ysqsQV7Vr3ulpcmG4gcCVOd2etc5JLLHezy3Uax3C/LuHRwPWtzS9SilCCUFVccegPpStcuTe5q6bsMcqtGGJPKsOtcvqtjDFqrTQIEUt3/AITXTXv+iTb0JboH9Oe9Z+qRxy27RNkOwyrY6mqVtmEZa3RJZXiXEMcMp5U8Z9KfqFu6MHiO9cbhWBGs8UnlsjAgdT3960LO+2Eq8gJ6fN2ocVa6Haz0KBmFzcosqEGPouMfrWjDFNFFLJabgwf7rHk09p7Vn8plHPRs8qaa9zI7JbBvKIbduxnNFind7Ft7RLq2iEh2PjLH0NUpbi9064EcrLLH655A9RWgqySKdgd84yF4xUd1ETOmcNtGCCME0uYhLuWdMuLS8RkkkBDccdqteQYplXO5G4BPp6mubvrb7LIJ7JfLRxuIq7Y37+WGuASSBjtinYhwa1Wxp32nW8oBaJTkYwetYF5oyQAMmWDcY7D/AOvW2dZtjNGk7btwIOO1Oazjnt18qdipJIz296OW2oKTitTh7qy1G5gAGfKjfJJ4Kj2rpNC1UxW/kXbF9vCvjtmtae3KWojI3kqcc9fWuet7eRXZhhgvUEdqSVjTmU42aOpRYb+NoogeRnOM8VS+zNaRSJIpcFuMDNZ1tfzWTuAp2fqoro7S/tp0R5WHmEDpTaMm3H0Eit4GijmjcAk/MD1/Kqd5YKkQKElWbAHrV3UY1QER7ljbJ+U8H3/CqjPKoRNofrtbOc0ImN2iOO5QW5jZQz7gAO5qC5ieVB5eFKNgnPC1K0UUx8wRtHKOCM8UkeY1yoyjHkUy722Ktm8s8rxzSMoXjGOp7Vs+ZJEqxtI+0DG3t9ayNl0bhpVQFCflHeti2aOWILkh89H6VIple4QpcwyRzkRLy8f97NPaNImdWy0b/NtJ/lS6kVMWYkO9eoxwfSoo71ZLACWRPOTOemSKYtySW4i8qWNg3lFPlJ55FV7dzbyBlbKSDOe1WmjilgRIS22RQMEVSe1Nqrid12ngH3qkm2CtaxJc3iXEEqypgJyCewrDEsV6A1sxUR9iM4PcH2q5f2++2DI/ydCAeap6XDtkkjjw4cc7uMU5FRSSNawjHlF2O0g5244FW2u/NJUL8qjHJ/WlRYkto1GAAOh55qpcCMyYQYfqTVRT6EfExrlZmzKn3QBk9MVOsKYGHIjxVeORS208p05q3thePCjDL05wKfqTJtEbwYLBCpjAHBHatlrkIbqCOGIeSFaNSoIZfX3rDctHhQcx524Izg097GODUAxnvhND8odCAPoM9qEyGr7k+uyHzihjwGVTkHpx0orJ1KZ3kcW7SPkf8tOW3dyaKaN6cGonycigCnnpxTR1pxOO1eyeAJQOtFGfzoAXv0zQaM0vagBtN5ApxNNPrQMb9arzgEGpn5qIgnINA0ZUqHPFdH4b1Z4GSCZvl/hY9qzGg3MBimSxFOmRjpWcoXRrGdmd1d/LcxzbhiTgOvUGrFwxlUx3J2zIMo46NXH2OoObQwOxJ6gnqK62yuIdStEVjmRcdOoNcs1ynZB8xLZMbu2dpZCSvVT6UwXSNazQNhk7FuT+NSPp7QLJLaykMvJB71nTwGeNbmNShH3wDwazRepvaXr62ll9kuFZkI2g9Sv/ANapdISDUYLm1bqCSB/IiueiH7tlLgsoypI6irthqsSqjMpjuY2++Ojiny9UClbRnVwtusZYy22WJcOjD071keH2nt9ajecHyZDuBHQirlzdR3Nkt1bKTKfkkH97NUbK9lkhjRtv2i0kG0f3l9KiUbmsZHpWreStiZYMsGwaoLIy6dHJC+905IJz8tZOo6hIbCOS2JCucNGT9096vyG2FrG0J5cAMo4rFo0jsrmvYSG7jPIVl+bOe1asJWSFI3JKZyo6iuRsmWx2yZYxE7TntW3LL+5D2rrnrgVEheSLV7A8sWYIsqp+aNe9P025jb5CzqRwAwpkd3JHewsT5ayj5T2yKn1CzEqNPE6rLEdxIqdBt9BNYFrPG8EqEPkEMB0NYVxYXFkTLBL5kJxye1byvb3liZXkImXqD61lXMpiTE2Qh6HtQtDSD0saGjazOPOW8VZoiuzK9hjrW9a3ljeQKEk8sx9uvNcTcF7VI57I/OF/eJ6itK3MU1gl9CGE2Msq/wAjQ0hNW1NTWNMuI28+2k80MeM9/pXP3txJAqyPbSJcjhm25Qj39DXU6PqsR2IwyDxg84rQuIUnfE+zyjwoI71NrCU7aM4W2uGnulmMWF6exroLeWBpVkYF5SOnp+PeodT0trYG4s3DL/cboazE1S1e7WOYNDdLwyVXNZGkry1R2unzxOw2L5Z7g85qe9tY5kzkbjncR1rk7R5VkYqZI+enqKp3/iGS2kKuSGJAJ9aVjLkbehv/AGQIRGHLLu+Un09KWe1aCBjkYc5J64qpa6pDcQKC4GTgdjVqS48iNhEolQ/eXrxSaHd31Kn9kNKhlthksMeW/G0+oqGG6vtOjZJItyD7wPatyG4juECxfLkc5ODUjWsjWWN+/rgYyce9F2Nz6MpWevxzOqXMZTdwDjGB61bmlspb6OK1mVX2/MWXrXN6jp8xmijztRWyAvGRVi10hJpVm890ZeFyeRRcHCK1TOgZVQBZkVsnkisaY2ltdOQT13KK0baF0H75/mQYBzxiqV7bkPI+zeoHDY/l6VSJiSWV/dzTH7OA0ZUgqT1X2p7X01uoXylj2n7pOQDWPaubSbEOR6Z9DWvaW8d1A/73dMckZNUkhysiU7pyuGYsx3EA/ePpSrG6tlmMYUYKnpWWRcQyMhJwhG05/SrwmmdT50yAdO2T9akTZpxSxOI8/d9Bxn8aS9TczSRMOBnrz9Kz40azQqjebGwz16UWrsW3K5VRwwPegXL1RfW485FWWMAjJ+v400WVvI3IXHZh61CYZ7iNlgUhV+6VP6CpNNcRIVkwMjDA9RQhPbQJIXt7lRbuGi9AelWr4G7tljfywMYDe9Zcl2sDv5x+Q9DjqM1C024Zt3zFnOepFVoKz3LNnC0MpWRg4zkqDUwghE5b7mckZFZ/2kNKNvySLwc960rW4DrGZSN3UZFNaik2RzYSLeQScYAxWSJCs21xgnjNb17Mt0qjKAYxtFYsm0jacgL0J6CtY2LptW1JLdcgKq/Mc5Y9PrVi0diXjlTKqN271NVI4pIl3LIrqR2NT21wsW4SDP8AsiiSuRPUt74iyqrFcnnjoK09VS7hYG0tIp4VUbC0ZLYrEsorea6eR7gxopBC7S2f8Kv3Wo2ojKvqUiBflP7tualaGUl7yMie6ka+P2iERHugTZjj0opshgN0dspuISv+tcHJ9qKnnl0NbnyiRyMUp96TPvSE17Z4Q7tS44po9acCKAF20UuaSgBp6UxmFOc1EevSgYh5pyqANxpypxkio5GLvtWgolt13MWpLpAw96sRLsj5qCdu4oFcx5naOTKnBBra8P35S6Xkg98d6ypIt7E4qSzc2s4ftWU43Nqc+V3PS4T9uhfGQ2OWz1qpBG1qwR0LxtwcVhWestGSEbCntWxb6j5sI5GRzXJKLR3RmpIWWIRysjD7pxt74NUpoTDI0ewtExyMjkVJNcLLfRMzMW/iOaku7h5Z2MbZwOfeh3QOzJNKvfsLyB9xiP30zyp9a0Zpormya4hAedOTjqwrI0+7jluJWdQu5cYPeorZRbsHjlKpKSCB2osCdtjba/B01iZGPIbb39629PujdqsiSAqqBlGcfnXJGGOyKiZztk+4+7ofQ1a0e9MUhjtXHnR/MBjOR3FZ+z3NFU7npcN/DNCHeJTE64fHaqduzW4lMIJhHzqQayNNuorqLcqupbh17A1bLpCCgZ1DjHJ6Gs+XuWmjrJ1j1DTIp1J8yLDqAe/pV7SdRa7ljXywI2T5hmuM0nUJYXeKN9jEfMjDI/Ck1H7Xpcvns8iWzncrIM7CexFRKN9ENa6NnaarZhD9otomKj74xwR6VX221/sikwE/hHTBpdF8SRzwxm5wfl2sM9femRmE3r+Q2+NhnYvUGoBNorahaPpbLHgzxSHAOfu0WEyWxk8rIx95G7+4q9cMUKrOQFPK7un4VSvEFyPugDHUGm12LjLmVma11CscC32nyIx43x+lOs9WM04NwQrdNvr9K57TbmS0uWt5x+7zn61PqCxAmW2RmVeTzyKlD5dTtbW9t5YXEwQqe5/hrnfFmjxNbpcWqiRg2QVPzLWLHPIFYKx2vxgnrTpLyfYqs0o2dNvSk1dBBOEr3H2bX7GP7RlNg7d6i1GDzJBlvnByGx1NaOn3ontgHcmV24Iq9Lpe5PPiK7umPQ1cEktTT2iiypo9spifzlDMBkFeOasTgW86mPcFK5YY5NRWl4sMzRzbQU4YYqYhzdpPFKrDoQeRim12CWruTATW6JcbgVcdOn51o2eqxFPvYOcsp4OasRyRMn+kxq6Dgqe9Zep2EhQzWBEkTdYjjipZhZSdmXWu4/tXnsqPvPXtiqkGosNXWFY4grdfb0qsthNFGrKjq55IPas+ewkS6S4DMZRzt96h3LjZ7nXfZvNLiXBJ/i7VE1uIIpAjMyDAUA5yazrPxEMiGQN5ucEY/Spby6ZZN8I+U8sPWmRqRiDylLsA0mc4I6e1NW3dy8yBoXPI7DPpWoZ7e6hXA+/ywxyKq212wzCVbyQTgnvVqxLk2Zthb3ThluXAfOcGm3EgiiaKZQGU4DD+dXZ4iZPODMGP8PrVS/hkZ14LNt5B60W7FJ62Yxb0hFWOUMc45FW4pikWAOejD+tQG3ihiUzx7ASASD3pI5PLPzBhk/u26g+xqdVoU7PYvWt49upGepyAO1VftC3jbo3IbcQwPU5pyKfOO5dkgHJzkGqOobrYiQFd4O4gDrQosI76GldwoISrtlh1Df0qG2VY1D4OwHgY6j3qvDfC8lJmjKY454q9HGw4Ub89NvOK05Qk3FWY37LBcTeaJGRz6/4VXcTQzlJHBkByv0qYpslkkYHOBlTVd5trsbhWbP3Wx0pWsiUWhMuz96DuxhsdagSRg7opLnryOgqtDN85D7gpzihfJR/MUsJC23ngYpoa0LciyPCrR4B6nihoyYkZW2lj365qNboRsyEEI560s0uI23sWQDIGelPmZnzNBbRXVxdSJaofMQZYkgD9amn07ULjbvtl3LzxIvJ/OscRC6uCXd1BHyMDkVvvpukWzXBkjuJHtCod1lxuJ6nFJe8XJ8pQuEuYLwRyRqpUAkbgfp0oqTWLZFvCtuGjhwrqc53AjOfxoqnC5UbSVz5WLdqTPHFMDA4Ip2Oa9k+eHp0p6imDqKetCAd0FMc4pxPFRPyaGA3OTipIk9eBTY05zT5ZNgwp60DI7iTA2r3pbWIj5mpkab2q2fkX0oHcJXwtUiS7GnyMXNORO9IQ3y/lqCWPmroNNdc0WHexmfPG2VNXrPVWhBDDn1xTZYgc55qpNCc8ColG5pGbRsW2oLcThieBWguoQxMwYDn3ri3Vlfjg099zYySfxrOVO5sqrRt3s3zNsblm+XBrShnH2RN33kI49a5FHZJFZixAOa1obyJ+N209aTgONQ6C8voWiydmGwCG5NRMqWzxT2sjeYp69gKxZ7iDy8FtzVEtxJcsIo2O0Y3GpUbFe0O3bULyKWO4Vk+fhlVshqvW2svMrQt90nlm7GszTrtIrREkhVyBjdgVVjEVzO6O+Dn5SprJrU2jLsdra3xgZJgy5QYcHncPathtW/tC3FtCu9XGC79vavP4Yp1P2dJwxxwCM5qzp800aFPMKSg8ZGanlLUtdTr9Mmh0y5eG7gDwuR5cxOQn4itZtNmt2+16VcBtw3mJj1PtXIQXD7NsiSZPDADcpFX7bV5bVDDaM08OMYI+aMVnKNyud9DpI9bXU8QyfLP02Ecg1ahYQEebwBx7ZrkU1KznXMhbzEOVlC7Sp9ac13eTboTdwyrjcOcMw/lmpUOppzHWShJ5PNzgrwR61E8zR5kAO3GCCK5iHXFjCee7LIvDBu9aEmrWl5arGJCWbsexrNwsXGSZcGqRMJQG785/hNP+1BQBIpwRkEd6wzphmVmSQopGAfWr1jHJEpVg0ka8Emj1NW49DQEpaVWg3YUjp/Wtq21KSCYAg4cfMD0NZ9msCputygkYcYPerGXuYgJgcjo4GcVSS6mTdy9fWiXo8wDacduTWUqz6ZPuZt0OevpVq2mkUYbJxxj1qOe785trqDt6HFXZFRk3oy3FqBfBAbHbFSLqnlgbXJcE8Y7VRil8sbM/Ke3SnvsfJ2FQB17ik6ZNkmddY6vFdKu/jIGfeqmqyCIfaYmRsEAKBXNonmxloyyOnIA/i96ZILmZomJG9Sc9gRWEtNhRgkzWnhj1BGuWQIxAw44wfaoRFcQqqSOd6jn3FRadFOAQ4JmPBXd8q1ZuJibgW9wGAxzIOlC1G/IYYZ45S0cny571Lb3DoxVnypHb+E0SxukK7JRLGRj3+tMglZHCzDMbcbtvNaNGadzYiBliycbyvfkGqc00ynftBfoBVVpDAqPDLwDnB9KZcXUkjMVTIfGPUUr2Elcgv5xKyLJkqpyUOasxTfMGDADsjdKyr3cSJZd3BwOcVUhneOdmdjtK9Ac0ctzS2mh08JBV2WTb1+Ut1PtWRqdyVdlMh3A8Acih5IjGGm4XgZBrNmuFecxBCQeN3p9KuKtuVS3ubVrLGVAJDDuT2q7H50TF4XYjHIBGDWSkaRwD+IYyQTVP7fdsTDHuWMnjjOBSm1cGuY2LnUJBIihSeckYq3eXsbQrsBXcAW46Viq62sRZDvY/ep0dyVh3sGIIwc8gCou2Q0uhbS5QTP8AuyQBhWJ6U6aZVU70GWrMLGUK8TDyvXPU0O80ku18hfUjjHpQmwJEmLnIUsVJGV4q0t8G/dupAxzmq+liRI3VU4OTzQHWPJMXXkk96bukJ2ZOpMv7qJyueRgcVo3MuoWmpxx3s1i4kiCTh1O3HYyY7/SqEMUqky7mIGD8q8L6CtXUY7W8nM9xb6lG8nMiRw7gx9Qe2aIxdiHLUo6vLN9sf7UUjmAAIT7u3HG31GKKz9cukuL4PJbSwBUVUTuqgYGR9KKUnqawTsfMYbHFTJIeM1WHT1NPBr3T58uLg4NSLVOOTBqyrbulADqaF55p9KBQIRsKvFQ43t0qUjPWnABRQMWMBBnjmopW3cCh23AAUiJQAkan0qSnjgUmKAEIpD60rdqbntQMQnrxUbjvTm4FNUbjSBFWeEMCaijQE4rTaP5TwKo7dsp70FXZVuEIbgU2JC2M8GtFId5JNSRwDdx0pWHzGW0JB7mp7IvA+5R1q88Q3jjgU7yfalyj5h0OpmIYlUsOwpbfVIi3I6H6Gqk8PFZ80eM+tQ4IuM2dla6wBgbS3dcHBH41dbU0mVfNjmVl6OF5/OvP7d3VhtYite21G6h4D7l9GFZ+y7Giq9zq7fXXhyAd3qRwT+FWINYIuUmU4J6r3H4VyP8AaKMf3sAHoQau2N7DvG5yB6t2qXTLVRHd/wBoRXqoypELlDuIxjPsRSboZdtxDEsZDYaMGuZ8oMyzxnJPdaJZTFIGG5uMnaxwfwqHHQ1Uzs4xZ3QGcqhHzVQ1HTPJmD2k6BByeP0qlZRQ3qCTcqsO3mEEUpRUuWjMjofU9cVDiWp6mpZ6lcRhRMrYXo68j8q24dZtZZIx9oVQx+bHFcytvHIjMLmTevTBxmq7288THDq+45DHqppOCK52dzvgB3WT4lGSDnvWlZ65bNGIbqRY2PDDpz615y0ssMR82JZH/vK+DVM3WZAXaVcf3gTUun0GptntMaRmDZC4KkZDD/GsqdfKlcD+EdWrz6w126gTEV4MjopPb6VO/iaSSSITSDHcilyNDjJo7uBlOHdcuRwvpVtQz/JIPkPp6VyNv4hsZYsNK6vnrjINX28RWsUarJKCCMBhzT16jc+xvGSO0hIQHpwc96otPe+U+wIf4gCeaxrzUrecCWOcx4YEjP3hUw1OHCSLICSMcc/pWLiy1sa9jq83LXHAHXvj8a2Xvba9g2xsrE/xdxXMWkqTRAofk6kUkT+SzFIFK55yelHLoQ97nRwQyRviHmEHoehpTcGKZVmGMn6g1kRamMbyxMQHryKjj1m2nIbDOpOM9TTasTdy3NSOYfaHMigLngGkvZWyHjARc9RWTe3SG3YQghieGI6VWs55vJEV0Q3H3hxxSs3sWn1ZuxzGeNhJtZB2rIaJjM6IQFzgHFONzHAVCvgnsRRDdJs3e5z7Veq0GpdUN2SR/LNHuj74Oal8y2EWAcEHgMabeXojAFqNyHqT2+lZtyDHLHKNzKSQec4P0paIabZtQOrMV+fdj5fSln8xcGJf3gPUVkWhZ424cDPfgiryzFYWXcxK85oaE5K4SvMXDyIhXuCe9LLJkFUk2A/w9hVOS7cqPMbhjgBhio7fyovMeTLOTwC3HPpUpDvpc0rdisRRQGPUKO1TW8zRy7ZiSxPpxVBbiCORpl3bwMYBzUcdxJO4lKsCp4x3+tPbYjc2bm5RQxUPn0WoleJ4csTuwcKao/amQMJG2qvcd6pG6dn+VgEJz70MIm/a3s9taNGA2HxuHZueBXSzzJayeXca7eiQ43ARkhM44PNcLHdsqcv8x5G2uvtRLeql5eaNIZ5ACQLhYxL/ALW088+1VBkTjbUi1fTcfaLiG7e6mhC+cJlwSp+6wPcUVU1XW2S2vvPtPJuJWVHBbGxFxhAP60U24oIXtqfJ0FwGAB4NWlYHPrWOCQeM1YhuSpweleseMaQODUsb49qqRyq44P4VMtAF1ZAeKkVhj296pqe9ODHHFMRa3Y9KYTk4qHcaBkHrQMmVRmpCoyKrgmnhzQBL0pMGo959TSiTHWgBWz1FMakaX0pm4tSGO2kkCplTH1qNc08NkgUAOYnBqlID5oq/7E8VVumUMMHmhjuWIV/dE4pIxh+lJbybo8CpenNMCvKf3tWkUFc1RlPzZq3C/wAopIBs0QrOuYgegrUlqnJyMUME9TMRMSjitFY8qDjmqUnDZ9K07Rg0YpWKkQmLgjFRNH7VqCMEc1FLD6CnyiTKKTXEQxHK6j0Bp8WoXSHIbP1p7RU0Q89KnlKU2XYNYlY4miDe4OKsxaxEsieesmPUOeKzliIBPaq0yktxUOmio1ZI6WPxIqSAqUkX0YVq2viezkXa8RQ57HiuBKDjrSbM9M1Ps0UqrR6KdXtcMWjZh0UqR+tO/ty18tEMTqo4ycV50PMJHLZp6yzrwWyPQ1PsS/bs9FkvNOdC0sSup5UqPmFZcwt5HEkMTIo9ARXKJeOCMjpV6HVZFjwrn6ZpezZca52+mXVq4RLycKxHy5XANav9nwk7jOrxtwCMYFedJqMhHzBX+valj1OWJswyPH6qP51LptlKsdzqNnFZ7QjsWJ4OODVUMnlk+ayjP3sVgDWLqaMeZKs6+jDBqxZ3G6PeIZh6hTkflWcqTNo11Y6zRnkjlKrLlccMe5rZ3s0LMZsMQcDPFcZbauYgqshKjp8uKmn1udxiOPauCCCtRytaFe0jJnWWXnQxFndi7dyOKfa3lszPGxQTL02jHP0rkU1e6+zCOEjIHO8k5qkl/eC4abKqy9wMZqeRhzJ3udjqDSvdLHbybnP3lK9KswzOmVZPMYe+BXNDWGcr5jyCTqSijNXv7X86L7jFiMDjoKOVhzdGaVy7StuS2O5evzVWQ3UVwpe2LQtyVByMfWs22lvPNYq7BR138CrDXssIPzsQRwueKLNlOdtDRkuY96obaVIQNwIHerFrdRbgz856Bh92sKDU7uUFZYgB6oMmmz3SEbP3qNu+Y4HIpcor6WR0klykeShHsR/Ksx57iS4ALokf3sA81UhnjdQBFcbM/fx2qVp4HLIIps44wBkirauKOhaS4iO0bxNJzgDmiWbMajy1LdPmGMGsa1aSAlrZJPmOGBX7v41bin+bzZWMm3Cn2pJDb7Cx31wkjhUjDDqorURi0IZnGSP73Gazpb7T13Bz86+neqTXfzEi3nMZ6BemKaiJyubv2dJotkJLSL97J4qvLGbeJQ6jjquazEvnjDPEJIUP3nNIb+KSZfNeSQD+M/4UuULs05bhmRZQh2LzgHBPPSuivS2uXb3tnqlmbN8H9/KI3g4GVK9eMcYrkprW61O3cW0cxjX5mEEZY4/Cn2uhXFraHy7TUScZAa3Yk/pRawXXc3PFWqQXuoS/Z3FxCiJHv7yFVALfjRWf4oQ2/iQiS3MMRtYPurjB8sZz+NFTyc2oKSikfOW2mmpT0qPvXsSR4qYqMVIwTVyC6/vVSpO9TYZuRyBhwc1J9Kw0ldDwauQ3uQNwphY0RyadmoIpVfkMKkDdcHNAiTIxSZ9DTc5FApDH7qRjxSUUgE5JpyjApo604c0AOz2qVFxUaCns+KYwml2g+tZkzF34FTzMWOPWoGXbzmhscS/ZkBcVZkOEqnbNxUz57U76Ce5BIfmqaE461CwJNSRjikMsOcjiqsx4qc1BN0oAz5jycVb06TjGaqyoSc9Kda/I/JoK6G6hGKHOaZE2VFPYd6ogiwD2p0cYxSY561PCvc0rAMmAWPFU/K3Gp7h9zY7UiHFIZEYeOlAgHpVjOeakAyaLCuVxB7VG8WOgrQ2gLULrkdKLBcznjJJHWkEPqKuNHzmgIBRYdyuIyAKPn6Z4qwy00oM8VNgTK5eQHOcGkF7Ih25OO5BxVkxYUnHNUZlwxBHWpaLjI0ItYZY8ebKB7nNW4NcbHNypGMcjmuduE2pnqcVmMck1LimVztbHotlqsX3i6Fv9pc1oR36SOAwgw3cA/wAq8rSR0YFHYEehq/b6rPEecOPfrU+zLVXuejpCBNugugWJzlR09ua07J5ZRsa4lIHGUUV5pDq8bkbt6P6g1rWl1HI2VuZFJ6lXxUOnZ3NFWvodrItxBuMlwxiPGDjNTGGz+zqfPdZByCW6fhXMJcLHFl3eQZxkncatW9wvl74ovMB7smajlK5y4ty63JV7n92OijnNTm+tmcBpFEo6buazVuQ7bFRQ/wDu7aTz7mKQkxxqD1bg/rU8hfOaw1F4ipUscfdBHFCXtzLcK8cRx32/LWa97dGNd0ilO3FJG1w/WaQKB2wBRyj5zUe5nwTGzpzytQCdWLqJJI9x+YE8GqD3UqsFbaw7FmpwuQYivlQhs5J3UNIFI14RHEiiFFDH+M097mVFU5AB/ujislHkk6NGuO2c1aivZIMokiucYCsOlA7im6QylG5JPQnrUN9I6xJNEPuHoDg0l3IJgWkO0+gUD8qi3RBFMm9xnjDc0N30L5ka2m+IL6KBpbS4ms8j5yr7S2PXFaMHiXWXQOuoXJBGcvMR+FR+HrfT3sdRvr62luY7GNWEBbarszYBYj+EVYuLGz1vT5rvQrc2d5bjfcWYYsrJ/wA9I88kDuKViLoy7m/e6umk1CaSWRhgtuLNx0oq34uEGn6+IrUBUNtCwRV+XJjBJ/E0UuUpSVjwc1HUjDgUzvXqyPHQLxSgc0UoFCQDT1NJjHQ4p+KVUHpT5QuNV2U55q1FeFfvc1WbHSmEVLVhp3NaK4RlBzip1cHpWErEd+KnS5kXoakLGwOKWs+K9yPmqyk6MAQetAFgUucVGHB6GnbuOtAD92BUMjE0rNx1qMHJpAOA4qGbsPSp+MYqBxlqY0WbXpUzHrzUMPSpGNMTYgPtT0OaiHWpV6VIXJCRUT4xTs1FIflPrQNFa4bHQd6jiBY5pHyz5qzEoCjA5pl7IvWx4FWCf1qlbk5xVrmmiAGCallcRx4qNBg81Xu5SXxQIQHJzTgcVGhp4pDJVbrUobFVwelOB5piuWA/GKD7VEDinbs0BcDTTjGadUb0Bca7UitkimMck0iH0NILl1FynvWZdj95xV/ftjPNZ87AvuJpMaKt6dseAc5rKPWrl7NuOB0qnU2KCiiigApwYjoSKbRigCZLiaP7kjfTNa1hqd0qhRKwHpmsRRkitWyi4BPei1w5mjbTU7kjBkyKl/tCVtu5hgd9tUAuBTgOOtLkQlVaNL+1Jw3zEEeoFMN+xPDdfU4ql0ppWl7MpVma6TqygsefSnR3KOSPNVG7A96xwWByDzTxK3GQvHtUumWqyNcKwYOpTb/EasfaNsLJujcdckc1hx3BHYZ9aet2d/zrkVHs2WqsXsa7ys6q6jBHTnj8altZy+4yRh3HTDAViNOBjA/WhZju5JAz2pODNFNHb+HLzVY53l0SzuJZFXZLGkXmqynsy9COKmtdI8S2moR3lvpeq288ZLqyxHg/THT2rlvD2tX2karBcafJI8hba0XJEy90IHXI/Kta4fxHHJNMllrcFsWLIrmR9inoN3fFS4D5zR8QXN/farLJqsJgvWVFeN0EeAF4O3tkUVysupzzvulldpT1dzuJ+uaKXKxqR58WIAz6U3gmnMCQDTeleizzkKBSjpjv3pBTsVSQMTvTgDQB608DmmkQMYcYxUZqZ6hPtUyKiIKUCkp1SkVcbj0pQSKUUAcc0coXHLM471Mt4446iq5HtTSKTiFy6LzPUc1IlwpFZ1HPrSsBrI4YcEUHrWWrle9TpcEYzjigaNRDjFOaqUFyrcE81bVlOOaBDlHrTxTd1OBoAU8VC/OakamMO9AIgC8+9WBwopqrg+1PbGKCiSLgirSnIqrDk9qtR7QOaZLY53CKc9az3O585pbmbc2N3FQh1UcsKTBEwPNODVX81f7woMyA43UXBlvNKGGeelUzdKP4qQ3aetFwL26nK/vWa14g71E1+oJxRcNTXMgpjSD1rGe/J6VEbxyetFwNd3GetKrgd6xTcue9Na4c96Ljsat7ehVwtZclyz5BJ5qFmLHk5pKT1BIUnNIBS4o6UhiYop1IRRYBDRS4o70WAmtk3SAVuW0fyjsKz7CLJz3rahT5elNGcmJtx0pSvFTBTRtzTsRchIFJg1KV9qTbzzRYL9iMikPHNSFeenSjHpSsO5GB7UhHepcYFIRmiwXIsYzRg8HNPIyaMUWQJs6jwHM6DV4bG7hs9angVbKeZggHzfOqseFYjoavxaP4/jnEq3VzC4OfOk1BQg9yS2MVi+GrHT5bTVdS1iGW5s7CNG+zRPsMru21QW7KO9T3+k6fq+jz6l4aSeF7Vd15pksplaNP+ekZ6snqDyKhrU0U2V/HNza3Xii5ks5YpRsjWaaAYjlmCgSOvsWzRTfGunWumeIPs9hF5Vv9lt5AoORuaMFj+JNFCSsP2skeen7o+lMGBT+qD6U2t2SOAzTgMHrSDmlHfjmqiSxRyTTwOKRQM09cCqIZGRkc1Ew5qZjUTfrUyLiMpw/SjFKBzUooKMc/0pTR356VQrjcelGKeaafahjTExR+tHNLSATAzyaQgU/FIaLAMII5zUiTOvekpCM1NgTLEd24PPNTC9Oe1UMUYpDNEX3rinpdox5rLI5pBkc0gN5HUqCKU81kQ3LJjNXFvFxyKYGjFx3qvqF2I1wuM1VkvgFIUms6WQytkmkA553Zsk0nmtnqaYBSkUWAXzX9aQux7migUABZvU0m4460oooAbRz60+jFADVFJ3p38qKLAJS4zRilosMbRj3pTR2oASilozxQAlFL1pBSAKfEm96Z3FaGnRZOTQDZp2MIAHFaapgUllDhQcVbC1okYNkIUCmlOOKshaTZRyklTbRsGaslMGk2UuULlcoD+NN2egqyycgikCZoaHcrFO9IR6GrPl8c00p6ClYLlbbRtzU5TPSkKkCgLlrQ9XudFuZJrQQusqeVNBMm+OVOu1lPWq+m6jc6dqUd9p83k3SElSmMAHqpHcH0NbHhbS47uWa5uYPtMcLRwxW2/aJ55GwiseyjBJ9hWtbXUt5qd9p0iaHeQW6uUt47QRLcBRllikADKwAOCTzioZaOY8QarNrmqvf3UcUczoiFYVwnyjAwO3Sin67YR6fqbxWztJayIk9u7/eMbruXPuM4P0opoXMefrnaKX0oXoKO9aJ7Gg7FOx3oTpTjVohjlGOafimr0p4pkMicVE1TPUL1Mi4jRTqbThSSLFpcUnenJ94UyBppKeKYehoZSEPWlpOwopDF7UYpewoFAhvag0dhR2oATvSkUvakWgYfTpSUp6/hS9qAuMop4pDU2C40570oxQO1OoGN4pKc1IKAEpaDQvWkAlFLSGgBetFC0lAC0lLRQAlLRSHpQMT1opRQOtIBKWg0lABRRS0AKi5YCt/TYcKoxWJb/wCtrptO/h+tNESehqwptTHpUgHFA6in9/wrRIwGYpcU6gdadhkZHNG3OO1SHrSjvQIhKdM0BBUrdaTsaAIivUUmypRS0guQbOelNaOrNJSsFzQ8NXsVm89vdTNbxTFJY7hV3eRNGco5HcckEehre8qCGaa8Eeh6e0ysr30F6Z9oYYYww9QxBOM9M9q49/ut9KjUAMeBUuJSkWdeuY9Q1F5reMxWyIkMEbdVjRdq598DJ9zRUDdKKOVCP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photodamage signs (elastosis, hyperpigmented macules, actinic keratoses) superimposed on intrinsic aging.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7139=[""].join("\n");
var outline_f6_62_7139=null;
var title_f6_62_7140="Mucinous BAC high power";
var content_f6_62_7140=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F63152&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F63152&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucinous bronchioloalveolar adenocarcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High magnification photomicrograph showing mucinous cells in a mucinous bronchioloalveolar adenocarcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7140=[""].join("\n");
var outline_f6_62_7140=null;
var title_f6_62_7141="Lichen planus tongue";
var content_f6_62_7141=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 281px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEZAYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDx7x/e3lh4p8QJpk4S01+e2vVf+GWOUGUDJ/h3Ng+617UdakVNQtPPgOp6SYJvMeTYZbZkxJKFxw+12XrggevXwfSrq21XRvDdjcwyfa7bVvs/mGPMctuxD7N3qrF+PSSvSHlt7T41tqUINtYalYWmowPHnAVkjDbh/dJLhgfWmrJWZ41SFmk90vv2X5IoXupW6a/4z8OalMwbURHp9q4BIjMZ/dLj02tke4Ipfhp4gm0nwHDdXE7xNavPeCONCHu4IlChS2OBvfH0H+zVnxTpmh6v8RNB1nQLjy9V1ENdHT1jLQNNCpZGV8gbXKBdvUE+hrf8MPp1v/wjwtZ/9F1NWtrVwm/Y7gzbWHQfPJtxjFGqdmRPlUbb3s/wa/T8CloPh83Hh7T7s6read4ciiv5YLnTZFVnSUqRGqMGZmIDArwAVNcf4u17TE1S00LRreeXylLA3N0xYzsmMyuuGZzhQQCFB4A4NbVnerFoXlpcW+mQ3N7L9idB5hsJGGFj2jjAZXUn0b2rxvxDZXema1dQagk9tqEbb5VmPz7zzwRwc53Ajgggihu2htQpKo3zP+v6/rvc1rxBqupWFpHf3sssMS5WCR8jcSw3bfZRj/8AXR4evbAeXFrE1wio+YJoSQ0B9z/cJ6gAkdR3Bnmt49TsVi07T3lvNPsmmvJoSMSRYRg5UnO5GbaSOqgHAwSc3S1h04RajqFss4OWtreQfJKwPVvVAe3fp60KXNqdijHkcUren9f0jvUiu/B2lLfalf2VtrV3C8WnAKW8qBmJM4dQTyCQvfnNcbHYaVMWkvvE6+YeTstZpGJ+rBakn8TyasRF4iLXkMm7MmAJLdiThoz2A4+T7pAxwcEYepWT2F00Lski4DJJGcrIp6Mp9D+Y6HBBFJ9kKlBpvmdpPtb8Dau9O8PpM62fiWeWMBSry6e0e4nqMBmxj9axLtFilYQ3S3CZ4ZQy5/AgVVooN4wlHeTf3foh29v7x/Oje394/nTaKDQdvb+8fzo3t/eP502igB29v7x/Oje394/nTaKAHb2/vH86N7f3j+dNooAdvb+8fzo3t/eP502igB29v7x/Oje394/nQiM5wilj6AZqdrG7UgNazgkZwYzQBBvb+8fzo3t/eP51qL4d1lrdJxpl35LnCuYiAT7Vdt/BfiCZSw0ydPQSAIW9gD1p2uK6Oe3t/eP50b2/vH866u3+HniaZnU6a8TIMsJWC4HrnpSJ8PvErJGTprq0pxGjMAz/AEH9Dye1NRb6C54rqcrvb+8fzo3t/eP511Vp4B12fO63EGR8glOC5zyAPb3xVuD4aeIpIppXt0jjhTe7M4wBnGc0/Zy7Bzx7nFb2/vH86N7f3j+dd0vwx1vcquYcsMrsbOQRwx9qhufhzrMUAeLyppFOJUUgeWc4OTS5X2F7SPc4ve394/nRvb+8fzrqF8B68Xf/AET9yg3NOGyij1PcD6isdtE1ETtD9lk3AFs9FYDqQeh/ClZj5l3M/e394/nRvb+8fzp80MkTMsi4K4zg561FS2KHb2/vH86N7f3j+dNooAfvbGNzfnSrK6hgGI3DB57VHSgE9AaANA3ckFhHHbzSIZkZZgD1XcMD6fKDiqYZsqBJ1xzk8VN+6t42DKkszDA5+VP8T+n1qEODu80Fy2PmzyKexnFWvYmaUgNHJKWAJOE53NzyTWrZxrNeStMjrpds4LxKSPMcDATPq2Dk9huPalhsLW4jCx3dxDbFfNLNbbwpX5SWKngDj/voetbVkV0lLa4aSW2Foi3MeSAtyWIIfa2Tk4HG0ZUdRTd9luctWqktN/6/E3NR1lfDngQ2Zt5E1fW5vtUyyxmNY4gflbHXacnav93B78u1aa81vU9M0y7umS8lhf7fdFSghjAyQF4xuULuOMkEDuRXPveX/iWS4u2lFxcR27Xl5LLIWLSsxCcHC5+aNQAMD61d1q1dJtJvLdrlJCgsNRCHzXNzAyqxBzg/I8bAdMr7VC00OVxs7PSWv/A/D9DQ8X3N1d6fp2n6fAw0qwf7JCpOz7Tdk5xj/Z3AkdAeK7DQ9ZtbDwtr3iG3lF54g021GnXN6iZ+2SthYzGe4TPznHzbUP15G8he7vrTS/DKy6nfTq3nSW53R2ULE71Rum5gSXk/AdTmpd6zp/hLWdDt/DYk1K1sJJZHnkUpHdlztkIx1G1dgPQAZwTzTerCnT5oqK/rvf1/4PRE5s54bi40CSZiguftMzxj7xKLhWP95MkkepFdgnhbRNTghku452eNBECj4G0dP51Rh0a3g8W6uNMvmurbUGF5DcZyTHKA4VvQjOD34rqra1McQRQAF4wOlYy11Z72Eg401d76nhepfafD+sWcV7LcywpcreRydI7iAY8uVB3yN3JPscEGvV9P+zR33hGW5lR1jtILO4Rmw4jlHkbyp5C/NbuM/wB1/wAeE8ZQRWH/AAj1hqrT3nhyOzBtLq1RUlBk+duWBJwWzsJHB425zWv4VGi67qljY3Wqw3QS2GmxvOWha4DK3kDafuyRuQuclcFTkEc7LVNHg1lzRUvXZf1b+vU0/DeqReHNYsrPUYrcLYX0VtcTyqH+yTklkbnoCFkRj2GCOmKp+PNG/sHw7PcabdXdrDaaq2mPAkzFUxvkilXJJyUETDB5B9qLrTnbxXqmlavaavpeqX9sLiBrq9hMMzou79/5oIK70c8EnOR0PGtGsWseHJV1+5L6qscEyzR3CzRbouVZxAuwpy6biSVHBI4os2rkL3ZJ+l/6+8s+NBpWtaFq3iLSntknKwzanDbOrtbu6lEuFQDg/Od46g5OQea8N1bUL+8g0+K+uzdQ2sBhtS3OyIO2Fz1xnOAeg9BxXrFk0ena14R8R3ixzafq/wBp0/VP3Y2tC1xJEHkAGDwcgf8ATNao3HgEXWpz2L+HNbjubdpIPN09VNsxRzufMpGAQQc7yBkDtSOmhKNL4v66f15HnfhjXJtC8SWOrBRO0Eu6SN+RNGRteNs9mUsp9jVrx5p8el+K72CzlaWwbbNZSZPNtIoeLr6IwB9wa3dXsvA2jiRJY9aub+P5TarewlQ3IO91jIGCOilvqKwhcW+vx6fbXd0tjJaqYI2aN5A8W4sqjaCxYFmHPGCOmKqzR0Kd5c8U7f1b+vMzLTUnt9oMFrOgOds0Ktn8ev61FqV59uujMLa3tlxgRQKVQfQEmukg8IR3txFHYXzBPL3SvcxeWQ2TkAAnjGOuOa6jQ/hnE/nS3s6SW+4xgs3lhGxnJ9ceneto4eb3RfPTi7rc8opwRiCQpIXqcdK9v0/4c6QstiPtEN4vk/vo9pjLMzHHJ5O3GeO1djYeB9NnigtLfT2aweUCS5EvlR3Sr3IJzwSPpiq+rNbsv2q6I+aP7PvPOEX2S480jcE8s7iPXHpViz0PUrzi0s5pmyV2oMtkdeOtfSC+H4FiYtF8wJMNxafMdrNtKu3Uj2FXNL0e3tLuaOC3+wGFFkkmmjKspz0yOgPv61f1VLdlptpux892PgPXL61Wa2gRicjy2ba27ONvIxn2zWhZ/C3xLc8fZ44z2DNyfXHr+FfTEETzITDDFLDcYkMYlAa3/wBvd6mpNOAF8lyitNbWqtEkfZ89W554PHFJ4eK6mLlU6HzZP8J9chuIIHkthLKDgZJwR2JANXLL4QarKcz3CDa3zIowSB1wTxX0gjhJ7hCpF05EyCOImOUDHDHsfpUcE8iEHUY7SZJC2CkWwwjseep9SfShUYi5qjPC4PhFbO5jaa8BX5t7bQCM8Vu6f8JvD8bql752SpO5t2OD047ntXq90tmUia31Ca6G4uxKgKCBww7ke1TTrIhhN9vdWUMXhCj5T0ZR2q/ZxXQl05vqzzC0+E+gxWs8iWRuPPYlBJIS0a9uh+tXbT4VaKs0fk6bDcBoztzliD3JHQ/jXcl47YxzxvJL5gCFAPmQ5+8fY9M1DcNdxbWju/s8LN/q4zl3PYAjoPWhQiNUp9zJ0rwXptp5zWmlxRGM5by41A5GO38qlg0+O0eSe4t7a+u3gMUfmnbtBz0AHH41pRwTSPGDc3OFHKoeGz1z69qlkFxAiyW4TzwxVZp0yN3cY707R6D9gmylBp0gsY5psnJA8rg7VI6jPPBFXF01oi07rIByVxgs5UA5IHK8fhTYUuhCou5d9y7FWxEPnBJO0D+EduO1SXJWazkS7eFA4VSy5MjdhGvt25o06G6oLYqz296bP/RbmKCZSeJf3gkLds9we3pVTxBLEoeME3VzcoAkZBCowwMjGNpHXPtWmZJLe8gVrKPymIVLZgd8nujdAc8YNOMkZuzHLpz26rlBNIwxvJOVwOv19quE7ag8Ot7fkZGi+G5oLq3gtp5GaCMqh3BjLu5bJPT0q3qelqqRx3sc80qHdHESMN/skenerlnLcgqbi2guLK5f5CjbpFPTJX8KsG4njdE0+4j1B4pDFsnfDwtjgZPOAO3p3qZOd73H7LX+vzMoaVHMr29pAv2i4YxlASQgx1Uj27VVt9JtoGaLbapdpyVdSqyKOM565rVla1aaa1hbVBbxsrglxGnm8ljuB7Y6Dj6VFczLFafa9ThlkgkYizuh8zggcA0NO1ylQvoZsmlCa0klju4XlRFbYW2u3PEZB+8uaqT6NbSO0kturTFfOjijUFEYfeQoTwD61vibddASymW+nSMwNFFtjkx13Z6fUU7ZF9suE86NDDJmWdI8SQ+3+0PXFSpakSoI821nwRa3nmXFpYxoVX5Y92zKHll469/pWFq3gC3JU26JcB1LrKkG75dvK59Vr166s3aSRVJghChzBnJxn5mA6jPB9Kq3kCRx+U8haNW3qTLtGCeWTA79wapRi+hKpu+h876n4HeaZP7HjchU/eIxOc+o/wAKx73wdqtswAhEgIGWUjAz719HSabCJ1DRwxOF+UEkFh6nHXI705NEt1i/1ceGyw79PQ/41LoRZrytI+WL3S72xRXuraWONuFdl+U/jXT+A9Y0bbLpPifS7e8tZzmG4MhhlhfG3/WD+Eg98jIGeOR7BrXhWOaPDSExj5/LPIA9eK8h8UeDH0+ZnhcLDk5dwxBPYAAE1lKi4arVGNSMZrlZV8a+HP7I1WWO1tg0CW6zMIJml8kMcAyEqNpORx05GCc1j6PYi5Zd5gy52Ro8hLOxIAARMsefoPetPQvEqReVba2txPbRJ5UVzbSeXc26/wB1GPDJ/sNkemKu29np13eyS6Le6jc3jruiBsV3h/Q/NtA9Wz+FZct9jmlOdOPLL79f6Rotau3h3VdKsL22kh0+7innnaMJE4Iw6g85VWCcfxdfTPO33k674lmczybZCAh8v95O2OML0UE9M8KMdcVteFdEtJb+/wBL1a6torq9s5ooY1nysEqjzEZ2XKgF0AIyfvdPTT03RbXQfDt9q99d2N3qQZVhlS5eJoNo5CcAtJ0HGcY5pcttEYKapttO76fO36r/ACM7ULf/AIRzT9RsbyKPycQsVs5sjzirNGsjHkkctjGOBxzW18MJoDY61a6hZC/tLSe31SctKEVYD8kuHyMPtlDD1KVx/jXRLrSrvTo7pr57m+t0upDdnDF2JH3TzwABk9SD2rNsWnEXlWRa386FobppGCxsu7dkk+g28dcjipWpapKVO99/6/RnousyaFokM2ieAp1nkltpm1DXpzIu+3BJ2qAMdQFyo5OByTXP/C0WX9o3MusKRZJBta5Rd7wOx2ptHfqSR3H0qzp+pnUPh9FomtXa2aWs0k+jX8gJSQqQZLdsAkKSwZSRgNwevHW6X4YlvtOttYs4hHb7iL21iIZYpyf9cCOqv2/u9Kl6bG1CCbcZPd7/ANfcui2Ow0jR5bQzJdxKXYrtmtuYygHysp9COaluNkMzLsmHfAqzpANvaCEmTb1yemfTFRXUTTTuzTuD04IqZPSyPboLl0Z5L4m1LXdT8K6Mb7TBbxQubG0uBGPJuERx5eST8pTcQr/xBiCetcTqNnDZa2ouZZltZh5nmogVjyQSF9A6kfhXuPhvUbfw3puo+FfGdlb3vh1ZI7+0dt0kgtpQDIEHUhMqzAcqcnBHI87+Jvw+l8NMtzpdwmp6DIjS21zH95Ii2VZhk5U7gAw4znOD101PnaEo3te1/wBfPy/X0N7W9UuPGHw3m1WxuTJqWmzK2s2LkOkytgC4RSOhKgkDGGZzjkVxWgeM9S0LT4Baag2I8xG0RfKHlsGDjcuDk5BB6g/So9K1G48O3mm6ppcrpZSggCdRJESVCzwyLj5lPHH90g9a1db8P2Miwa9Y2xk0K5G25tkn3SaXK3ADPzujJ5R2yCPlJyMl7aoajTS5ZLR/1b+vT1d4k8V69p+l+H7FdYv/AC5NJ3SoJ2BJlmlkDHB5IVk5POOO9crr3iG/1i5inubq4dogFj3zMxQBVGBk4A4zx6nrTL2zS4ge8s5h9kjxGi3B2yHaozjseo4B7jikttLuJdSe3SNSqMVY9QPbPqM043lJJHTSpU4621G2zajrUn2UzvMSd5MrbsHpnPXvXTaB4RmXVEMoDhGxgHjGOv59q67wz4aj02NJo13umMEjIyfX1rrbOExEMI1+brhBg4716FPDqKvLcu3SGxT0rTTaFPPMdrGGLufI3k44AQd66GxthFd2019OsOY8JHFD5in5e46bv5VLpMaz3SMFS2kkB2TO/wAsAGc4HfNdBbLOpT7GtvDPGjNbxM+0njmX05q2WqVun9f1/XelbWstwgebas13kReZBtLDoAGz8oxzVi8tIWMM9yk1qIwbW2gsmKRbjxl26c9/al3iHT95kXWIiqwxTKPJEUrdgDzgHv3qa2ie3WUrIFsrZG+0RRSiRw3QsCepJ9O1Q27m8aVv6/r8iGaCUTRy3GmRR3aqI4PIXzY2U8YGOhzzk96uCMrLHHKjQRB8RGV8+c5HPmP3IPaooYbSwtUgs7+/UzKtzNNCd8cYByuQOd3YDtUmwSxwSRQKouHKtE0gHlKcgsQfusSetF9P6/r+vMtwHItrOFiaCKWeRykwSMrFleihurEn8OKsWbs9yy3UYAiXYAn7vyz/AHS56np0qrbwrCHjjieRUQGG3uSMMqjqGHIGafbrAbe1N43mNISdjA8Mx6IO4GOtJq+hModv6/r+mJDJhpImixaoS6eXPvdSf4SD+NMjhZU2PND5hbLttL7k/unHHSpruR3mnsLe5iF44EYRlLNJGeSdvqOmRzUQ+2wBItNe2sIJ/ubslZHzztPY8Hrkc0bAoX8h5hvWjWGEQSzZJXfECrA9QnI5AqKKQ3OUmt4rREHk/M+VcjnI7jntUN1rAWMW2qWNtG8cgMklvMZFyD3A5Hr71pW/2O7SWYeY1qjHfO0f3g2MNg8/QVTi7alODitUQhlhuFjbf9odXCIBuHGMAt2Xk/jVGW8S0SW3ECCeTCRhlPl7vQH8O3eq2u39xawSrYwQRTXCrGHZ/m7gNkn5eOopvhKSa10u7js9SWYLuMhkQTO8rcbY1P3Qc54+tLl5dWaKkuXmZuR3lpPLHHqcE0M8mFMkYLcDHYegqFLqzREUbZJpG2jzlwyIGPYH7x44rLik/wCJg8X+kwypGrNO5X7oIX93j1zjpmtVro25injtbeS2sfMlkO35wxAwoJ6t/jSlHsR7KzsibyvKWWExsLqZd8UkallXB/iHUHtVJL+G3lurq4k/0YTFgYhlU4AKsMZznvTrJJWv5brVZHVjnfMkn7tI27H3HrS2L286WcCwxX63TyBWVfK+RM/MexyfWo721LUbb6/139EXotPhjsIUvtRkNxdnzjnJijYt8qBxkD1qrK17PMsVvOkSQzAMjxhhckn7ysP0rX07R7e3m+ziVo7ecESxc7B7Ad8eooe2m6o1t8oaGE8ksGGMkdOMYP1qYz952MJVFf8Ar+v6uUVleC22NFunSUfuxnIyewHLHg4qFpGiuorhbOB5GdhEFZlO7GcOQP61ELe5gu4kuiJg42q0S4YHsPpx2qVZjNPaTpHMqrPzKoB2grzgH1z3rdq4RST0Lq3l4iCGTSLKYyKI5I9+UdhyG5xtyM1hpdwW0r6idunToxa2tE3PHHg4KYPBY9eK27KZpLqQzRAySRlEC8rjOAQfXvRPBEzQx3IV9ItJcyPA3zhuuR6gd6FEuMop2a/r8fQhguZprgpZ3kd5ZwRl2tpRtZWfsOMrznjtVW3kmhsLaYwrKiSNujdR5iKRgHP8Qq9fK+sRpPpl1AZzuMsq8uvJyCvXBAzxwKqm11B5dP8A+JgI5pYGiRREuySPnjB6njr1/GsnG247Lrp/XkVp08qNrlRHcMmEjmt2Id1bkqR6dqr3VzFDMsUaSRQ3AAjCLkBlPQimR36yXszG2FuhJWQRNgL2IB9e+KYXKSSIikRrjBVufrk9QetWomqpXeorwSyDy44AGcDlW5H50ttbTQW5jLhcnKpj9M1KzRrK3lv56A4DKNhYY681BcTlD5MiyHcMKPSq5Vua8jasJe2wlVi5UErnIHf+hrE1K0SNmDOxKgOrg8g9j+FdNbSFoArhWYdSeDz61SurZJA0ittO0g9xx3p6nHWpaNM+eviKdUikKTSLJaTPyPJQNuH+0Bk/nWB4e0C71bUjaRWU0s6wyT+R5giaRUXcwXIOTgHgcnFepfEvTzN4bkYowZNrcDo3FYPhN/Ft5fafPdNBFaxMAs98REIto4Ytjd07DrXFVppSsebObpwfLZfgczomraZbXkckGhmZYiGDXFw0nld8gDaO3U1tWs97DG/i7xDK0qWf7nSIZh8s1z1BVTwY48lyehIUc5NdD4h0qPWzfX3w4EF5pVxj7dpsKbpLNkOSVi+9IjEZVhn+6QOK5LWDrXi9rWa5SMz3Uq2llag48iOPjCr2BZse5BrL+6YJKpK6Xk9dfx2638vkc1qOu32r6zNqms3E17eSht8jvhidpA6dAOOBxxWdEjSyJGMkk4Ar0LWvAkZ0Sw1DTY7qOWNvsmpQSLny7heCwP8AdbqPQ8V1XhnwJa22n6P58XmXU6vczNnOxScKp9OBn8ah3uehS5NLLyt6Gfo3gyTVfA+jqyF9kt3G5PSKRwu3/wBBBr0LwNDFYWunXMKYWaEJLFk/Oejhh0xkGrmhQvaWN5p8DbU8xZ099vUfXH8q1rG1j8lhGwGWZ8Lxt3HP880bLQ2jC109tfx1Jr21giufOiVvLPKp5mdo9DWfJNAXb5BkHBxV+VQY1/eqzZwSOCRVONkBcRqmAxB471jKR0x2OQe5S28U+DnltftVsbAtLscxSObeEqXUg5LbFZHHQgAHoCL3xQii0TwPqlzBdrqXh2+nR9OVm3L5cqhiikY2EOrnI6g4NYeowXfgTxX4ci1BRPb2MCyOI+sDuo89h/e3ElWHsKy/EZtrG1PgnVI5fs8dt9shjglLMlySSpQcBsqT8h9TjnBrrTVro+cdJ3j2/S+/yX5nJeJ7XRoLK2tdIguTdTN9pn0+STesBUyZ2SADKsOMEBgAvJpngfU9e8OalDrumpEW2eUkTt8jxlhujK5+6Rnr7HrzWtHbrFYwal50tzezQbZ42GSJc7ee4B4NX9Kura70prDTLVkmjvZHaUkP8iqFA599xqHod1Oi2uVq997/AImT4u0rTtJubHULCaW50HVGluIgF4gc4DwN23IQOg5BU9K0PAOmgaWs02/fdv5pQ9CcnH6fzqnqNpNb2GoRPeSvaOUlETHALqNuVHY4J6dq7TwrHbOAyBuOo3Hk47Z6fQV14OO8jR03G0WbmmQFdsSnCKevXk+1XbhQzRsPlRBtVeu/3+ntViCGUIVwE38sepPoKsW6+SVMMULTIN4DHPP0Peu1s6YR0JbNnaOKMi3KSqI9pwCEXn8M1cEtq6qLs+RbynGRGHYoOiqT15qjH5kjecqh7iVSWJTAUd+vcVZt5y0EiW9tbzyXbBYgy7Qu30J6A1mzVRsXjaXfmSXTG1guZAsElmkWxooCOZAOnSls0aG4VtPgs76CxyIN0e0uehaQ98dRUAtrZlka5soJ5l3ec9u7K0bcjZjODg/yq7oUpsoka1tZbWIDI83DLIe5Ge9Ra43Kyv8A1+dx5tTYWlwbadGEv764lkxt3DnC+x6Y9qiuRcsj6hFbW1zPcKm+G6QmNwfu4H071PLKJGi2wpIvm+YJmOQp916cHmmS6WkTNcpcyCVcSBkfiRvTGMZ+lVbuTGXV7lOKOZ7mIC3mt71H8qKW3bMQZs4Bz6VJezwW7vZ3d3EqrGzM6uZmideoBHQ57etSzSX5tBLH5UUKM7+TMN0ssjcFFx149upqr9sd7KWX7DHYSCHyvIhxuZM/eYnhSMHH40rM2S5tSW0EqQoxubt42IG64ADsTyVyBuGf6U6Wwg1hrgQQo8ltH5sqjP7gD+Er74zmqIuJnkW9sdIuLm1OHkcSb7iFVGM9h1yePxqO3huXsba1tbi4iJiZ7u+a2KyIC2dg/vHHU0vwZKhZ3vb+vI2Nr28P7+KKFXjDseofPAJ9DjOAa5y7lmWWO50+R1GQpC8qR6VYvLW3fToVttRkngkB+ZQTIACRyCM8YqtNd3OLqWUjUVVVQpbp5O3gbJE7HGOR3rRIqMP6/wCHGWSLPqSDYFuGUMGf5sgHPP6dKl1eC90zUDf6akG9TmWHy9j+X3Ix1OKfphS5NxLbCOTCKHAyoj5y47HcPStF7i4mtpJlnlgxktGXwJwOQUU9f9rp+NVK6Hdxkc/ZyJreqfa5S8BKxR26MQqB2yQ2c8HGTzXWNb2lxJa+VO1xZxZ8t402q0+drDJ6gHv06VzFvaWb2Ek92ltGRhpowfKcvv4KEdWGfxFTXupX1vrK22xNPtEJS3ljlEmY2HJ54OT+Iz+NQ4uT0LcOd2jpb+vU6OO4jmkS2vJ4vOR97WzqA23HyqABg9j7mukhdIY1DwGU5JBTCkIeoPv3/CvNH8Q2srLZw7fJikJZIYC7xsuAHVx0UjnPtXbadrloYIze3EYi8rCXYBCll6q/oxz1rOdJ20Rz4ihKKTsat20cMaqoJIOV5weO35c0671HTHijaCUCVh80LDmMj6cYNcZqviuJJv8AR4mmQDtkVRXV7e9SZpQ1v8wZ1ZSN/sfarjhH9o5lhptXaL+p3Ttc+dbtCoTcRFKPlc4xk45p+kapHPbBZvK3sm1kPBG3pgj/ACawb/VrV7WUR2rpHn93lThT35+tUC8b3ZCWk1uk0Yz5RIG8ema6HRSR1xoXjZqx3FtcNdSLbzMtwyrhVRNrY4G3j2FRXV0FP2S3XakzgSu/SIdOP0zWF4Y1e3i1O7/tYyJaW8SM2QBIylwpwM8nnPGTxVlNVNvPdy2NvDdWolOySdSGkTPB29jx3pRp62J9jJSehvpYmCS3miQqynajjhh7D2OKfrNjFLpqLsXzFy6SM5ypLZ49PoKxNU1HVluYtSii8q13CQQx8gjrxnnFdSZLXVrW3nVFClCXUjHzd/pWc1tcxlzwakzh3NlBqNxa2M072l04wxQl1PUnB5+8DiokkWZkWZZndMhyAARg8Y9T65q1q1pBb3jrChmkV9++MlMJ6e2OlVB5wjPmJiJpF4GMcf3u9JQsj0Yy5lcuTXVpJDFCJDJNISXcRlDGe3J61Ek07ABmRiCCS/XHrmp4l3xoZMEkFF5wBz6Ux4md8pbhlIy2G4GD3p8thq2xYjaTcxaNASeFDHpUF3DskZ+VOPmUHCn6ipolXywQ2FxkJuyB7CoZ5kmhJLbl6HJxj60WOepE5fxdCZ7CYgHBUbwegOeDXlHhvR5rTVo7y/LT21yrxwsecOeAcfTNetauNsLktvTBBz3rkdE03UJkDPeW8NtGzeShPODyMVyV49Ty6kbNodp/hm9HiWyk0K2kshbqDcTwAxlAGBJLjoSM4HetPwf4pvNe8Xy6neahJFYR3TJAs8Ss6xoPlyxGck9ea2tbSfXtL090u7oRwusctpC2wLOvKycfeDds1R0O3t7O8mknjP2SSbfKnQ7+5/GudS5dBRoqbu1ra39foaAtIdVu7+aC/uEi+SSSSVyPOXcAV29AOprXeLTIdVvE0qN1tzIcHPy/h6iq1n5ckg8uJlhcHPGR1q7aM6EpA0b4JVgy9B7VLlc9CFFRHNCI5hIj72HQkdK0bdCyb7cRsSuWjDfN+A9KpRYV2WRD83eq6Rpb3zF1wD0YE8Vi3YbVxb1fPuVZZfLaP7y46+xpgk4+YAn1UU+51Kcq/mSRzRLxh1DH8+tZUepiXcw06zAzgYldc++M1m9dwSaW39fgYfjNrnU/BdxeCMy38F2ls6y9hcSlwxPpncv5Vlazoc9xJeazqWBcxyCZJC21UZfuAdzjgAV0+q218s6JCSbOUg3MRAxJsO5OfZuaL+Ka7aEalHGI41Hlw9Bn+8Rnk+9dTfMiFh0pNrr+X/DnO2yadLJDcJcKk14p3pt6NjJXHbBzVi10+OyDvLZCZHYhWRtoBJ71oXGiRzWNvcQspJeRoiEORtGCKku4ZFsrWaCbdGwSSf5c8Z5UD1IqHJXV0bRpKGkTz/x+t1f2jxxRIogIIjUdQDzzW14HvFWyifJAHLZ6g9x+FaFzrUOqJHbW9mYFVi+1hjc3cj2rHt2FrqNzBAgAlfzDjgFiOcV6VJcsUznkr1HFq1j0qC6WYMm4M+M7s/mKsQu5UGIr5x5UsuWXH/1qydLJW0wQrSvjDdNvrV4TNHYpmRS7H5to547+1dG5oo9EWnZAlvbos7SHi4lYcqc9BzyCKSO6b7RJK88aWoLLsKA5wMAY7Uy0TziVZxGsgLMxkwWXsPxpWiVLoW7LbPbplY2Ry6vIfQ9z71DRql0ZoWm9IARqNjZ+dGF2zRFFwTgjPrjnNW9PurmEFl2hsEK6tuLg8cegxVKeyW7RZ74XVxAHaOO3Y7sMBnjtyT+lXm328IjgjltUfaHg2jap9AeTjgc5oSM5WaNSzs45tyTBhuONh4UA9KbdxvaqUjYERZPIGUH17iozNdW8paQBnOAQDgdOKbqF9dG2ukimglvShKKZP9XjGdoHXjjmhJnJFtyKt5qL2d3Z3l6qultC2CqYI3HqzA8cD5eOOcVjWcJvZk1GSaCUPMXLklVgbd8owOGHPT3rKfS7+5uPO1GdpLqc87iWX246AYrbkF1Z2lxDcpYXNraxiRoYnKF2YADK89P8mtIwSR6ekUlF6v8ArT5suW76dDJNNOUv7vY6PBEjebJJ/CygYCDp19Kv2s13CsIuCLOGNxJJebA0rP8A888E42+vr096wNIm1K9KCOE2dtcp5f2kAB1fJAC45btjPerIWGQ3ds/mzvD+7leRXDmRcYf2wQBWUoq9jKcbOz/z/wCB8itqt2bT7TFc3btJGxFvL5XkKVZv4B/EOc4rMl8SWsRVALmSFF5CoNxfHJBx0yBx7Vu6xBdi8t7K+jZ5oVDSBj5oVuuR3xzTZrFprKZHgPKErIyhUVfU468mtY7JlKpBW5kZD6jC09xL9kkuIruFWuGC8rIDkMMdz096gs9a1OXV5rGGae2sFQzgXqLGdmOgJ4PYD1zWhCklrFCiK0YLjcu3AZR1O7uBVbU7qK7t3to8Sygu5KxliBn5Qqkce5z3rSXkVFp3Vr/oaujatpk2lxtELBp3lO83EhVI2LdWGeOB/hWfouhtqAuft1puDhQsTn/VqRnfnsT1rN1TSZ4IjdWdgNsSqCiEMyjg8nHPetPwh4j0+e3aFrl7ebJMwlTaHPZgRwTjHXpWLjzfCU7xg5Uv+CvuN7SfD9zY3fm6fHFd2MaCGXJEUgPVUUjg49/WtDS9Jj8qSe6svslxI3zxTAAg9MEdx3z3qSwEls6QXbSPOuQO+XOMcDqec9T1rbhSdHkW6nQyZwcKGUuDjGe1ZNtXR59arJ9fn3KUGnRRnbsj2dMqKqXVnEjeZ5aswPp/OrV9ePA0aK8UrsSGwu0L9fWqN4zMcyXakuoYbCMD2/TpSUmnqc0OZu7ZRxBOJ1WGPdIGc7sDn0x/Ss+/d72e0jtRKrIhuGMqc9MY69OtV9QaeNftMGQGYeaUAJyOMgUyGZL8JKI1VULZZmwXPTr2xiuxLS6O+MOXUZ9in+2LdrErjYUbdyOe9bFtYeW11CxkT7RtV8Hdkg8EGn280K6elqAVcnbgdT34q/bXbPp9m9uW+1NOiSiaDKp/d+Y8HOc49KnmaFKcmVLywv54Psr3StaWm2JPLAUqDyR79ea0to0YeYPMltWwCDyyn09x71PPAun3gF1c7IpJlhnLNx7HP6VXklV7yWKCMzRRNyykldvr/WoT5vQ53Jy9CmbfTNQ1ORlmeXiNTHcq0cIZjgq3f05BHSuZu5r2O5K3ryXVwXKmRQFjbH0HtgV2XiiR7jRUZ4pDDs2iXb3Bwea41JGWYRyC5khA+RZByBjnnv7U0tLnZh7tXFuJlCSSR2eFYEEf7XfA7Cn2ayMOA5IUsVDbSfY1PbQs4IkIA7K3ofU1KIEjJEygEKQHU9s1PKdTmkrEH2ny1BCkZU8EdsfzqpKqFJCrBkYA8jlqu3ICAfKzE8CRf51TnGZBwCrDO4UmYTl2OZ1mYiJmUlgnGD6etZGn3Cmys3NtGYNzeY3U59vetPxSFgtZ5h2GDke1YGn6ZA+iwu92AJHAJjf5l71x1pNaHm1uW6v3OrBtLS3WWwviJ3G2RHPCrnjI71etoIpraQSyb3LbmBGA30rlrq206KeF7aYOpGW59K6DSrm32yDziS2CqMeAf9muV92awkm/dZuabbm2m4bKMOVzzVxVCzMyptLelVbJgoDyMoY+9XnVcM4YEHp2FZHS5FW+ukskE0jbkLYxjJFLLKkqZABLfyqqZEm87HVTtJx1NRFig4PA5+ah6qxKh1KGtbYLOV4fklUZAXnP4VjQXDxxgbYeeeBir0sUs93LJJIPLxgKpyPrVNoWDsFYkA/3aycXF6GkX0Zq3qX7lo0myhymOuB7U3R9PuY792ubmF0ddqK+cptUknd05xjFW5pLm2mdS6PngAdV/H1p6zQXCLuLZ3bXZeOa6EzeSbVrFaO7SRmf59pfGY+NvuaJL23t5ZUS4dmKkknr+FR3GmA5cI3lhjuCPj6ZqG/sY5beIRYgMn7lyF4cDJ3ZPOecccU0nuKShbc5S4e0i120ihBClXy5fO49eKLm0KXCXqsDFHklP65rP8RaCbO4ivLB3KWbjzNx4C9D/OtzSgLy2lD8RGPr1rtoy51ZnHUfLU5k7nVaUoFshdx5eOCR1J7VqSRhY8eWNrEZZuoArC8N3AntQu7Hk/uyDycjv/n1rZtZBcRyuwJK8cjkn/CuuOqN0SrGjTqrofLb5di8nHf6Vds7JL65mMNuCLcNLHESF+VR97HTjvUUMayLKVngSVULmMvtdgBn5fU+1QtskKRyMgAGNisT7ljT5eg3cWyuobZkk+0j7W7NiEDhAfaulv7q+t7eI38FluW0M0RGCz9mySOcZ7c1yhFwswGmJFLOpKI78hEz95T+NWLkSGDa8s+VTAbbuCqxyRn8yaTjzbilTUrMuNeJJpD/AGd183HG3nmqsKraMFYIZZCG3c7uan0XTIrfUpo7RxcJHGDhAz+YCB8w44GTVi5cM8dw0MbhF2nI6CtYO+xyv3JOK2Kd28MokhupgASE5baB6DPaq6wyaUyx6bYx3N4oLQSrJv5buzHk8djULxDULuQzRSywMMkR8Agdj6c4q3bWbWl3a2mm2flSSEySuXKsgK8Arjkhucg89KqTsddOyjb8OhPFdh1ZLPT4ykzbTHJKd8LYwWyvXnnjHOKku9JtLg29n/ar2W7LrH5/zF84JOfmySO/BzS3bx+ft0tLeaVZFkEw/dgh05BXrkMDkepqaCAQLGL5IDchD9rkBGHJPykHqOPp0rmld2sZyly6p2FmjVT5moXEMIZyquyNtGD1P860YbVbi3aSJQzW65kiC+XJEcHDf7QI5OO2Kw9J1eyHnWkyOLeOQ28qqhLSjdu3Nk9RkDt0qK31DV1WMmNCvky7FuF8xLhWIwvHIYYGCD1xWvJK2/8AX9f1uZuk27PQ1mtYmcxl4GDMVKJL8wA6gE8D1Hsax9MtJIrtT5csbbGXK/Lkg84J68Y6etVZtH1GWxQ3N409qd08ZQjbE54PuMlcDPpSWd8YreCG/wDuoojgMQYBiSSWZgc7sHGcc4qnC6aTuWo8qaTua3iSwS1W185o8SKJAiS4jRcZbd3z8uOTXJ3Hh+G/Vbm2jls7iXLmNkwVXsNo556inu9/PqJtxdXLCJ1YW8/Kled25hyR049K6fTPIvrr7VIs6TQYb5jtePHOB/eX0pRThuaKTpR0ZVsrWXSmje5srnyFIRTcTCQn0JUcDnPOegr0yysvtFiXiia3G0G4gcAEA871Pp9Kw4h9ojgukuUVOAFwr7lbBywYYAzwSD3rLiutVl01rYmKOES7nlV+JRuOMjH3c4wMkDFRUvVt0scs/wB4rvRl7X7eK0uohZQTGPac3JOUbPQAeorlboSJKxkQg4wSOhrvNa1Bmto5t6uIphMdzKcn0wOMfSuUu7rT7pwWlCQFicjkgfT61zQ51vqZUZNFuG1aPR4bkFWVQitjqu7OMg8n6isL7PIut4tIDLLcqdkarkAkYJwePxrRk1+1j8NwxBCZ9gDAPncw+62O2Qf0FVvC97dQeI7G5ltGn8wSWqxockb1wCPXiuyKlGLbXc64xau/UR7dVtvIRWZyR8+cnNb2n6UI7eGJTIxI8wg/NGzKcA49OoxUl5pBl1WG1slXyJSXjyuFKqDnkduDV2OKCO2E+wRb428tkbheccc9+uOKiVS6VmYzm7aGcInvWgtZwEzcCPIGRnOe3pV3zIrPUJ7eJxFA/AI43DPI/HFZcE161zHPZv5TJcb0PU5AxUWq3M10xV0Mc1u28yNhUfgkqGPGfbjNVyt+hkouT5Te1ALFZxbUlms4wHYGTyxIQc4zjA/KuJMN7dwzanIDDHJK22JxtC85249a7U3qHwx8sgmheMhoj1wRnOPyriWb7VpDG9124kkeXzfs7ODhsAKx4yeAByeKlJnXhL8r9S3BG8iYSSIgMMxKcg+2agMzrOix5SME5jb+WasWwh8p2aVo5g4WNG4JXb94kcdeKp3xu3S3NqIGUMftDOTlVz2A70N3N2yG/Lm5VLdZNxb5h2UdzVdt0DsgUifn5gcg+hGamjlJvpWXeWBCKzPjPGcYpLyMTRllG1sc7iMgis3qrmclpY4jxpck6dcQEj5U+UDjLdzXM+H9Avfs0UVxuuBKMhUPOK2vF8B2GRnwozk9gP8APeptCluIrWFVkEsUKkIrDDY68muCuk3qcFW8WkjF/saRZPKRj7ox6e1dBZWtzbWoARRLnKs/Ix6E0r6nBbRj7bAoV+Q56Kf7vrWpp17DLHtS3Lc/eJyMVzJWRtS97dFg3fm+Usajfxke9aUE0rIQ/YDOeKzZoZ3QOsSqmeCP5VWnnvSpVFLBPXg49KEtdTrtpobkzqFzhivUhTyaivpswKqZUenWmWDZtEB4kIztB6VLcB1dTlCT29algmU7c7mAKMM8AgVU8mcM+Tn5j1NWtRdY0PzgSHpzjH0rLhl81Mu7bgcE+tIxlq7mzq1yI7UMAZGbDBUxnGcE/wA6z4b+ScTxqqRlBlweCTmo9StGaQuIEwgOHLkFcdgKymEMNyxvbeabCbkTdhWYkHk9cEVomludzSWxpTawLa/huLjzfs8QXzUjG0lehIz1NZ5mOs38kpuZPsgdjDv+ViueCR0FRX+rQyoIzFJckqFTJO6PnofXjirdk0MccnmWxZCMKCMYPoDRzX0uRbW9rDNaitptMurOJJTJ5TJu3feYnjH41ieCb8XFpGkmUkA2lT6jgj8xXbL5M1rHcQR+UEYs3G4AeleYTyjR/G+oxK4a1nc3ERIwpycH9a6qU+RpnDWs24o7nTro2GryxFdvnYKg/wB4f/WrtAUmj80AhFXG1QOa84EUlxdW07NkxHzAD6gjg+tejQMhtxuj2g5wPVu9ejHdmkXomTzxhQDPGgZOAAMc9qhli225M8u9mbBMR46ZAzQxJunV0cEgYRG59wKIEkKgRRNCiKXYou8t7t9P0qjoitCSJLy8C2YS4ihkG1lVssvucDJzgcVo6dNePZ+UqZsVwwkXIKkcAnsQM9O+azYfMed4La7dt53NKjcOR9eea6zSImisIBeqEthKBlBtZ1PJX6dPoaiSsjKrJRWpV0S3ntmGso8t1EjmMBR5axdflx2yMY7CqF+4VFg5BdS2MZIFdrAPJtbyJJYrW5lVTI8zfIWjJ5jx8rZHUds1wkgujL9sig8xcFVAI6en4GnR1bbORu8rsmuNlimmrEkiwzsVjZxjfxzkZ7H17VZiM6iWS3jgu5Y42ly0WTGyspAjGeeOc/Wsqe01PUNBLSQwTXNud0NywzIFyAIlPp+Hc1Z0iWN0j+17baKVSpjb+IkFc7hyCM44571pKPfU3SUdU7kf2+FZ5RGjTSAJKzxoUVMnLA8cgFtoP0qTV76XRLh5VVZHeIGNCynyyQAhdf7h3de/PpWRPrivevHLLeLObb7NJJDhlkYEBEcn+E7RnA4wMVq6Xpiz3U0mqCCcmDyRJcdIwAdoXGM+gBpKKirs0qQUdZFrR4gdNUxLDNIEaWby+cEn5iT9Tx7VsmWVNOkjs1RbJN0gcr+/UDGQv93kkZ9Kx7RluLaKDAtoZSHbb8oVBx8w7H6+lammvZ20q3txdRT6Z5bgseGbIwDtOfX/ACayktdjld27mTqVlPBHeedbbZQR9ohc5dRjbHhhjICkfjUJV/ItoHcXVoredgSjLH5QIlH3lYHgnv1q3FcRT6DHGDF5iyEpPhw0mASyHdwf4SSOO1YrXdjfXOmOgQthRKnmffC8sM8bTjPfr3rqhFvfoXqnZnQpa2zak8t3IqknMrBNktv/AAtEy4xkcHd0PPrUNpIsenIsCRS3Mc2ftC8blBOBg9QeDV6W5t7e1nvBbT2puYxHJHLIXeTb90lWGQcY574rKj1JYbhoo7IJJGDvgDZVGxztGf8AJrBRcnexk5NtpHTWCfaJNsDfv72QhRnYsR6np64OBjGTVzWbHS9PjulmEkVmkkczYXcVDD7ijGFGe5I9K4q61HU2YBMwJJgsx67h0rrl0W9/sFpNY1Rjb2mWEcxO1lHzZIHUnPBOazqR5Gm5FJNLU5rxhq2lpoiJaylWZugHJI6ZrzB7O4uQpWVoo2BZQTjPPSvVPEUVleR2MZS0Ea8xyRtnIPVn9PfisK9sLYW4EYRwozgHp9K2pzUY2RWHqqlGy6mH4d1uPS9F1Cymt4Tcl/MjuZGPmAFdjKv4fzNSWmuxpeafJZzR+fFcRyZbO1MEctjnGOtXvA9na3Wo+Im1KCGUx2Mn2feejgryPfmpZdItbdfOMQwmCwHy7lGCR+PNaKcW2mjqdSClruzoNR1l4tekvLCU3Uc8L26NHG21Hfp5e7kjgjPvxUtxdXd5p2nS+UFiZXhVymGDh8bSc81djNtqunzXViXtrTT444VSZd+wEswORz6A1a8SW6S6NpYtQCtyXnVEADIWA3Djrz0PtXJzJNK39WOd8vYouqWmTbWckEQG1o5Ww24HknkjPXp2xWZqM5n1ZReMTFO4JjbBQkYAYj1/+vWxeWptNEtWmkIwjF1IAIwcDnvx3rL0zTm1R4pWiUvuUlHzyueRxg9K2ptWcn0MotJ8zNmWfTZI7x5dkM1vEUOyMsCPu7mA56sOgrlZppToll9otprSNQDGPIXy3U8MzNjcTkZHbmtvxJY6fp88E3IsbhtjrbZVlXjKgv3JHrVDR9QEl3cQ2U1xawxCdfmLz+ZH95M5+7tHBxz1NZX0UkddFKMLrUpzbHiP2aSO6Qx+aDu2soB5yOx9qq74JBi3d/MZMYJwC1OmkLR5LQ3IVgT5QKls9gagEKmcTkMkO0oFB+bj1rRlvYpySsbmRUCryOcc8ccGrZjE0RJyDjGAcY/GnR26AIZAF3EYyvOPWrTMqKNu0k9hwOPWsJJim0o6Hn3jGJfLkiK/KylSM5xxyao+GQsWhvLOWAx82BzxxwK2vF8PmxNK7LGpbGQcjOOgrD8NxxnRQp813dsHjjGelcVe90zgra2LYtY7qFWeAybjuG4dqv6Naw28MkL3OWY5BIxgelSziSO7UW8mxEXChhkfSq158jgldwPO4DvXLF2OulFWTIp7C/SZ2sJmba/VnOB+FasF7ImUvIgWb7rDkZ96Zpckkbfuf+WibWDdatt+5OX2l8YNO7N3q9RkVyoU9Ez0qWYbfmc7lccFe31qJvLEgVMDnJGKbcXXmPJEMBlHHGKVtDOcktjLa5SV5EmQHy+mabEuVJQrgn0pNomjdldWQnHA7ihEZchFGM96lKzMaki7faijiUJEzSMQFP8ADz1PtWRc3JCuI4vMlVeCc4/OqJzFqagFpUCAlixwPQCtrIjMbKVQYOS+enpV8ttzpUlJtRKVqskixzPGIQyhwvfB7+1WriUxA3QhVow3zMTgZPcir/2aCNIphaqwm3KGJJ3Ee1Wxa2Lqys4d2ySA3CY7UuWzHFpox7K6bTopWmJ2SvjgZGSOnvXG/EW2mzptw+CInxn2Y4Ix9cGvU0020NuEklbnDKR2x6VyPji3gm8KanDCrNLbYkWQ9FIOcfjit4O6scNVpS5iHQpBJbQvJkD+6On0rtYpy0cDxnGDxj2615j4Pujerc/LtQnKg/n/AFr0XR5SkeVUfJ/C3PWvSoyvFMuD6GoZfPukiijbby7MzYJ+tPNy1vGIrORo3GFLJkdff+dVABHECmSxcnOfTpkeladnFEjCaZS7hsq+eueoH4Vte51pK1zX0HTPtlu1tHBbxXkKrcm7dTlEz1U9G9PrXVaba/vd88bee7EuT90nPUdvyqS11fTrS1tJZYyXEPyFsuAAeAoHoe1aFlex3h88HfGX4YKUA49D71zzlPXTQ87EVJSV7WKOuCbSNITULPaVgcn7K6B1YM3PHrnvXG2kFwutQW1whj06dWcogwEbP3a9HnQzbWlIcHILMOM1i+KXgtbPT5Y1bcJtjfL0z0P0opTa922rMI1HblK9xpEdgVNttMDYDiYnGD1I9P8A61c1fwHTL4xTELbLKWgdfmDbWGSM+/OK7GbUd9qedwxwCuR9K4jxxaE6pokcdxdLps6vKYn+7G54O0nnsB+FXSlJtKRrhW5O0i9rFjY2UVjdXtpJdxzz+ZcsGyXfO447YKkEc9T7VHojGWSEpBLc5G0qhwy853Y6EjHSnyWr/wBhfZtPupZ5d+4RshIC42n5v88VSW4e2+1C2sPLEZYJCshcgY6Bu/41aWlkbylzR8ypc6Nf38t7c2lwglfMl0JnEaEsSTtyfpXS6V4bvtP01LzTZpra0uI1g2eYH+Qnlecgcn261mTLA2jRfbIDKzlVhjPGX6kk/wCz6Hrmui0q7NjpMP2TTGuYpZJJDbRsXZ1HDYU91IU44/GlOcuX3R88pKxzUmgzyw4nuJZI7JHVleYMtsu4KAACefb2rLh0aKe4kEaO6pkyuq5C44VsD1rvL9r+41G2trq7tLaaWNriW0SEhooc8bwudxz61kWzLo+sSrZTwtb3S+TL5wZEK5/iyAQQf881pCtJrzJcpLcyIrWbUjK05nkiCrEJXJO0gcKT/KrujpbRWMbxWyHYhWVMAfd68/rUl35djc5trhWhZQR5coJk7glPbpVS2nWG+lKJOsczHzS23yiWxgKfXAJIP4VTbktNjCTbWmxqi6QGCWOGGYxtlUm5VuMcj0H64rdtdUe11fTrG1uLm50y5MgEFxEAGO0gKrHkoSOh9cVzImgsbkFy08buyKUbKPt6/MPTNWItctrm+iv57+3s001gERYvOmkwCcKg4xyfmJ61lKk5LbT+v1Lppt2toW77wzp9u8rSXTs0rs0cUUYXaWx8p5+UKeMH8q4Lxgh8O3sMH2hXSQHGMEV0utR3fia6ttYtPKhS9mMMNpBhZgQThpf7xIGc9hxVDWtDiLwC+H2i5C5BLZA9quC5bKcrvsXflmuZ3XY5Dw9rEVpeM9xLnzs5I4KZ966HWNSjuLFbe3ZDJKASd2OPek1XSES0ia1t48vhG4+771mQRxaV5kEtv+8Q583rv9PyreKjJ3RacZvmW56Jol/arY6mkDIVuYQkAnKjp1BHQ+tUbi8LWFpb5B2kAAdR3NUPB8UjWWpwz25Dy6aZ4dxABQuCrA9j7VBpu6LWLWVkZmF5FaeSSu0hgGY+vTvjFYKnFSYnDVrsdLrsf9sXUVgjZWOJFJi6Jgcn65rX0jw8lnPbGGR1Pmby8pyTx0Psai0+2it7/V5rSOORHnZ2dD0XJPT0FWzf+fMpLAOxzgcYrmlOVuWOxySlJe7HYz/G2nf6HdJb2mYlBmlkC7ip9z+XSuPutJFvLptvZpLNcXVt5vmRHJMmPu4U8jr1Axnmu51u5bzporaSZYpNud/BkAIJHoT1rmr+CSSYa1pdzia4LyZdwWATAwQMbeCOvOeO9FOTUVf+vU7cLNqNmU5bxdO1uOWKM3Udo/8Aq1wo+7t+c/3wevH8IptnpV82nDUpYN8U6Psb7QC0hOTuI9gCcVVezvrua8cWs6NtYyl8cOOpwcZPPStDRrK9uHhlSOK4iuI45dsKBIpDGw8yNyRhGAHI43Z9KbaitGb7rQzITJLERbW4diuCVYkk9enbAqES7omDqFQkDJAO0+n1q5q9vDDqU8dq8K+WxBaB/kByflVupxnHNZl832WEmWMOOAHX39fehu+pMtdjkvGnzWEmMKwBJYHCk9j7Vg+AblrmOeOIPsgk+dyPlJ74PetH4gSFdEW7LL5ZbZIndV7N6mofCrQ2WmiGAho85B6YzXDXacrHFU6LzOkknjSPY0JEjHr6VnX8L3HlrJLjaQwAOKtWNw91OEjTdJj0yKt3NvsgkW6QK468VyWZ2U7WsQQFVt2ZcFgN3ByQKozX5z/pXTOVwOazryVYCPISQSlvlGeDVuDUZZCFu4w5IADFcEUXWx0QSeu5owXMUygopRl/vHOaJXC5cFNzdc84FVFktwxXIjz/ABNzn2p3mQSOgAZexIp2vqjGrZMzIbhYpJ5HY7Qcr6U2XWoS5yxb3HGas6hbqHbDJtI6Z61SeOGTDLAG4xkGi9tzllyrcnyVuWkcoWc7V2ryFp0t3I86+UjhEJGSeOOlaH2cLJvAQBGLDaecVUuA0V7HO0X3upZsjHbA9abl0Z2pJPREsb3CMkk4MgBLYDEDJ68dqmkup0mkeGxj2NHj5j94/wCNEvmNseCZGbI3xEYOPWtC6j/0Pc5T5sZJ5wPb3pPTdlKavsLZ3LlVivisQERKfKTuPdaxdYdppbyIT4tpYuUC5ByMc+h961FuI7iLylB3KRhj1NVNVi8zY1m6jcpQg9ARV02cWJS1POfAUxRFIJCqWwrducc/lXpmiSMLh3LMq4I4HtXlWkK9teyWzHa5uXycfdGQRx+NemWbSLIhY5jK4Lep7V6OGd4EQld+p1cez7TiGM4AwXk7ZHcVdtNRZhFDCu9omGRtzuAqPS4pb7zBa+X5jpgGYjBwOuT0Fbx0yyg020eyuYr3UJYgXaJsfZzkEEAdTjIINdN0nY61JW94davM2pQS+Sbl5yFksLYHlcEb89mzzWr4Va6R7mC8eGRoiHQrMCeTjB9ee4pNK0z7DAJ/KkMrkBnRipKt1B7irKaZFHeT3N5GsXkofJljXYpb/ZA7fWolJO6OWpUhJOJumXztOkTaPmYsrMSChA5GKyNbFtNo7C9lMDKN0BzzKcjgfSnWl3LfeXhIAoJLoWJ3j0OOnrTvEdrLa6F/aUSxme0O9Ocpg8MCp6gg1EVyySfc5FG0kmcpb3c8hVQQI+mW6Edq6Ka0i1Xw2kNzKpaEkxLgglW6hSOp3V57BqcCLCqP5aA7hEW7E9B7e1dEmrNNL/ofKRAPu6KT6fnXVWpPobOEovQl0tpdKnhLRPvjdQ0JQ5UnnnHUc5q3JbOuo3k7PAIzIhlaKUrt3dDzzz3xwM1DcBbPdqizzfaDFvbajEsQ3PP970HpVayupYrW4e9lVN0IZXK5bk5Knsw6DJ6AVhq3ctLmuzLv1N3q8q2ltJFL5xFoHkzGme4J7e5qeGfxFb3jT295DHcrdsZCoDIJQCCTkY5GeRUktveprU7ytsS42PkEOELDO044BxzjtUOnQ+ZNLCJNgRjHuZSwzn0HbvW8Wrf0zTmtp/wS/FpFxfzv4h8RanLf3hP2W3ihBiDc52/LjK5z0zUmuabe6tJG011IWTHlxtIWMaD+E/iO/NT6pdx/6L9vl2QC1Wa1IfzUa4B+YkD7pJOPYVJp955koa5YnGTJhDtUdj/SoUpJc39fIyqOd+a5RbQ2vp3uU8m0HAEVqvyA9+vrXPa1os9kLaRrlChnVTM0eZEByMZzwDnnj0rvFurxN8VnaTPbyrvdPl+XHQ4/zxXN6+/mWsqXkM0LjkAj73PBBFVSqy5rPYUJTvc0JdOOl6FEJPssmQdrSOA7puwRGAMls9z0FZ0OnRS2V7I48qeIIY4x/EC2Dz361sXOns1jaXNzL5kCHy1Q4zExGeB79asI1tc2zeTazzXCOOI2A4IwMZ6nPJ9qz9q194oSdroraRp0iRW2rWkMaS2jNHI7tgSnsOvPBwag8QRm+SFwjwSQvy5Hy9env2rVFrPb2fkTNJHk4midyFUE9CM4wfWoJLeKAG3MyyQFiOcnP+0v+FZup71yJS1uY11mG0CyMrEOAvP3jms3xBbJcq8kZUoowSD1+lbV5axMpDxBwu5Ax6gEdQPWueCLc2628e4wJGFcqc/N3FdFN9Ua0rbm74RsJ7/w0ji4tUzGU8+dGeWFkbbsTB6MCOD+VVbHSzbeMrGadzLNGUPzADI38E46kHrntWh8OY7Gzur0TeeZoQZooVJ2BQhBYDpu7Z9MVovaI2v2xSc6fBvDTSS8fJtyU565HGfepdRqco9DSUrTaWxqPb3MNrf20sSMZJt3mM2PKA+nHOcY9KorDKjebIdirwXBBIJOOn5VSmur2WykNtaiG3kuANyysXG0k4IPGMY49xW1p+qRmwlS6iCspG/oGbOQMr3571zvmirrUzcZLcyriKe6XZMwYkEJk43/AF+tYt9HPdajNvg8yTaqxwcIAwx19j7d+a171LtYEju7m2JjDPCsajdgnPPf2GazJL+31CFBqdvKAoJaWGXZKmBwMnIIJ9emKqDb1X9fkbUk09NjEuDi4mm+0TxSxSqjQuzGZ8j5sHHb39RVq3sNRt7yKOxg2XBkDbZ5lYOH4UbSdpb3H0rNEsUc0r2huY5VPmRBd0hZQCSxIHbHJ9/atDT9VihfSp1cTPbI/mJdsVVWAJQrwcEZwO2fzqnJ2sdzi0tEFzPcTajOGUQMkhVoHCqPMAw2AoxkkdBWbMol8xZAVjTJAU4G7HXFa2sS2Et3Bc2EhlWWAS3DcnM5Pzgg9CCe1ZMyiOzYZ3HblccleejDvxUdDCa7HnvjqMvbNEQrE4TnpyM/nWV4L82fTRJuzHgZA9a1vGiE2aAkBt4CkYyD15rnfBsjxaQI8soAwcHHc152I0mcc3qj0zw87RRyiMfMfm54qxPqH2+5dpigdQFKkcGsfSLxLeAea3J+6WqOe633uIYg288nGBXNzdDopxbepQ1PSLq7uwT/AKsOHhZTjBHY1N9nlBxc73OeBjAzW95iokYKsoHv0qayEF3dwxZfA++c96aszpj7q2OcS3vJnYC3jMYGQG60lsSbhz5ZVwMbQeK6zVFstPlaAOy7jy2eRVO4NpaRIEQuZOp9R61SVupnOV1scjqE6SDGHLjjaw4FRB9g2/d+jYq/qksA3spXy0Ockc1leajksA+D6UnuckzqrJAJtzRJGCOV7kHpmjWLeOZvJRDuAyD6H1qha3Vv++SOXzdrYE5yFK+wpftu6VV8w+Yozvx0HrSejO6STLNqFt2AmdXZecnr+NaU1i8nlzNKHjOCoXgA1mxzRx3GWZblDgNno2a0bKVI1SzHyICXRc7sD0zRYl3WqG3yeVJuaPiMDkdeR/jWNqTrEivFhlb5mx646Yroru382N2MrFiu0oB29a5efyoMxMvlAHarMMlh2J96uO5yVneJ5wl0IfEU7MSW3q4LDjoRn9K9H0y5W5jXc4VHYYYdBXl3iG3kj8SxqSCJUwCOOASf6V1/ha6+02qAH5VPHvXbhZatGNNrlTPT9LaNVVNnnKpJDMPvAe3auqjuRdFJ4YvsgKKjo0m4ZB+8D7+lcjoKlojJJu2L8pLetdJYTQR2tzc3NqbtIVQFGYCNQzYOe/PGMV6G2p2xs0a39pPDmFXaW3t3Ks4PylvTPfHrVxNTyzRPJJHAVyN5BIz7iuZhjlAtLcwSxwuhclgQGYYzj161avoJbWGJ0eFknUqULBiBnHTseOoosi/YQehf0meOad0AuGQHYrxrgM2eM5PQnvXUSR3F/aPAbgLCwKmEjcSgHT2HvXDX09v9nTy2lQjAkToG9vfFdJbamlvFJHHlV25ikbgupHBx1H0pTTeqOfEUna6R5drGk3Fzq8iQwNbWasU3gfeYdQD6UWjalZEwQRSS20m75UG5gwB5x3Fdi1/GdFvrC7mMcq3Au7Y4wrsRh0J9ccj15pfC0ztdtGt4IZ5GKRytHnyixHT+X410SnKz02LlUcd1dG3pOrJPokUguI2ceW8U24jbng461zGreb5RjWGSS0RzsYDd5gB5X6g8fjT9d0280bxI11CI4rWScLMsKYjhnxnIVvuh+TjoCDXWT6fa6pZqLWZbdLkl1UDbGs2MEkckggYz0zXNeMUprqYWjSle+jMdU+36eIrNCJTExZUwdsoHGccA9Bg8bTntWbo8E8ews5TJBky4bY4659854rR0CW7S0nhuR5csiNCyoANrL8oJIG4+mPcVhCR9KvrkwRyXVq0rMsSqUNvg88Nz17HmiN7tIpJtNI3btlil00yBHTc8Xbdydw47DJPPNWpbhVhikt9+wOsjsGHzp3UKf4vSsPUk1iDWIWmSO1lEaSWx+8HzwQemCAeQf8Kn8i4jgXe6nyuT5S849vWpbTQnDVXZLD/bjSrquqX8+k2ZcvbyQbRuHbdnIP0qS5lmuYxFcSebxu8yWEKfbp3/AA71FeyrrFuq/wBoxRxQx48skh5lx8xAIwpGBjHU0y8uXhSFy4laQ/OzcHp1IHQnHarWu+5pKN7aJeVjXiml1m7a0GIdqI0q4AQEA/MAO3+NPvJpdGv30+Uxxy8gkAMroy4yBx25rC03VN9jcSIJxKWwgWBTG64A+Zs7h+orS1LRzd2i/bo7VLgxfu7llYu2TlSozyR057VLSjK0tjBRUHaWxYFzFJtgTzFLHBJfzGm44Az0P6UxDPH9oWZY1EbbI4i5ZlUdyehPH+NYmlaReQwsk6rPKhLtdFismc5xs6EdPT8ae8Oq3Nqxe38sy7QfnHA6Ej3xRKMXsy5U47XRNrF1skjjgl/eTjLEDhMHr+NZdmsdjZI/mxiJz83BG1ifeuku7GGy06Fo4jEsDBXU8lVI61Slt7cJcAlRDINy7umKqElayM4zSVkT+BHstQvtRF7mN5IvIimIIwcjOMeta/kyy69Et0izyWiSSSguHJVVxn5uCPTvXM2Uk5W0srBoxIyCNGdsCIsf9YT3A9Peunv7j+wZCdOjhmgRwk07MGlkyu1hk9O/TilUi+bTqXe8ifxAlo6QvYSqLxBl1blSrL14PB+lYKXlskrW97cQjZEyLIEDvG+OCC35VYN3ZrILS2URhCWyp3LIh6c9DgHrWO1rM2nGS1Gnzwxu0bRXCBnAkym9R1xx3PHGKz5LRszWjC2jY+Qs1tCLyUW1xbgx8Nl3Tqox3GST+NUoLmyt75I7p5kgnKMZFIYgEjcCvU8VatFj0UHz3nubi5UwpsQHjuuSMr9eKln01LbSb29uHWYpJFFt8sBfnGcZPO9cjgUm7M6FYpmytb7XHT+0Y7W1MzosgibaI/4D14B6HPT3pJpdOe1W1CRo3mECeckFBuGGZh97jr2x05rLvYbu3gEkJ+RSFdZVw2Cf6d81JMilIZLKU3t0yM11GIT/AKOAcDDZwxNN9DS90tR8zvbRpvuYJIgxKzRZZieg69uB+FV/NIYSQAksvzKB/Kq0U0MbHckjKCQTnDY9MdjTbi5W2jQRyHcP4hwCKlmVRaHAfE3VEtLeMlGUSS4PIycfw+2OtVvDsEaWhJ4VnJwPSsX4uPLPcweWzbChZkHIY5HNb3h10S1iVkOUQL/vEAc151d3mzgle6R12kR28sBWeHcFOR6VcnVWmURoEGOlZ1v5yIgwRxzxWnbxgyhpc4A45xXI+x3wjZXZFcsYlAIxnjnmqUM8cYcFhHIDkOOpq/cv5lyQqs4HOAOMVnX1iWjLbduecinr0NYtdSGS5MskhuXEjn+LdnIqmbjZK+AxQfdyc1Gi24kC7GcA8sD0rQksF+zPPGVMIO3rzn6U0mzKrNLQwLhI2LmaUDd2xVUCOP5WyCPQ1LqrFD8ueOScZrKiaRwxJzzjJqr20Z59Wb6Gws9yhZpYI4kySQpyT+FaNrLJdWbmwgaS4Rd2xhgn2FJZX1pfS5GD5uW+UjJH+FbkSReXG8TmORe+elU420Z6K5Z6oo2lnJIvzhVmP3lxnbVtILlZoncgKPlO3v706aa3jVJvMc8Ele3XqKtWk6yQsikYbnn0pWRo5WVhP9XM4Mucrnjt7VlTTsAUBJ4K7ivUGrd2XhBweV5JHORVGZmW5kWN1YOgwMU09Tjrq6PJ/HP+javatEW2oOp65zzXYeD5IWlVEjAChcgcdRyK5r4hWhjRJBtI35JHbParXhDUAHAfbuYcj2OOa6sPK0zkhrD0PYdBnRYZkbHzSe5wPX0rqdLmt3EsMu9o7lTFMiJ8xXsVz3Bwa43TJRFFhD+6XGVIxvz71uWkrJgxf6wkbEA6ev4V6cTqi7rQ6a/SW4smuWa4+1aMqq7yuFEsRJATb2cDnqelY11q0qys0TCRo1PkxO2VUn+WetPbVmis7u2RY9lx/rQ6gnI/iUnkGsO+S4hcrcRyQyW6ZdTw2CPlJHcYxTkmlZf1/TOqjJX943xqlrqIhhubWO2lU7RFarktjnPPXnr7CtGzsFv9aupJ5o4bWCNpoxO/zScjGMfyrC8OxMlzDc39y9vM33ZYkDFDnjAP4ZPpWpq1lJfTi3s54Zjbhv3cY2yYHzPKxOOpJOamF0jSfLzWT0Nzb9rsWa1MJmtCLiIMu7LD+E/3gelcHLqZ0+5m+0okZ3Z2oCMZ5wPp0/Cus8PXL2NjFPbSDzQ4mZsjOM449eO1J43t7nV7WG3srlE/0tLi3ikYGaTzARx6YAzk4x0rVPlZxKKjNxexnadrB1621KOeJ2a7aKKSd3JZEj9FP8Wec/hVG31XUtOnltLgmRJD+7LnbuXs3HQ0aI02lXN1BfOzyvOfML9d3XJFdtq9quoeHfJulKtFKZATFgnjpv8AQqenXOKqTjG2mjFJqMrNe6c7pMuqQXcGoOq2/m5ZHjUNmVG2sNp6HpkH1zTtcs5LO4GpXYivdPmZnlWPf+7c43b29AT1HFZer3MVrayTWT3c7YMkKQHepnGB82ezL36/lVjQdavNWsVzC8Vg6PFMo+84JBII7YI69azaad0OzX7xLQ07vXrfVYY5HktlNpOGQg8qPKC8eoLAcdsUljdLem6jSSNzbvtkyQdoA6g9D7U2wttKureU2CQhbZyN7oBucfe6DOP8Kz7yFL7SZUglsLe0fkOWYbSSeRjA/M4NZNJaJEJRk7bfoRReIdBvLiOztpJYbhFaFhJD/wAfH90n3yT82c9Ka1teX+rx6dIqlACzSwtuAH49+OtN1FhpGkoVtpr2QRFbeeGMlVjyRlT/AAKCTge9WPDsl3Z6U91qaPapHGA5SMyeZIcbVIX/AGQDkjg59q15klodcoe7zQ9Ffv5HZWem2wUQTyQWreQPvSDaRnnnPX/Csye6lS3t45roRTD92PMyFYDhev8AD1GR61XtViuLqAjUbUWLyFHlK8RyZGMnoqnJAPrVzVJ7eCFZo7iS/MJfDRkOhiz90Y7hutYddTijTadnqPtr6e/uils+1oXCXYlbO7ttXjcTgH8KmvHhaK0jhAgWQ8MZtwlweg9O9Y32q6ubRbi0iEVvHtaSR5dskWScYA6nAPNWbi4jOlv9kj/dDa7ERl2YEngYGVBbpipcDR0+yNSCSKWKe3kR4w2VfeMnHYiuLvhcxXJ0nz4yhJZWPQRnrx6Dk1s29yDHDOLiQW07MiCQHezKcHOeeDxzViG2iSXV7iOVvOIiTG0MAuTnBPuP1qqD5W7mSj7Nu/8ATOc8RSfYBbpbx7mDLsWIbSy9x+VSaTrlpf2uowSxILhEZ43bJdlyDsH4cZrO8W+Zd3tgpd4i8hyzADFc8Ybi21J1sX8+7dSoSMZJ45H1zXYtVZnXRpKcVfc9L0iN9VvrRJIVhgaMohUbPkRffqc4HvXV24sNN0u8tZy915YMkEgTA2FRkkDoFIrmIFsoNHsY9cufLu0i+1RqspETkKD5TnAIY91BzXXraxPo2/yU2+VI0axuJEUHGNpzk4IAIPrXLWa07GE7rfRf11OS8V6MEgWe0ubiUKolZ+CeRnC46VjQ38U9o6QQR2dvIv7y3Qlw8inIZuvXkbvpWxpF7dte+QIzFJHEWcEAL1xzngAnArm9TZI7uSbHkKSUbyWBzzyvpT5baM6KXN8MyeaRVvopJjHcln3OJkaVGB4OQDkmp7R0m8OXMauPt/2392kPyN5YX5jt7g+h6Y6VVg083ST4uZi8QC29umBLMSCcgdlUZJPXsK0tRj1HTbJLY+b5iwNApjTchjc/PvyTsckdR1GaiTu7GjaSSObuTAHQrHKqshEpbBBJ6EelZd1E0qKyq4j+8D0Bx1FbeoSQC+McEktzAUUOJYirAgeucEdR2P1rG1N44rS2uWuVXz7gxfZQclVC/fx25AHPWom1a5F5bI8u+J4Z54Jo2XerrGdpyAen+RW94bAa3Y7MAMQD+Nct8RDEv2eLeF86QuxxjBHX8eldj4acC0iwuCVGeO9edW+M4ZP3lY6qM4j3M4OVHtinwIzLulJ5+7SC1aaKJHyBjdn19KuwzRbI2cZKD7orlcdTthLQqnfE7Mi7lZMEj0qlJNLEjohJVhxkZ/Onzai0vnBYzuPAxxiqb3OxQXD7sYORTcjRrTVGLPJPEjRrkO5wdo/lRJeTRWywn5SeDkdaXU5JXQyhtoQ5DY7VBDbzXWyeSTzImGRWqi7XRySkm9RzpHh5GlVl21hs8RY4YYqxqCBWYbwAeMA9qzsYJ2sFHpik2tzjq2vodfa6ZJFO8jLEXJKIu3mr0iy28QZ/lUjB+taaStAysoQSLzGduTTZjJJbBCwLZyWYYz/9epvpZHswb7EFqGvBHBtwo/i4Aq/bxhLchCC3Q8VlhMYHm4J77sfpWjZZidVU78jAwec+9HmOaY18QvG0pBJJ3HueKoXsaG3Z0Vg65ypHWtTUdP8AL81pnBuVTIU8gn0rEXUWKMro6tjbgr1prTc56sbq6OK8d2zS6XK0TAoFDEdMY5rjvD18IJoZJGASHIbPcHp/n2rt/GQBsbvC/JsLBQeeRzXlkTBWIb7rDBrWL5XdHBS0bT6nvegagt1ZxszNgcqM5FdDay4A+c4JyCDnH0ryfwZqr29v9m3bgMZIx07Yr0eyuJLuFWKqnqwGP8mvUpzujph7ujN+c4O92xtHD7fvUkMLz3S3150DAYZi3bqfw7VnlnjU7QMY4BbANWVuGaz2AOMsQ5z8o9CPwzmtlK7sdMYtq6NcuPJfY67JHAIJzt96t6dItrfPqTuZLiL7kbsc5KkFs98DtWfA0bkNII5EihVUAGwkgc/WmFrh0gadPIhuW2id1+VgDgnjnjPIFUrPctK+iNazuF+0m6t4miiIGxWXCsP7wHuR2rYvrfVNRaC8u/KFvMrBVRCjsylcBxjkkcj6VkC2/s6R4LecSxQK20vGVLn6HkDPPIrtEupLezsoXnhmNmGKzQA4DEZ3Z9yevtTcrWa/r+tDmrSUXdHKatZJbmPVGZ51MyrOpPIwBjnrzjHNb8N7K7pZKVOjK5uEgOfkyciNmHOF5x9BTtQuZBpFxF9jYS3WxS23IADBt2Omatkxxae6xxB2cYRwBuY8fL+ePasZSvuc0qjcUjIt7eCESwyZMTSFjt/iBPXB+tZN9Yrpk5+x3EojuGf7SCDyvUFfr3HtWiupCS1mKW+6S2ViYBCDJkfe3HqMflUfiCe4utMSYSebNcwKTEZADEzHIxg8lccgjHNJN8w4wkpe8V9Nhh89bdbZo4dmWeJgPMH90ejYyc/nVCW1kke3ij8tRBO6BZpFiWORP4GHIJx+FXvDjyfbbcTkoYgwlAblSRgkD6Z/Oq+pl4w26KGdpJ2aVpIx8gOfnI9ac9GbwbU7f11II7wRRTQy291akR77piSqFf4fKHQr3yKs6TLrt/e3EcISCfzTGJJgI95xnAHbtz3qPVrZrjwvG8N0LgXMS2JjjTzBu3DHQ5X06c4pkhSx06OA3sENrE4QpcD55NuQ2D2yex544oi76HRZNXS1+8Zp9xq88giu7O2bSkyrorKNzDkEj684rp59Ltbe9SOzRWE6IyBFwx3DJDDsOpqpYtpt9Y/ZNTiuhHuQM06LDJsUZ4b+JQegPY9zTpdTj2zQRG8mmVQkDoFLrFzjBPOcKaGuxhV952irf1uYmsf2jptm6WUqXNhI+DEowyHjkY4I6e9UNO1bVWvra0iX7IWVkA2tvVx03L1UHPBrsba8zbMbuMNYzgu8cWCEIUbWPqentmsiO8a5Uy3xlWVMRgBCZJByAcjGAODntUtu1ma03pZxuUYP7esZZbS48loJoyqyxHlW3Dqp5yCc/nViKDUbS1mS4uYrncd28gxlmHp24zmp72S5isrU/Z1FnsaJJlbLSOrENkE5IzyexPNYF4L2edLLTrf7PAq5WcnAb+8F96hS5Xcbjz72RHqVtBPFPJcuJbnovz5AOegrV8O6aEsbO9ZZbe+RWlmfIIIDbkYY5AwBnvUS21tqMUUEi5jYj94vHPfH8q6uyga1tbuRo1eO0VYN27BAbsOOeMc9veur2mmn9dDCc3H3EXtbtoL24iht3jEc1qUhUwbg0zHLBSclc5Xk+tT2yWmkyXEEMEkbRN5W/wAwAI2xC2R3UHd0zzWZKkdp+7S3uA8bbgsjnJUqCVJHbn8qfFewQTzXNxG4SQ7Htf4ODnKEfeQjgk8556iseV2stibuUeUpakL+0u21CyliljuYmhdZiNoVhk9PYcfWub1lYbmdfIk+0qxBXzYEh3HpswvGR0J712DutzY3HmquwDdt/uDt19OK5KSNpUtbaW1YwGYAup+TAOSRjn696p23ZdGo0rPoT6BbQ29xbSX2n30W+J/KuLOYkuWYgszE4QKBs5xnJ71aFtZ21pqyaVuktAkciSOWWeKfcAYyeAw/DnNRWUsdjY6jNZ2d1KJ43O61Vh9nCuCu9x1zyeRkAD3qHUr42zSQQQw3Ua/8vqvlpkZcEKSOSpOORxj8aybb2/r+v60N223/AF/X9djNufNMP2aIEP5hkkV8biwHr6e1ZF5bGVFdQpATdnuv1FaBViriVS0mFdw3HXgHPftWVql28MLkrtWI4Ygc/SqdmrmNR22PKfiUE+1wxoWMpkVVyemep/lXS6DcvFAI2TeCMEjtXnXie4a78RRQr1WTcec4LEHGfYY/WvRNBLSpsOBGPl69a8qq7yZwt+8jo3v5HmijikAKjDDPNbGG2ZQEH+8Kzrey09iJo4mS4X5Xy3DVblcsjRRHZ25rFbndTj7tipbKltM2+YsM9MVa1BFFwEkZG2ruG3vmswtGjbZHBYHByaS/m5HRWA/Gi9kaTSSsZN3dESlGjPldOKQ3ilQqbwcbQAMYqxY2CXmorbvJ5ZkBILdM46VkX1yyubYRGB4mKkjnOKcdFdnJJdEU7m0cGWeZuc5C9zXMXUyTzs/nBMcYPUVv65IzxCQyFBjk9cVxwvLaNnVFWUbs7yM5pPXRHPK7PcIbuNp5BNt3bvk55Hvin3G7zGdZCsRIIQjOTWO8g+2yIV2yAkpnuK07RpiixKodlPG7nFEk2exSRXnUqhebCOhyI9mSRVyNoQ6zhmORjnjFS3ttJcyGfcpY4UjHWs+SDadjK5wcsT3pSujq+JF+5uQ4LRyDkYHc5rK1eULCreaWlHUFcE1YjilVsR8ovOQORVXUo5JoJEKEkNkMB2ovoc9SmmrHG+JA8lrLtixIFO0KcYyP1rzIggkEEEdQa9g1LTCI/wB3IxVVw7dOa8r1a3e3vpVfuxOfWtInmTST0NnwneRRS4lAJHynnt2/wr1bSNTje1Qk7QeNpNeF2U5trlJMZAPI9RXf6DeG5jXdwAc4B4rvoSuhRfVnqRuoggaBd4bsRznvV63ZHgVRiOQnJZvugen/ANesuwZJiAoCHgdeFPfrWq0nlkxRMxiIAZeNxHpXV6HZSbe5s6atodPuDqXmMsls7wNBjzEkVhgEHqD0qa3nSzu7ae1Te1mheZpcIJS47Ljtkj8BTNA09XmvmniVnSwmmtw5Aj3jH3s/UY96js4VuVuEtZryW0mMYNvFCjTlk+aQ/e+RFzwec96HLua2TT1LdjNE1zbSXkzv5nzN94EsPugH8ufzrUsr25iOFuTGzIHlWUhTJvPUDuuc1UsNJtpfDMmpJqV019bRq6JIiCLY7YVeOcnPU4PHTFQW8kgsrqCNLdpJAplldcyRnPG339R6VfNzGU4JnaxanHMqurPJGExskTbjB4HucY6Vh3UirdrGEmiLrkMkO/IJ7DueCMnjp6Ul/dTR3FlBpccGoWs6YmksTsbcTjLb+A3T9axJIL+xtibmdgWYlpCDvYIcFRjuOcVnFLoYwoJO/cfdQG0t4bj7bJaCSJkeTAeRyTyDjgDBH41TumNpJG1kpvJrotGJsY2kDqc8Dj09K1r6WytpAl5a3M9msSuJLf5fMXfuIKtgk8dTwOxqO5Ek/h2byAtvcT/Mv2hyMsOV+QdwDkN9c03Jo1u9Lmdeapf2NwgkVLK5YmRHcYWRT3P/ANap9Pa/1O4nlW5SQMqxtEOC6bvmfceF696zLhLkRiNpI32Kwdny4YDrt749qpRWlz50FpaTW8LeYrGRywiCEZVsgcZOeD6USasaU6cX2ubnh+7Oh6vNJYWscFrJC/nJI4R51xtBjU87s4x68+taWk2k15fTR31v5ccEivPuh8yV5MYGxVyuRnOTx61g3srywyNNaSTXMkiJLfFN6Rp2wO3zAgH3xVi2vZA6GbVnsbRc5ktYsucDt6A5wT07YqGzZx5tevzf+f8AVhJLzTlmk+2xyXsjgW7mZTsmAJOd2fkOSOAQMcVN4a+141G/Y+f/AGdAAn2QlZXY8Bcnpx1+lVnt3uLK5t7OJi8oSFJUUJliDlmX+Z45NXpLCLTIow01wjGGPznupc+eoyFJAGOccZIICnrVJ30HLlty9f6+7t/WklrcLPJHbBIbia6tooI1mxEQwOcjn2xntT4Lp7ifZLOy+YCjOzZWNAQeCcKSG5qva3VvYobWaz03U4JFI84R5iTn5iAeo6ZIPOM96h1LU2urh7hLhhGqIYIZ0DK23v8AiAO31ok7kct3ov6/r0H30726Qzy2yfbLgvcGQxkyyROMA56KhyxAHORk1Tuk+V4PKaTZHnLzBdoHfAPXnOaSB4G1G0k1C5HkMpkuzES4bOTgLkYweMD3pA7i3WZEiklGZQssfOCOFwfbHNZydtS5R7EtrcLDZwsjvK7jLRrjCHOMA/keea6q1vvtiNCmPtDRhY8qQSB19q4uKJ7rdHdRSKkUKyIDlAME7s+v+FbtlfyPMk6wb2G1lc87l9QP1q4zu9Dir07u/U0ZiIbpGtrqcssvEcjZZTtBOB6Zz+dad9LcqhtxbN5DMFSSWEhoiQSVz0A5zUhhszNHeRbReCQFWXngdQR265qfUJDc20Tec0xWEQLtyOc9x0Jxxn0rRtOxh7SLsZLzeVFdeazSCRAE6Ek4AGPauPvIZra9uIPtkUos36BjGrhhzjPOeorrdW3W9mGkgWYsQ4RRgha4+6+wm6EkUb3e6TymS6YMGz+GQoyOeehokbUVo2iyt1f2066dYT/Zw7EKrI0bZ2+3PKnrjpWay3cNsZFRdnnCOCCWQNIrY3HK9ce9bCvc6fp73c1+qXQuRFF9kKuhQfKSw4bBwQrDjjpWJPdmCVpL6N5HwDGwXAxnHJ67e3FZq9tzbbZFaa4lecTX0axyHLzeUCFznqPQVxmv6sZppEkmeJ2Zo4YjkscctI3tgV0l3qd5Lq05mMGxRtiij4DDrj2AzivL/Geq3c6pcyskF3EHEuBl2LHhST1GBWNWb5TGrom/6RyeiJJe60r43HJds17B4cHlWgGzeyHoOteVeD5PLuJ+OSAAcd69l0SEJaQyKMyt94ivMk7yZxxXNPU1bUF8YRgxOSTV2WB1geRFVgepz0pkMzJbnOdx9fWq8tyCmC7DscdKlWSPQW2hitNGJyZVznnjriqIfzbwso4Y8AmrF1b7pmCE4P8AFiqIja33DeCoGRnsarSxlObEaTfeCLJUA9QaoXVzGs7s6HK8Zb+I1ctpZI08yZR8vIyO1ZusXIni3xRAv1qdo3MW+hgeI7pZ7NwG25529D1rlIZIlUgwDOecsa1tbuBNBtCEO7AEDsKwoujZOTnrVwV9TFanuf2MyXfmxjAycF25A9K0ECQWwuRKGQttKdx71SnnhAO3c6seQOMGrMEyyW/leUF5HfpRfQ9hbkqXe/KKGEecjaeAaVpD5KSGRhngg8mpoUTyjsCknrRJCpld3VfKwMDOeandHSmmQQn5GVSVkPSoHuRkDLF8bTz1PtV1N8qq0YwRwcDr7U8iHbIfJUsABtYYwfWkl2M5nNXh2K0aOrMeBnpXmPjO2eK9jkKgI68EHNeqa3GslsZIQsRGQR6155rFjLcJIksnlxj5k3jjd3GafNytJnnVodTi62tF1M2gG5uEI6+lY7KVYqwwQcEUKcHNdMJuDujmR7r4YvllsUYv8zj5s9vaur091EY8xS6rz9fYnrXh3hLWGikSIvtAIAJPbv8AlXrttfQSW7BJVGP4FOc/j0rshO6Oqm7rlOhtrd79lihDPsBkf59oCjk4JPb9as6xqEM1xcy21tGtxK3zXVsdkk3ybduBwEJGSMZNcrLcLcQwxlpF2NwFbCnjuKuWciku8hwsQ3Eg9APStIu7O1JJXbOrhtBDZKitYeXC4inhjZkkuH27hIwP3gu4rntjvVfY32MonnXZysgQLsQsx2nJ6n0BFYQvmZlmjXfKg3oxY/d6c+9W7m7MlvGBcNI6gFVA2rg8kZ+tXclRba/r+vwO1XZp2g3VlcS2jAxKQFYyYdyzMm4fxKMfLVC4tFvtYktbe5sTZJGgeSGIjy3VcYVc5G49c9x2qGW7kuNJR7GYW1vDMDHFGpdoQcLvJxyf9o8nvUusrHqWpJMZXtMW4+zbwS86luHb0ByxBB56VOv9fIzSs2/UdpV/JNptxp1xdA3d4Rt+Quw2kjBCnnHXb3NQRTXMm21a1XZtMFqZ28p0IB3jnpg5696mjtbqSNni8m21GD5rSCJRtCgEs3mfdJ7EdjVZoYtTmtotUuFsoMFzPGgdwQuQSh7k5yab1vYm0W9f6+7+tyreK5Kf6OAHleGbYq8NtHzKB2Ixz65qCxEjWTR2z3AVSAIxy/JGAPWjZcxJFuM0uWw0MeA5P8JYVYuEnt/tRne4i+zANHIrhz7bhQ9CttCtpr20d0trbGeO327mZlYiRt2cOx7Zz07ip47qTTLdra2Nva+eeJ/KLcE5KEj+AtgnrzUx+03cH+hrdSQsiKy71GCegU8cknp71cluGSOO2v7WXyVH72FMKyv03Lj7p5GVHBI5FZOV3Yvmu7shIRLiW4urs3tjvP7y2Qp5p29NpOcA5OfanLe6hBawmF7iOKFhL5cuNwP9/B5JxwOOh96n/s24y7WbtewwqPMuIdu1GAyVHckAg4+vXFZRFxFHJJIxnieRDIykv5WG2oZQBlcgnaAeRRF2Q1aW2pYluXEyXC2RW3nIa0gmPmSW2cENgdRx34wailtPOlunuylx9sQzgu3lC32ffGFzgEkY+g9arahqJvWnltxDvRRHGqqF27eh46545qxZLI00Uc1uSgB3T2zBZJi68xsf4gCOmM8HmqbXUtJpX2/r+vUS7/dQ28CQNH5jKsmCoy2MLj1OCT9as2NxLA329JmWZSdkkmMoMYxjuPSs5n+zSwm3EUiq3yuzZlXtlT0A9qcBHudWtnWU7cMc4bvgnPIqJNbDlG61HSrFO8a3zSeZvLo0TnHPXPtx096sWpkleBhHIIUzuIYbIueMH+9ntVWNjLKHkjZolUuXYfKSPTvVu0iT+zXW4uFMQlCvbqNpcnncD0UjAz61Kb5jKZdk1VEWO3EVxeSXLiFVj6hj6DsSO9W9a1C4kXdYacyP5vkCNZlCEBBk47+x+vSsaGTdHdXbCeISMOIkw2cEKf8A9XWn2sLTyXEkM08NtbASTQSvueMDCnBx3J6e9aqfVkezitkPvdXa/wBJBUSvLAOVRcGMjsSfxrLhllS5aW1NtqTTxFYD5JJVlB+ZVPQjk8+lO1GYveQ3elXkUbOCvlMemORzVe2nhKRMZltELeY0nMrKw4LMBzyew9a0fvD5VGNkv6/rsWdL0cy6FJfHUIzPIjtal3PmyOpyxCjquDjcTwaw9SiuJo1FrdSqNgKhmDFEHYn61LKqQ3FwlxutmXcUlEeC57KR2BrOv9S+zW62jGIzOfkA5JB/oOaiVknqDlLmujL1KNpIkJDyTyHEc5ABbHUgeteQ+Kr43F55WS2w7mJ6knoPwH8zXd6p4khgkltpJNpQbYmC7ggz1HpXmeq3K3eo3E6fddyRxjI9cVy1pK1kcVaTb1Ok8DWYn3kBt7NjgV7DplnHbqoDNuIxhvXFcN8O4VSzjljTbgAgnv716fYXf2lnIQEgfKdtef1v3M6OsimftRZxImV7MOlVp08qMOeQeMVtEuWJUgIxweKp6taiCdnDgqo+VT3zVcqZ3NpKxk3FqV06K7klXY7EBB1XFclfXxFwiHlHbbkCuqu5x9jRWf5c8CuevFiR/mUdeMVEmtLHNK5PM9vtMJO4DnNZOo3McSlYhlcda1nw0ZVVUZGcmua8QArauq8NjGQfzq5Xa0OScujOU1WQKksqyncz4VR29ayoOVJ96bcMC+FJwOKdb/cP1rRKxUVZHt8XkxI2ZfnQ4K9Qav2KeZl0Hzhdykdq5fz5fMj4+U5L/Suhs9TtrZNhBYgZyq9aIpWPUVRmxAIvJVpEG8dT70/yhJbvE7hADkZ6mstL6B4mbepU8g5xTIpkJJYkBjnA55qXpozWE29i3JILYGOFyN4+8eAKVAZkcvKoc4DYHX3rNmcLLK0zt5bkFdw6ewp9uCJV2Iyljghj94VnJ2tY0d7XC6jTLLIS0eOg46Vzt/ZoWMkpzHuBVD2PY10l5HJAA8gWN2yAc4xXN6jL5ymMBWxnpR6nPVjzI848QWrW9y24A7nZ9wXGQayK7bxLDI1lwhHGPm71xRGCR6VrF6HnSVmPhkaKVXUkEHrXc6FrUv3SxeTIP4Y/KuCq3YXJgnjYswC9MGtYStoyqcrM9qsbkzFXUP5i8MXx39MVtCeGeBohHtaNhyuQSAOcj3rzTT9UmmwXLkvjn1rtLO5kMca2rq1ycHcwyM+ldkJ26HbD3ranSW0sjx7osIMkbxHgBcY/Kr2n3hivY2kVFQksFljL7crwduMHoDVGS/vLn7TvUSsEjV7eQECRVIOxsY444xUy3VrqeupBZ2q2PnRqI7ZZSBGMYJZzyTnmtuZdSraNm3c6lfT25jEdpF5gUKqoEllII4Lfyz2q/ZSJNA1o7RJcpbGKSSZyYhhgUj2Y6qQSCp6nmuaF5Ct3IvlogQgHaeScAYBHqRnpV7SpUWyUSOJfORi8fdMsD1I4ORnPfpQ9FYXQ22vvI05LO6tdOUT4W2csStm8nDM56DOM465waWK7hubmB/sIt2lDiW5LM7MDnBOepyMZrMtJsSCKylRbh43ICrxdOThd6v8AKABzxTksriKFp4LqAor7ZOfmhIHXnsWJGBnn0pNpO4mk1br/AF/X/BFniubqeANbRt56LO7KxAgU8fM46dMkc8VUWdorEDyI5oHR1kbd8jKOhBHPvWrcwDUdMSbTpVS7gDPKWOxbhyeiYHJxkYOPrWRqEbi4aynR0uEHliMdFxxlscEdTxScnew42ZIbGWfToJ7lYmS8xKPKmDBVH3ZCO2en4dqktLu1s4988ckwRysqibaVBB5Ddzk5qjZrYxWzQ2YDT8lpChESt0JJA49Pxq9I0EcrrbR3Eluoz5k6qJOBg8gYIB9B9ayd1qbX+z0+4tRRu3mQW63cy8SygKTjIxubb3znHsao3BeOCTIaNd2zejELLj1B644qxZXF1DCRZ3FwkcrnCJ8rPx98gdsHFVLx47h3aK1dcARsBIXDsOrDPY46U+YS3KoMU08UcIjGBhkk5LEdTn0xSQ6hbQRW6GWCKOBndpmVi7dgjHOGx2x2qNrNkgL7JEt0zHJcEBUSRs4GD0GPz5qpcfuEdMFYv+WbMocKf90dT6H3pX6Gqs9DR+0pcSrJBbxyLGMqGA2gN/8AW7Vb0+Rkt5AsqtEG3/e4A9ATzWMD5hETNMXcbf3Y2nj0HpVi9iW5tmtZn2BiELqMFf8APrUg7PR7GtduizRPKxXODIxIGVxkKOuc8Uti7m/MGAsIjLq7/cQnrnuTzVOGD7NJ9mikaFx88nIz2xuz/wDrqxPLGtoieassnzDyc7GXHIbd3z1pas53ZaIsyXa+XACZEuCgPmyZPnDORwOmOlQYe9jubJJIRexHzo2ckZZjhos9zyMVWub6Gwt2t9QjCXkcsQFoQ4eXd1UDHAxznj2p07uqQrbyQJEJhJFHFJnyyRyrZGcn9K1i0ws462/r+v66FzUDb2ulb7SWHyYtkQin2+ZvP3wAOoByfxrBuiogjjkWFdp2loiQ8qkkFgPUVpj7PLHcMIh5O4nyyQShP3mHrisV5LdIb9oVZmlUGMoNjZHI69CfarjoRzfeQ6rMy6arQTzTIMCaWVt5k+bAAH+znqO1c/qk9kkqyXZd7mICIoykluO3tWtG6yJO++SOCKPzPKDjggAkjvnNcfrv7m2juL5Huo7tzITvw7A9RntUzTMp1ElY4nxXqUF0I0tsK67llCr75Az3rmq0NW8qOZbeEAiLIL5yWJOcfh0p2gWzXWpRIkavg5IbpXn1JdWcba3R6v8AD7dBYxxyxKx8sAsTxXd6fL5IaTb8h44rB8N6X9ntUWbLSsPlwetdcsctpb+QyAJwduM5rCKdtTailci+0W7Ntl6DnisC91LzdRbajCPGAW71tzWga3lPKyewrk2Ro3bd8yHozdqd2tDeaW4zUlSWJI1Yhg24ViXkitcKg2gjk/WtO4kJmHGWIwoFZf8AZ89007ZVGiBYhj1qVHW6OeUu5XlvHRjkewrkNZvz9vmhmciMjp/9eupmcC3eQx5wOMVxuqvCIJJJBumkJC+1aJanNNq9rGJKgUBkYFWJA9auWFjc3EJeGJnXdjIrPr0HQE+x6XFE2A33j9TWtrmdeq6UVbVmxHcBsFBkng1NaZid9zdDzzWbbIMLtkbDcKpHNWfKKMXZyTjBArE9Wk7qxr288SNGA0bbu23NSs4jcu24AkKAKoRJbN5UcRbcDkOf5VZtLVp7geZIWw33c5zTfexvHfc3dNjjmhzJGHZOinoKmkt5niDxYbZ6fyFWLW1WyibzGYqTzsGSAaHmtYAws2d0OMtIMHNDWmpsmY1wGnRvtPz5PGTkisRo/ldIMI2fv7ckV0eqIzRlrVA3chOcGsD7eZlJdSrL8uFHes1vqZyfYyNTtmubVo9xLgdf734V51qFnJaSkSDivVvIVnDxy7Dt3ZNcz4n017pSLXazE5KDr+tWnY46sTg6KfKjRyMjjDKcEUytDlN/QdVkheOJ24Q5U9xXeadNKZxk4U5bcvIBryZSVII6iug8P3zi4jiMg2E5Xe2AD6E1rCfc3pTtqeuWt2lofMjkJkmATnPznuP/AK9b2kWduNMnM5j/ALTeRY7ZGfBG48k54wPcjmuO8K6jHYSyX85WXa4kjjK7ip9q6rT/ABFZx3n9rXBuXB+cSoRndyMjIPQ9a6oNNHVOUmvd1/rYjji+wtNbKWBhmPnlioLHOPlbpV3Rvt66nd3tysbWSYdUfG11PAJHcetGyzm8P+dLJb/2m10fMBkYSGPhlbb0x1Wqs1xbzIXF0u1E8uBOQAd3cjgkdfStJRvYaqbprc6NmeAJb+XvMbOvkRyExHdg/Kw9uoz2qvdqS8ckYRY4wAjK3QMQPud6i0+RYbz7VJAbxYyWKuAYmYHG4qOOhyPpUtrPi9ihu4xKFBbr+IKsOfTkUMmMrbf13Lk0zLawpK8k4cNFajYyFlz/AKxMdTnIx7+9Z93qGyC7kvo7lp5JElil8wgFB1DL1z1wau28cckcQ06P7LdxQyrNPNcHYzZ42A/ccj0qs3hBZVSWPV4f9ItxeyNcnG6Q5KpkHPK9Seh7VFRPoaU3CPxMWK4WbzVicMjgMJlGVIAxs2Dg845Perja80EX9nzJuwf3qSR5lhPHAJ+7n2OPWufsDBAgW3W5lEhwUTABJ9z3HI7VetJjauz5lRBI0XmyFSzqBwpTGRj1zjtU69QaiW8Sx6jc2zbmSJRJFMcsJh1K56YGQD9aikkK2TTPACqgk7ZADgnoAe3pVEs2FALiJYy4YygrGepwM4JPpVF54llYxlxwJcben+8B29h3pXSKH6otzdW7vNvk8wqsKu2UXH3Qe3ArLluIYMko0tyyiPyiTgY68j+lJe3ZQuqIxMpOA7kKR/ex1FVpN1z8484iNwqvjKhup2/gKhu7NVNpa7HTWWmahBpasbiK0tp2y0oUvK2B8qKn3uuOnWrNrcbLBbdpZLdGAmkMgJcFl4OT04Ga5rTLzUooIJk1Ro5EkYI7j95C3Rfrirls2pqhXVb83Uz/AHfnV3Zc85XGc/40Rd3axE9d2v6+RoT3QS6uooVBiVAWuThgCQM/U1fiukeNMJmNFCRPIin5QO57sfX04rLkmgjvDbzvDbuV8yXALLLkYVAo6cHP4VFcPLEI4rDEqsGV0OCI27AHuCKpaENppGjZhla5u5vPLOfMLsd0gI4jIJ6r2oUyNLBHcNHOJZGUuBh0LYBZh7dffFVINTs3tbjT7J5/tDRoyIqbi2Dnk54xyRisvVb5Z9RRJ5lto3XBKDJkbHXn/Oa00jsRdybuaOuah9mSO0tYjc+XIweeNyNyHHy47Y5z71VfVWllkjCMkbIAdxLKxBIVhjoAO1ZN7qMkEcTLcwM6KY3hbA49CP1zWTqGuW0a/ZI2kaQv88UShWJ/wovbVsylK6SS1N68up2EyXcke6TOyVNowQOOO5rzrU9Xa1huXkaRY5osW8bAEsxGCc+g/wDrVT8Q660l2/l3DsYg0ahT8vPB/Tv3PtXKTP5khYKFHZR2HpWE62lkck9dO4wkkkk8mvQfh1YRyKrunzMS2ccn0rh9Ns5b+8jtoBl3PfoB617V4Z0w2cAYhTtwMjp9K453ZlJ62O98OxwxiIuMuBwTzzWpdEzlkgJMzEZGeFx6CsTRpZIDFJtDYbIX0+tbUuoJHO0iqBJJ97jgGri1bU6Ixadyhqlw0aAPtBU7SPWua1p1kmMe1YyRnaBW7ehJrlpGBJA3Y7GuZvZjNcyy7ME8DPasm+ppJmP5Di4aQEhVHXHQ1l380sedsgLHrzW/PMzwycKg24OPWubvURYzuGXAzS2WjOWpOz1MHV9SeOyaBSAw6npXJXt21wkSEDbGMA+tbGrhktskqS4PQ1zlXBWIgk9SezQyXUSqMksOtdfFOCDuZQc1yNo5jlEgJUDqRVt7l/Mby5WKA4BBq3roZ1abqSOmvNXSUQpZqxkxgkfw1qWF0ZIQzxEKRySeprkLGWKG/kmWNwofBU10dva3Vq3nXEgaGX5kReNmazs22dsJpJJHSWkyCDymiVdwzu7mtHSVW3kHlrgjmuUtL+Y3RjmRpFUZEmOMeldVavbOAyMyvgHGelNarQ6YT11NltQQSnymyr/fA6DFNS2e8uRMpJtY1+b69hVSMphhjcQM57VNZ33k5AZTETkjoM0rpP3jrW3unQ2V3AgZY4PK8xcEVzGsWcUV0JkiUIxw4A4zV5bpp1dkO0ep71ZVEnhCSuGGclQOKrSaJcLanJ3IiyCSNi8jHQ+1Y93lhKqnYGXH1rq73w95MDzwThhyxj/u/SucuIomwCuXHrWbutGZzgmrHmesWz29xlyGLdSBjFZ9dt4h0134iiLKcA8c59a42WNopGRgQwODVwfRnDUhZ3I6cpxnuD1ptFWZJ2Om8MawtozW92d8TriMscKD712T6vfmOKG0iiEmdrqT8rJ6/WvLIXVW/eJvQ9R6e4rtb/xNbf2bbLbcysgWQhMbSP8AH2renJNWbsbxqtW0udtp0UmuavF9rkww4RTIE3sO248Ae5NSjUlsYbSKULbJPM0yxhvMjVsnAYHp2615x9utra2YvNO8jIcoB8jgjt9K07RhDYW1zqzyXLTFdkEY25QHoT3zWr1do7m6mur07Hpdnem8tLw3GnFZYmETyQPhFc98DjGDVvzYJNRZba1KRKiRRhJM75CMfMT2PX2rh7fVV07yxZfaCjhnB425HQP/ACqymsvLC7uE3SZYlQN4J64Hp71qpWVnuOOrutjq31MmUqkaRwqgRoxwgYcE49c1YLQy2RncqmAWYofmBUY28nGCecYriftctuisuSxBwXHqOB9adb6y1pCwlt/NRxjhQSD6nnil7VGz2906rV7m7S4tRc27SytGJYvKwC47Hn0755qI3cx1GBJIt6Tv88xOVHbkjnH0qhp2qrdwyyJL5MImB3ygELgdMH5iPfpSSX6raQLFtllWQoUclkdc/ewOVFQ1f3kzL2ltLGrc3ES3Bit4GMYbyxLsO1m5xs4zjgnPSsiRDI8cgRJJGXHnDcdwBzhQenpUmpanG2f+JhmKQKSgDL8w6Nljk49Kx7l3TUnSO3kKzIAJfMXyyMchQejE4qJWKhN27Emo33kQTq8hLuMybm3MGP8ACNpyfxNU0l2PbrLI4hRCFjV9h3n8/wCVN1a7tkjYBZI7iOMMA0JWVsHjAHGKykvNRa8W8njZL91bDXaqVZiORsI9DxUSbUilK8TpLW4s7i5Pm3lzBLAAAEXzWDHoT/nNalrfWenFrmWPzLdD80YJQscYzzz15zXH20tvpgaTVI5beeRMp5MIbzJAcYByCvXr7dDUs1jqFy91eSfaZ0gQb2Vg6QISApf69PrS9pZPuK6vq9Desb61nf7S+8TzHYyhxllA+8W/hq1Z3BhSGFZY7IEFmtw7E3IByAeD6Zz7Vx/9sCKxaKyEJQsFUbSNzYyVAY44PU854psV7DE88zyxW9yVEQMh+QKeuAfun1681SldCnPV3Ox1G5GlXAW5tFtJomeMgZSRW4OMdsg4Gc1lXOuBzDb3N2LcFmxGRvZPTc38XBA471xlv4hlfdEcPZxH5d67m3E/e59aytb1OSfUzJDMqmNSiMhwBzzj070/aXVznnJLQ2dQ1qSJJPOtIjH9oKuythsfwjjvwSa5eW/lEsxhldd7HLgncR9etV5mA+VZGfIyxb+93x+XWoaynJ7GDqNik5GOMU2ilrMg6HwfCxvGmRtuzg/Q167oMxaFBnKIelcd8PtLjuXj85QsSD5yONxx0r07RdNj0yNjCuUlOdrdvpUa7kRTcrmxaNGY0xxUd0geUxhwFHzZ/pVeaWZU2xKGKjjFXrSFp7AmbCSZzimtTrTsZDXTmNtoAj6Ed6zdTWERNIjkRr1yO9SahZva3YmkkfZ/COzVk6g7eUck7CeRTkQ2ZV8xUhY2G3qTniue1a9SJJGO5wOuOuK3b5o0VkYnOeK43xTOybFgG0EYb3qLW2OWb5nY5ue5YXJeNsqM7QeeKp09juOTjPtTK0NErFp0RbFGB/eM3Iz27U23+4frUOfb6VNb/cP1oBKxYRzEhk3kiQ7WArotMuzLB9kl8xpUGASePasQf6iL/rq39K6LTv8Aj8P+6KJLS4Qepd09ZVdrd1AIUMhz19a2tMW5mvUtYbZmdULs46YFUbf/AI+B/u12Ogf8hKb/AK9W/wDQaiC5nZnVe+pRsXlLNHGCIyc7xV37JEnmLKSAw4zVfR/9U1bGq9IP92m4pq7PRjpoiuqqlmiKAV/vE01WeNdq7TnqVp6/8eifU1Pb/wAX+7UN2VkaKKIVLTIVG70xVO+8Pysn2w7lHUKo6/hXRaD/AMt/95P510c/3ofoa2VNS1ZjV912R5RLLCLOSMW5O5htfoc+lcT4rsDdgvDblXRtxA6kV6HqP+sk/wCuh/mayLj7h+gqG3a5x1YJanj8sTxNtkVlbrgjFR11fiv/AI+R/ntWBTRxlOnKcHkZq1RTAbFdzQkFX3ADG1hkY9PpW/D4mRNO+yfZQ6EY2tyoOeCPQjpmsROv4H+VJVxqSiyr6HQi7mntminYupB2bxggZzz7+lSnUbu0kRbTYJlXo/zA9yM+tV9M/wBYn+4n8627H/kIXv8Avy/yFdcoJo2dblVrEMbooF1c6g3mGTMm4kEMRyxB6itVdUiVJEZVuY2UbFVwQSP4mJ6CuP8AEX/H2f8Armn8qgHWL/rktZ89nyoabnudXHqs0d1BcRadbTRSIu/K4WHIxnrwa1I9RuJUje4AjaT98WhnDeYCxUA4yQeOpx06VF40/wBRa/8AYOs//QDXNeCv+Qo3++n8zS5veS7kKXNDmt/VrmlqhZ483lwlwIcvCWnAdSexU4JHTkVlX+sl9OgzKqTyPtmkXknHp2wOO1O8Rf8AIUj+prOm/wCPp/qP5Vz1J2k0jpppySNZdSVtPk2XEkxCHALANnPXk5P0pIdSlvS+YrZQDlp5sGVgBnPJ+U5wM8Vzafeb/dNaN1/yCIf90fzFWp3M1PS5q/2rZ2xnuba6uJ49xzCx5k4A3BiMjH0rK1LUEM5kkMqTBMxqAAB3G71qKz/18X+6/wDKmL/r7v8A65H+lF+aNxOTjqhJ76O8S3jy8JhPDhBlsnJYnjvVC7vJrmdpZ5XmZsZZzywHQew9qWiouYObbuVxK4RlBwrdV7VHVyilcgqHtSVcooAp1d0u3+03ar6c0lbfhL/kKL9KmTsgPYvh3poOnIJECog3ZI716TpqR3jpbsFEKDliOlc54Y/5ARrp/D/3h9TWqWyHFWuRLY2Vs84BBTJw1c/cRS+dPIsmIkPGe4rrL7/jwl/3jWDd/wDIOb/dFKyOhHN6jtkt1+0kgHmMZrD1XfFsjjRWQDOc8mtPWOsX+6f51m3/AEX6UmctbU5O+bzTvI2/7JriPEU25iFk3Dd0PUV3t194/X+lcFrX/Hyf941jHexhHWdjCoq5RWp0FT6VPB9w/WpKmt/un60Af//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This patient has lichen planus which in this case is clinically indistinguishable from leukoplakia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7141=[""].join("\n");
var outline_f6_62_7141=null;
var title_f6_62_7142="Clemastine: Drug information";
var content_f6_62_7142=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Clemastine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?34/51/35636?source=see_link\">",
"    see \"Clemastine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/13/25813?source=see_link\">",
"    see \"Clemastine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F152461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tavist&reg; Allergy [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F152492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Ethanolamine Derivative;",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, First Generation",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F152465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rhinitis or allergic symptoms (including urticaria):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.34 mg clemastine fumarate (1 mg base) twice daily to 2.68 mg (2 mg base) 3 times/day; do not exceed 8.04 mg/day (6 mg base)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      OTC labeling:",
"     </i>",
"     1.34 mg clemastine fumarate (1 mg base) twice daily; do not exceed 2 mg base/24 hours",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F152478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/13/25813?source=see_link\">",
"      see \"Clemastine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rhinitis or other allergic symptoms (including urticaria):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children &lt;6 years: 0.05 mg/kg/day as",
"     <b>",
"      clemastine base",
"     </b>",
"     or 0.335-0.67 mg/day clemastine fumarate (0.25-0.5 mg base/day) divided into 2 or 3 doses; maximum daily dosage: 1.34 mg (1 mg base)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Children 6-12 years:",
"     </i>",
"     0.67-1.34 mg clemastine fumarate (0.5-1 mg base) twice daily; do not exceed 4.02 mg/day (3 mg/day base)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Children &ge;12 years:",
"     </i>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F152466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lower doses should be considered in patients &gt;60 years of age.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F152447\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral, as fumarate: 0.67 mg/5 mL (120 mL) [equivalent to clemastine base 0.5 mg/5 mL; prescription formulation]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as fumarate: 1.34 mg [equivalent to clemastine base 1 mg; OTC], 2.68 mg [equivalent to clemastine base 2 mg; prescription formulation]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tavist&reg; Allergy: 1.34 mg [scored; equivalent to clemastine base 1 mg]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F152433\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F152448\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Perennial and seasonal allergic rhinitis and other allergic symptoms including urticaria",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F13931347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F152490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Palpitation, hypotension, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dyscoordination, sedation, somnolence slight to moderate, sleepiness, confusion, restlessness, nervousness, insomnia, irritability, fatigue, headache, dizziness increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash, photosensitivity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea, xerostomia, epigastric distress, vomiting, constipation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary frequency, difficult urination, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Hemolytic anemia, thrombocytopenia, agranulocytosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Thickening of bronchial secretions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F152451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to clemastine or any component of the formulation; narrow-angle glaucoma",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F152437\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use with caution in patients with a history of asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease (including hypertension and ischemic heart disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased intraocular pressure: Use with caution in patients with increased intraocular pressure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pyloroduodenal obstruction: Use with caution in patients with pyloroduodenal obstruction (including stenotic peptic ulcer).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use of this potent anticholinergic agent due to increased risk of confusion, dry mouth, constipation, and other anticholinergic effects; clearance decreases in patients of advanced age (Beers Criteria).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F152489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2D6 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F152442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F152459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F152443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14387198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maternal clemastine use has generally not resulted in an increased risk of birth defects. Antihistamines are recommended for the treatment of rhinitis, urticaria, and pruritus with rash in pregnant women (although second generation antihistamines may be preferred). Antihistamines are not recommended for treatment of pruritus associated with intrahepatic cholestasis in pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F152467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14387200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Small amounts of clemastine may be excreted in breast milk. Premature infants and newborns have a higher risk of intolerance to antihistamines. Adverse events were observed in single case report of a nursing infant. Use while breast-feeding is contraindicated by the manufacturer. Antihistamines may decrease maternal serum prolactin concentrations when administered prior to the establishment of nursing.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F2524731\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Syrup",
"     </b>",
"     (Clemastine Fumarate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.67 mg/5 mL (120 mL): $19.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Clemastine Fumarate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.34 mg (100): $33.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.68 mg (100): $86.05",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Dayhist Allergy 12 Hour Relief Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.34 mg (8): $2.03",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Tavist Allergy Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.34 mg (8): $4.24",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F152445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Look for a reduction of rhinitis, urticaria, eczema, pruritus, or other allergic symptoms",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Agasten (BR);",
"     </li>",
"     <li>",
"      Alagyl (JP);",
"     </li>",
"     <li>",
"      Aloginan (JP);",
"     </li>",
"     <li>",
"      Alphamin (JP);",
"     </li>",
"     <li>",
"      Anhistan (JP);",
"     </li>",
"     <li>",
"      Arrest (JP);",
"     </li>",
"     <li>",
"      Benanzyl (JP);",
"     </li>",
"     <li>",
"      Clamist (IN);",
"     </li>",
"     <li>",
"      Clemanil (JP);",
"     </li>",
"     <li>",
"      Clemastinum (PL);",
"     </li>",
"     <li>",
"      Darvine (TW);",
"     </li>",
"     <li>",
"      Fuluminol (JP);",
"     </li>",
"     <li>",
"      Fumaresutin (JP);",
"     </li>",
"     <li>",
"      Inbestan (JP);",
"     </li>",
"     <li>",
"      Kinotomin (JP);",
"     </li>",
"     <li>",
"      Lacretin (JP);",
"     </li>",
"     <li>",
"      Langjing (CL);",
"     </li>",
"     <li>",
"      Lecasol (JP);",
"     </li>",
"     <li>",
"      Maikohis (JP);",
"     </li>",
"     <li>",
"      Mallermin-F (JP);",
"     </li>",
"     <li>",
"      Marsthine (JP, PH);",
"     </li>",
"     <li>",
"      Masletine (JP);",
"     </li>",
"     <li>",
"      Piloral (JP);",
"     </li>",
"     <li>",
"      Tandegyl (PK);",
"     </li>",
"     <li>",
"      Tavegil (BB, BM, BS, BZ, DE, ES, GB, GY, IE, IT, JM, LU, NL, SR, TT);",
"     </li>",
"     <li>",
"      Tavegyl (AT, BF, BG, BJ, CH, CI, CO, CZ, DK, EE, EG, ET, GH, GM, GN, HN, HU, ID, IN, KE, LR, MA, ML, MR, MU, MW, NE, NG, NO, PH, PT, RU, SC, SD, SE, SL, SN, TH, TN, TR, TZ, UG, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Tavetine (MY);",
"     </li>",
"     <li>",
"      Tavist (PH);",
"     </li>",
"     <li>",
"      Telgin-G (JP);",
"     </li>",
"     <li>",
"      Xolamin (JP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F152436\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competes with histamine for H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F152450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Peak effect: Therapeutic: 5-7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 8-12 hours; may persist for 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : ~800 L (range: 500-1000 L) (Sharma, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic; metabolized via unidentified enzymes by O-dealkylation followed by alcohol dehydration, aliphatic oxidation, aromatic oxidation, and direct oxidation; significant first-pass effect (Sharma,  2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~40% (Sharma, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~21 hours (range: 10-33 hours) (Sharma, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~42% as metabolites) (Sharma, 2003)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, &ldquo;The Transfer of Drugs and Other Chemicals Into Human Milk,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/62/7142/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/62/7142/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kok TH, Taitz LS, Bennett MJ, et al, &ldquo;Drowsiness Due to Clemastine Transmitted in Breast Milk,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1982, 1:914-5.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sharma A and Hamelin BA, \"Classic Histamine H1 Receptor Antagonists: A Critical Review of Their Metabolic and Pharmacokinetic Fate from a Bird's Eye View,\"",
"      <i>",
"       Curr Drug Metab",
"      </i>",
"      , 2003, 4(2):105-29.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/62/7142/abstract-text/12678691/pubmed\" id=\"12678691\" target=\"_blank\">",
"        12678691",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9274 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-203.80.222.8-5CA963D2D9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7142=[""].join("\n");
var outline_f6_62_7142=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152461\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152492\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152465\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152478\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152466\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152447\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152433\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152448\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13931347\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152490\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152451\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152437\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152489\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152442\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152459\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152443\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14387198\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152467\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14387200\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2524731\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152445\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038583\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152436\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152450\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9274\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9274|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?34/51/35636?source=related_link\">",
"      Clemastine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/13/25813?source=related_link\">",
"      Clemastine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_62_7143="Calcium and vitamin D: Drug information";
var content_f6_62_7143=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Calcium and vitamin D: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?40/62/41956?source=see_link\">",
"    see \"Calcium and vitamin D: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F3343750\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cal-CYUM [OTC];",
"     </li>",
"     <li>",
"      Caltrate&reg; 600+D [OTC];",
"     </li>",
"     <li>",
"      Caltrate&reg; 600+Soy&trade; [OTC];",
"     </li>",
"     <li>",
"      Caltrate&reg; ColonHealth&trade; [OTC];",
"     </li>",
"     <li>",
"      Chew-Cal [OTC];",
"     </li>",
"     <li>",
"      Citracal&reg; Maximum [OTC];",
"     </li>",
"     <li>",
"      Citracal&reg; Petites [OTC];",
"     </li>",
"     <li>",
"      Citracal&reg; Regular [OTC];",
"     </li>",
"     <li>",
"      Liqua-Cal [OTC];",
"     </li>",
"     <li>",
"      Os-Cal&reg; 500+D [OTC];",
"     </li>",
"     <li>",
"      Oysco 500+D [OTC];",
"     </li>",
"     <li>",
"      Oysco D [OTC];",
"     </li>",
"     <li>",
"      Oyst-Cal-D 500 [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F3343754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Calcium Salt;",
"     </li>",
"     <li>",
"      Electrolyte Supplement, Oral;",
"     </li>",
"     <li>",
"      Vitamin, Fat Soluble",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F3343771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Calcium supplement, hyperphosphatemia: Oral: Refer to individual monographs for dietary reference intake.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3343772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F3343773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use caution in severe renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F3343780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Caplet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Citracal&reg; Maximum: Calcium 315 mg and vitamin D 250 units [gluten free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule, softgel, oral: Calcium 500 mg and vitamin D 500 units; calcium 600 mg and vitamin D 100 units; calcium 600 mg and vitamin D 200 units",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Liqua-Cal: Calcium 600 mg and vitamin D 200 units [contains beeswax, lecithin, and soybean oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, oral: Calcium 250 mg and vitamin D 125 units; calcium 500 mg and vitamin D 125 units; calcium 500 mg and vitamin D 200 units; calcium 600 mg and vitamin D 125 units; calcium 600 mg and vitamin D 200 units",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Caltrate&reg; 600+D: Calcium 600 mg and vitamin D 200 units [contains soybean oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Caltrate&reg; 600+Soy&trade;: Calcium 600 mg and vitamin D 200 units [contains soy isoflavones 25 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Caltrate&reg; ColonHealth&trade;: Calcium 600 mg and vitamin D 200 units [contains soybean oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Citracal&reg; Petites: Calcium 200 mg and vitamin D 250 units [gluten free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Citracal&reg; Regular: Calcium 250 mg and vitamin D 200 units [gluten free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oysco D: Calcium 250 mg and vitamin D 125 units",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oysco 500+D: Calcium 500 mg and vitamin D 200 units [contains tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oyst-Cal-D 500: Calcium 500 mg and vitamin D 200 units [sodium free, sugar free; contains tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, chewable: Calcium 500 mg and vitamin D 100 units; Calcium 600 mg and vitamin D 400 units",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Os-Cal&reg; 500+D: Calcium 500 mg and vitamin D 400 units [sugar free; contains phenylalanine; light lemon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Wafer, chewable:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cal-CYUM: Calcium 519 mg and vitamin D 150 units (50s) [dye free; vanilla flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Chew-Cal: Calcium 333 mg and vitamin D 40 units (100s, 250s)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F3343752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F3343775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer, preferably with food, 2 hours before or after other medications.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F3343755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dietary supplement, antacid",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9405019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Os-Cal&reg; may be confused with Asacol&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F3343763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined; also see individual agents",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Endocrine &amp; metabolic: Hypercalcemia, hypercalciuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Gastrointestinal discomfort",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F3343759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to any component of the formulation; hypophosphatemia,  hypercalcemia, evidence of vitamin D toxicity; history of kidney stones",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F3343760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal effects: Constipation, bloating, and gas are common with calcium supplements (especially carbonate salt).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Achlorhydria: Calcium absorption is impaired in achlorhydria; common in elderly, use an alternate salt (eg, citrate) and administer with food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoparathyroid disease: Hypercalcemia and hypercalciuria are most likely to occur in hypoparathyroid patients receiving high doses of vitamin D.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Kidney stones (calcium-containing): Use caution when administering calcium supplements to patients with a history of kidney stones.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal failure to avoid hypercalcemia; frequent monitoring of serum calcium and phosphorus is necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Minerals/other oral drugs: Calcium administration interferes with absorption of some minerals and drugs; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenylalanine: Some products may contain phenylalanine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Shellfish: Some products may be derived from shellfish.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Soy: Some products may contain soy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tartrazine: Some products may contain tartrazine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Absorption: Taking calcium (&le;500 mg) with food improves absorption.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F3343766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Antacids may decrease the serum concentration of ACE Inhibitors.  Management: Separate fosinopril administration from antacids by at least 2 hours. US and Canadian recommendations for use of other ACE- inhibitors with antacids may vary. Consult appropriate labeling. Monitor for decreased therapeutic effects of ACE-inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Enalaprilat; Ramipril.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: Antacids may decrease the absorption of Allopurinol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists: Antacids may decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antacids may decrease the excretion of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Hydantoin): Antacids may decrease the serum concentration of Anticonvulsants (Hydantoin).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): Antacids may decrease the absorption of Antipsychotic Agents (Phenothiazines).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: Antacids may decrease the absorption of Atazanavir.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisacodyl: Antacids may diminish the therapeutic effect of Bisacodyl. Antacids may cause the delayed-release bisacodyl tablets to release drug prior to reaching the large intestine.  Gastric irritation and/or cramps may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Calcium Salts may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral calcium supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Antacids may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of antacids containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: Antacids may decrease the serum concentration of Bosutinib.  Management: Administer antacids more than 2 hours before or after bosutinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Acetate: Calcium Salts may enhance the adverse/toxic effect of Calcium Acetate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Calcium Salts may diminish the therapeutic effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the cation exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of CPS effects. Avoid magnesium hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefditoren: Antacids may decrease the serum concentration of Cefditoren.  Management: Concomitant use of cefditoren with antacids is not recommended. Consider alternative methods to control acid reflux (eg, diet modification) or alternative antimicrobial therapy. If antacid therapy can not be avoided, separate dosing by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefpodoxime: Antacids may decrease the serum concentration of Cefpodoxime.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefuroxime: Antacids may decrease the serum concentration of Cefuroxime.  Management:  Consider administering antacids and cefuroxime at least 2 hours apart.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloroquine: Antacids may decrease the serum concentration of Chloroquine.  Management: Separate administration of antacids and chloroquine by at least 4 hours to minimize any potential negative impact of antacids on chloroquine bioavailability.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Oral): Antacids may decrease the bioavailability of Corticosteroids (Oral).  Management: Consider separating doses by 2 or more hours. Budesonide enteric coated tablets could dissolve prematurely if given with drugs that lower gastric acid, with unknown impact on budesonide therapeutic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Antacids may decrease the serum concentration of Dabigatran Etexilate.  Management: Dabigatran etexilate Canadian product labeling recommends avoiding concomitant use with antacids for 24 hours after surgery. In other situations, administer dabigatran etexilate 2 hours prior to antacids. Monitor clinical response to dabigatran therapy.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Antacids may decrease the absorption of Dasatinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Antacids may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Calcium Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Delavirdine: Antacids may decrease the serum concentration of Delavirdine.  Management: Separate doses of delavirdine and antacids by at least 1 hour. Monitor for decreased delavirdine therapeutic effects with this combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: Antacids may increase the absorption of Dexmethylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Focalin XR brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOBUTamine: Calcium Salts may diminish the therapeutic effect of DOBUTamine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: Calcium Salts may decrease the serum concentration of Eltrombopag.  Management: Separate administration of eltrombopag and any polyvalent cation (e.g., calcium-containing products) by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elvitegravir: Antacids may decrease the serum concentration of Elvitegravir.  Management: Separate administration of antacids and the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate combination product by at least 2 hours in order to minimize the risk for an interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erlotinib: Antacids may decrease the serum concentration of Erlotinib.  Management: Separate the administration of erlotinib and any antacid by several hours in order to minimize the risk of a significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Estramustine: Calcium Salts may decrease the absorption of Estramustine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gabapentin: Antacids may decrease the serum concentration of Gabapentin.  Management: Administer gabapentin at least 2 hours after antacid administration.  Monitor patients closely for evidence of reduced response to gabapentin therapy when both of these drugs are being used.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Antacids may decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: Antacids may decrease the absorption of Iron Salts.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: Antacids may decrease the absorption of Isoniazid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Itraconazole: Antacids may decrease the serum concentration of Itraconazole.  Management: Administer itraconazole at least 1 hour after and 2 hours before administration of any antacids.  Itraconazole oral suspension may be less sensitive to the effects of decreased gastric acidity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketoconazole (Systemic): Antacids may decrease the serum concentration of Ketoconazole (Systemic).  Management: Administer oral ketoconazole at least 2 hours prior to use of any antacid product.  Monitor patients closely for signs of inadequate clinical response to ketoconazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mesalamine: Antacids may diminish the therapeutic effect of Mesalamine. Antacid-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products.  Management: Avoid concurrent administration of antacids with sustained-release mesalamine products.  Separating antacid and mesalamine administration, and/or using lower antacid doses may be adequate means of avoiding this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methenamine: Antacids may diminish the therapeutic effect of Methenamine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antacids may increase the absorption of Methylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Ritalin LA brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Antacids may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, antacids may decrease the absorption of orally administered iron.  Management: Separate dosing of oral iron-containing multivitamin preparations and antacids by as much time as possible in order to minimize impact on therapeutic efficacy of the iron preparation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May increase the serum concentration of Calcium Salts.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Antacids may decrease the absorption of Mycophenolate.  Management: Separate doses of mycophenolate and antacids by at least 2 hours. Monitor for reduced effects of mycophenolate if taken concomitant with antacids.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nilotinib: Antacids may decrease the serum concentration of Nilotinib.  Management: Separate the administration of nilotinib and any antacid by several hours whenever possible in order to minimize the risk of a significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PenicillAMINE: Antacids may decrease the serum concentration of PenicillAMINE.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Antacids may decrease the absorption of Phosphate Supplements.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Calcium Salts may decrease the absorption of Phosphate Supplements.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ponatinib: Antacids may decrease the serum concentration of Ponatinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: Antacids may decrease the absorption of Protease Inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Darunavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Antacids may decrease the excretion of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Antacids may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of quinolones.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Calcium Salts may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of both agents.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Moxifloxacin (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilpivirine: Antacids may decrease the serum concentration of Rilpivirine.  Management: Administer antacids at least 2 hours before or 4 hours after rilpivirine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of SPS effects. Avoid magnesium hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Strontium Ranelate: Calcium Salts may decrease the serum concentration of Strontium Ranelate.  Management: Separate administration of strontium ranelate and oral calcium salts by at least 2 hours in order to minimize this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Antacids may decrease the absorption of Tetracycline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Calcium Salts may decrease the serum concentration of Tetracycline Derivatives.  Management: If coadministration of oral calcium with oral tetracyclines can not be avoided, consider separating administration of each agent by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May decrease the excretion of Calcium Salts. Continued concomitant use can also result in metabolic alkalosis.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Calcium Salts may diminish the therapeutic effect of Thyroid Products.  Management: Separate the doses of the thyroid product and the oral calcium supplement by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Antacids may decrease the absorption of Trientine.  Management: Separate trientine dosing from other oral drugs (eg, antacids) by at least 1 hour. Monitor for decreased therapeutic effects of trientine if an antacid is initiated/dose increased, or increased effects if an antacid is discontinued/dose decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Calcium Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Calcium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vismodegib: Antacids may decrease the serum concentration of Vismodegib.  Management: Carefully consider the need for any medication that increases the pH of the upper GI tract (PPIs, H2RAs, antacids), as these could significantly reduce vismodegib systemic exposure. Vismodegib dose increases are unlikely to compensate for this effect.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Calcium Salts may enhance the adverse/toxic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F3343769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ethanol: Avoid ethanol (may increase risk of osteoporosis).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Food: Food may increase calcium absorption. Calcium may decrease iron absorption. Bran, foods high in oxalates, or whole grain cereals may decrease calcium absorption.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3343756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Available evidence suggests safe use during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F3343758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Available evidence suggests safe use during lactation.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F3343774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take (preferably with food) 2 hours before or after other medications to minimize GI upset. Some products may contain phenylalanine (avoid use in phenylketonurics).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F5685564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Calcium Carbonate-Vitamin D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-200 mg-unit (90): $5.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Calcet Creamy Bites Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500-400 mg-unit (30): $16.24",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Caltrate 600+D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-400 mg-unit (60): $7.58",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Caltrate Gummy Bites Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250-400 mg-unit (50): $8.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Citracal Calcium Gummies Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250-115-250 mg-mg-unit (60): $10.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Cal-Quick Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500-400 mg-unit/5 ml (480 mL): $15.16",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, 24-hour",
"     </b>",
"     (Citracal Calcium+D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-40-500 mg-mg-unit (80): $10.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Calcium Carbonate-Vitamin D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-200 mg-unit (120): $8.02",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-400 mg-unit (120): $5.46",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Calcium Citrate-Vitamin D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250-50 mg-unit (180): $5.06",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     315-200 mg-unit (180): $16.35",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     315-250 mg-unit (60): $2.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Calcium-Vitamin D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500-125 mg-unit (100): $2.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-125 mg-unit (60): $3.76",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-200 mg-unit (60): $5.59",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Caltrate 600+D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-800 mg-unit (120): $12.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Citracal Maximum Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     315-250 mg-unit (120): $10.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Citracal Petites/Vitamin D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200-250 mg-unit (100): $6.52",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Citracal/Vitamin D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250-200 mg-unit (150): $10.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Os-Cal 500 + D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500-200 mg-unit (75): $7.13",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500-600 mg-unit (60): $6.60",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Oystercal-D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500-400 mg-unit (60): $3.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Pronutrients Calcium+D3 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600-800 mg-unit (100): $8.63",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (RA Hi-Cal Plus Vitamin D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500-200 mg-unit (60): $5.19",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F3343777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor serum calcium (particularly if used in patients with severe renal impairment)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10961929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Calcio 600 + D (CO);",
"     </li>",
"     <li>",
"      Calperos D3 (HK);",
"     </li>",
"     <li>",
"      Calporosis D (ID);",
"     </li>",
"     <li>",
"      Calsical (ID);",
"     </li>",
"     <li>",
"      Caltrate + D 300 (HK);",
"     </li>",
"     <li>",
"      CDR Fortos (ID);",
"     </li>",
"     <li>",
"      Os-Cal + D (SG);",
"     </li>",
"     <li>",
"      Os-Cal 500 + D (HK)",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9162 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-CAE323FBD7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7143=[""].join("\n");
var outline_f6_62_7143=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343750\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343754\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343771\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343772\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343773\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343780\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343752\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343775\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343755\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9405019\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343763\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343759\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343760\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298932\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343766\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343769\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343756\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343758\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343774\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5685564\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343777\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961929\">",
"      International Brand Names",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9162\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9162|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?40/62/41956?source=related_link\">",
"      Calcium and vitamin D: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_62_7144="Early deceleration";
var content_f6_62_7144=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50036&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50036&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Early deceleration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 482px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gradual decrease and return to baseline of the FHR associated with a uterine contraction. The nadir of the FHR and the peak of the contraction occur at the same time. The deceleration's onset, nadir, and termination are coincident with the onset, peak, and termination of the contraction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Aron Schuftan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7144=[""].join("\n");
var outline_f6_62_7144=null;
var title_f6_62_7145="Bulimia nervosa in adults: Pharmacotherapy";
var content_f6_62_7145=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bulimia nervosa in adults: Pharmacotherapy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/62/7145/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/62/7145/contributors\">",
"     Scott J Crow, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/62/7145/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/62/7145/contributors\">",
"     Joel Yager, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/62/7145/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/62/7145/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/62/7145/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1600846\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapy is efficacious for bulimia nervosa and may be included in the treatment regimen as part of multimodal therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Antidepressants have been most widely studied, and are the drugs of choice due to their demonstrated efficacy and tolerability [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2,4-8\">",
"     2,4-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The neurobiology of bulimia nervosa and the mechanism of action for pharmacotherapy are not known [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/9\">",
"     9",
"    </a>",
"    ]. One hypothesis is that central nervous system serotonin pathways are disturbed in at least some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Psychotropic pharmacotherapy for bulimia nervosa is reviewed here. The epidemiology, pathogenesis, clinical features, diagnosis, assessment, other treatments and outcome, and medical complications of bulimia nervosa and their management are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33577?source=see_link\">",
"       \"Bulimia nervosa in adults: Clinical features, diagnosis, and assessment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7560?source=see_link\">",
"       \"Bulimia nervosa in adults: Cognitive-behavioral therapy (CBT)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link\">",
"       \"Eating disorders: Treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=see_link\">",
"       \"Bulimia nervosa and binge eating disorder in adults: Medical complications and their management\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537074608\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The core features of bulimia nervosa are binge eating (ie, eating an amount of food that is definitely larger than most people would eat under similar circumstances) and inappropriate compensatory behavior to prevent weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/12\">",
"     12",
"    </a>",
"    ]. The diagnostic criteria (",
"    <a class=\"graphic graphic_table graphicRef70006 \" href=\"UTD.htm?2/46/2796\">",
"     table 1",
"    </a>",
"    ) for bulimia nervosa are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33577?source=see_link&amp;anchor=H22668229#H22668229\">",
"     \"Bulimia nervosa in adults: Clinical features, diagnosis, and assessment\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537075322\">",
"    <span class=\"h1\">",
"     OVERVIEW OF TREATMENT EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapy is efficacious for bulimia nervosa and may be added to first-line treatment, which consists of nutritional rehabilitation plus psychotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Nutritional rehabilitation aims to restore a structured and consistent meal pattern, typically three meals and two snacks per day [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2\">",
"     2",
"    </a>",
"    ]. Cognitive-behavioral therapy and interpersonal psychotherapy can effectively facilitate nutritional rehabilitation. Pharmacotherapy alone is reasonable if specialized nutritional rehabilitation and psychotherapy are not available.",
"   </p>",
"   <p>",
"    Additional information about nutritional rehabilitation and psychotherapy for bulimia nervosa is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link&amp;anchor=H251818#H251818\">",
"     \"Eating disorders: Treatment\", section on 'Bulimia nervosa'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88015819\">",
"    <span class=\"h2\">",
"     Pharmacotherapy combined with psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combination treatment with pharmacotherapy plus psychotherapy appears to be more efficacious than either treatment alone for treating episodes of bingeing and purging [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/6,13\">",
"     6,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88015891\">",
"    <span class=\"h3\">",
"     Compared with psychotherapy alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combination treatment is more efficacious than psychotherapy alone. A meta-analysis of six randomized trials (257 patients with bulimia nervosa) found that remission occurred in significantly more patients who received combination treatment compared with psychotherapy alone (49 versus 36 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. However, dropout rates were significantly higher for combination treatment than psychotherapy alone (30 versus 16 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88015898\">",
"    <span class=\"h3\">",
"     Compared with pharmacotherapy alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combination treatment appears to be more efficacious than pharmacotherapy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/5\">",
"     5",
"    </a>",
"    ]. A meta-analysis of four randomized trials (141 patients with bulimia nervosa) found that remission occurred in more patients who received combination treatment compared with medication alone (42 versus 23 percent); this difference was not statistically significant, but if real, would be clinically meaningful [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In addition, depressive symptoms improved significantly more with combination treatment. Dropout rates did not differ significantly between combination treatment and pharmacotherapy alone (34 versus 41 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88015905\">",
"    <span class=\"h2\">",
"     Pharmacotherapy alone compared with psychotherapy alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapy alone appears to be inferior to psychotherapy alone for treating bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/5\">",
"     5",
"    </a>",
"    ]. A meta-analysis of five randomized trials (237 patients with bulimia nervosa) found that remission occurred in fewer patients who received pharmacotherapy alone compared with psychotherapy alone (20 versus 39 percent); this difference was not statistically significant, but if real, would be clinically meaningful [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/13,15\">",
"     13,15",
"    </a>",
"    ]. In addition, dropout rates were significantly higher for pharmacotherapy than psychotherapy (40 versus 18 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1600853\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapy combined with nutritional rehabilitation and psychotherapy is indicated for treatment of bulimia nervosa, as well as comorbid anxiety and depressive disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2-8,12\">",
"     2-8,12",
"    </a>",
"    ]. However, if nutritional rehabilitation and psychotherapy are not available, pharmacotherapy alone is reasonable, in conjunction with self help workbooks and educational material for patients and family members to read.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of bulimia nervosa are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33577?source=see_link\">",
"     \"Bulimia nervosa in adults: Clinical features, diagnosis, and assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88680516\">",
"    <span class=\"h1\">",
"     CHOOSING A DRUG",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H82011921\">",
"    <span class=\"h2\">",
"     Medication algorithm",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest the following medications for treating bulimia nervosa, based upon the efficacy and tolerability of these drugs in randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      First-line treatment is the selective serotonin reuptake inhibitor (SSRI),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Second-line treatment for patients who do not tolerate or respond to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      is a different SSRI (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"       citalopram",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"       fluvoxamine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Third-line treatment, in order of preference, includes a tricyclic antidepressant (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"       desipramine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41624?source=see_link\">",
"       imipramine",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"       nortriptyline",
"      </a>",
"      ),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"       topiramate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"       trazodone",
"      </a>",
"      , or a monoamine oxidase inhibitor (MAOI; eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/42/20135?source=see_link\">",
"       phenelzine",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The dose, side effects, and evidence of efficacy for these medications are discussed separately. (See",
"    <a class=\"local\" href=\"#H28628957\">",
"     'Using specific medications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H362723321\">",
"    <span class=\"h2\">",
"     Avoiding bupropion",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     Bupropion",
"    </a>",
"    can cause seizures in patients with bulimia nervosa and is contraindicated in bulimia nervosa and anorexia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H86984566\">",
"     'Serious side effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86984514\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES AND GUIDELINES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537075155\">",
"    <span class=\"h2\">",
"     Goal of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of treatment is remission, ie, abstinence of binge eating and purging. However, many authorities regard a 50 to 75 percent reduction in the frequency of bingeing and purging as a clinically meaningful response to pharmacotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/7,17\">",
"     7,17",
"    </a>",
"    ]. Clinicians should regularly monitor patients with residual binge eating and purging, because continued symptoms even at substantially reduced levels carry a substantial risk for relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/6,18\">",
"     6,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7762593\">",
"    <span class=\"h2\">",
"     Pretreatment assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to pharmacotherapy, the clinician should assess the following issues that affect whether and how pharmacotherapy is conducted [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Intentions regarding pregnancy",
"     </li>",
"     <li>",
"      Frequency of binge eating and purging episodes",
"     </li>",
"     <li>",
"      Time of day that the patient vomits (if this is the inappropriate compensatory behavior used to prevent weight gain)",
"     </li>",
"     <li>",
"      Excessive concern about body weight and shape",
"     </li>",
"     <li>",
"      Comorbid anxiety and depressive disorders",
"     </li>",
"     <li>",
"      Sexual functioning",
"     </li>",
"     <li>",
"      Psychosocial impairment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients planning to become pregnant should be referred for first-line treatment with nutritional rehabilitation and psychotherapy, rather than pharmacotherapy. Nutritional rehabilitation, psychotherapy, and the possible teratogenic effects of antidepressants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link&amp;anchor=H251818#H251818\">",
"     \"Eating disorders: Treatment\", section on 'Bulimia nervosa'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28682?source=see_link\">",
"     \"Depression in pregnant women: Management\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The baseline frequency of bingeing and inappropriate compensatory behavior, as well as the level of other psychopathology provide an index for tracking progress. Medication should be ingested at least 30 minutes prior to vomiting to facilitate absorption. Assessing baseline sexual functioning is helpful to distinguish medication-induced sexual dysfunction from sexual dysfunction that occurs as a symptom of bulimia nervosa.",
"   </p>",
"   <p>",
"    The comprehensive assessment of patients with bulimia nervosa is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33577?source=see_link&amp;anchor=H22668257#H22668257\">",
"     \"Bulimia nervosa in adults: Clinical features, diagnosis, and assessment\", section on 'Assessment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88013551\">",
"    <span class=\"h2\">",
"     Acute pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapy alone is effective for treating episodes of bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/4\">",
"     4",
"    </a>",
"    ]. Most randomized pharmacotherapy trials have lasted eight or fewer weeks, and nearly all trials have studied antidepressants [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2,4-8\">",
"     2,4-8",
"    </a>",
"    ]. A meta-analysis of 8 antidepressant trials (697 patients with bulimia nervosa) found that abstinence of bingeing (remission) occurred less often in patients treated with placebo than an antidepressant (relative risk 0.88, 95% CI 0.82-0.93) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although randomized trials have found that many different antidepressants are efficacious for bulimia nervosa, the evidence supports using a selective serotonin reuptake inhibitor. We choose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    because it is supported by the most evidence [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/4,5,19,20\">",
"     4,5,19,20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H28628912\">",
"     'First-line'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Improvement of symptoms occurs more often than remission. A review of randomized trials found that among patients treated with an antidepressant, the median reduction in the frequency of bingeing and purging was 69 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/6\">",
"     6",
"    </a>",
"    ]. By contrast, reviews and meta-analyses of randomized trials have found that remission occurs in only 20 to 32 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/6,8,13,14\">",
"     6,8,13,14",
"    </a>",
"    ]. There do not appear to be any consistent baseline predictors of acute response [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No randomized trials have evaluated the serotonin-norepinephrine reuptake inhibitors (SNRIs) or the second generation antipsychotics",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=see_link\">",
"     aripiprazole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/39/4728?source=see_link\">",
"     ziprasidone",
"    </a>",
"    , which cause fewer problems with weight gain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88013694\">",
"    <span class=\"h2\">",
"     Maintenance pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among acutely ill bulimia nervosa patients who respond or remit, 30 percent relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/6,18\">",
"     6,18",
"    </a>",
"    ]. Thus, most authorities continue pharmacotherapy for at least 6 to 12 months after response or remission [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2,6\">",
"     2,6",
"    </a>",
"    ]. The duration of maintenance pharmacotherapy will vary for each patient, depending upon the number of years the patient has been ill and the number of acute episodes and hospitalizations that have occurred. In reassessing the need for medication every 6 to 12 months, the clinician should also consider the stability of the patient&rsquo;s recovery (ie, has the patient remained completely free of symptoms or have there been subsyndromal symptoms), the presence of comorbid psychopathology, and the patient&rsquo;s level of psychosocial functioning. An observational study of 200 patients (mean follow-up duration of 12 years) suggests that pharmacotherapy can eventually be discontinued in many or most patients without recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although maintenance treatment clearly reduces relapse, premature discontinuation is common, probably due to poor tolerability: &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One randomized trial compared maintenance",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      (60 mg per day) with placebo for up to 12 months in 150 patients who initially responded to open-label fluoxetine [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/22\">",
"       22",
"      </a>",
"      ]. Relapse occurred in significantly fewer patients who received fluoxetine compared with placebo (33 versus 51 percent). However, discontinuation of maintenance treatment due to relapse or other reasons was comparable for fluoxetine and placebo (63 versus 68 percent). &nbsp;",
"     </li>",
"     <li>",
"      A second randomized trial compared maintenance",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"       fluvoxamine",
"      </a>",
"      (mean dose 182 mg per day) with placebo for up to 15 weeks in 72 patients who initially responded to multimodal treatment that included open-label fluvoxamine [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/23\">",
"       23",
"      </a>",
"      ]. Abstinence of bingeing was significantly higher in patients who received fluvoxamine compared with placebo (70 versus 35 percent). However, discontinuation of maintenance treatment was higher for fluvoxamine (51 versus 14 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86984773\">",
"    <span class=\"h2\">",
"     Weight change as a side effect",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medication-induced weight change is a problem for patients with bulimia nervosa, who by definition focus excessively upon body weight and shape and make inappropriate efforts to lose weight [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/12\">",
"     12",
"    </a>",
"    ]. In discussing weight change as part of informed consent, clinicians should ask patients about their fear of gaining weight, and also explain that cessation of purging does not typically lead to weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/24\">",
"     24",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Antidepressants can cause weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/25\">",
"     25",
"    </a>",
"    ]. Tricyclics and monoamine oxidase inhibitors (MAOIs) are more likely to cause weight gain than SSRIs [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/26\">",
"     26",
"    </a>",
"    ]. Long-term treatment with SSRIs may result in weight gain, although little or no weight change may be noticed during the first two to three months of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/27-33\">",
"     27-33",
"    </a>",
"    ]. &nbsp;In a study of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    , paroxetine appeared to cause the most weight gain [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/34\">",
"     34",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     Topiramate",
"    </a>",
"    , a third-line therapy, can cause weight loss in patients with bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Patients who are obese, overweight, or at the high end of the normal range may welcome the weight loss. However, weight loss is a problem for patients who are underweight or at the low end of the normal range, and in addition, may exacerbate eating disorder psychopathology regarding body weight.",
"   </p>",
"   <p>",
"    Additional information about weight change as a side effect of antidepressants and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link&amp;anchor=H399780715#H399780715\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\", section on 'Weight change'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=see_link&amp;anchor=H24#H24\">",
"     \"Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects\", section on 'Antihistaminc'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7574?source=see_link\">",
"     \"Monoamine oxidase inhibitors (MAOIs) for treating depressed adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link&amp;anchor=H21#H21\">",
"     \"Pharmacology of antiepileptic drugs\", section on 'Topiramate'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86984566\">",
"    <span class=\"h2\">",
"     Serious side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antidepressants may cause serious side effects, including a possible risk of increased suicidality in young adults.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     Bupropion",
"    </a>",
"    may provoke seizures in patients with bulimia nervosa and is contraindicated [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/16,37\">",
"     16,37",
"    </a>",
"    ]. MAOIs can cause a hyperadrenergic crisis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7574?source=see_link&amp;anchor=H2#H2\">",
"     \"Monoamine oxidase inhibitors (MAOIs) for treating depressed adults\", section on 'Monoamine oxidase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7761931\">",
"    <span class=\"h3\">",
"     Suicidality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concerns have been raised about an association between antidepressants and suicidality (suicidal ideation, preparatory act, attempt, or death). There may be an age-specific effect, such that antidepressants raise the risk of suicidality in patients aged 18 to 24 years. The potential effect of antidepressants on suicide risk in adults and children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43783?source=see_link\">",
"     \"Effect of antidepressants on suicide risk in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H483095\">",
"    <span class=\"h2\">",
"     Duration of an adequate trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon clinical experience, a medication that fails to show a satisfactory response (&ge;50 to 75 percent reduction in the frequency of bingeing and purging episodes) within four to eight weeks should be discontinued and substituted with a new medication. Most randomized trials have lasted six to eight weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For particularly urgent clinical situations, it may be possible to identify within the first few weeks whether the patient is unlikely to respond to a specific medication. Two studies show that lack of meaningful improvement during the first two to three weeks of treatment suggests that the patient will probably not respond to a longer course of treatment (response was defined as at least a 75 percent reduction in the frequency of bingeing and purging).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of 785 patients involving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      found that a decrease of &lt;60 percent in bingeing and purging episodes by week three of treatment correctly identified nearly 80 percent of the patients who ultimately did not respond by week eight [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of 77 patients involving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"       desipramine",
"      </a>",
"      found that a decrease of &lt;50 percent in bingeing and purging episodes by week two of treatment correctly identified 80 to 85 percent of the patients who ultimately did not respond by week six [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28628957\">",
"    <span class=\"h1\">",
"     USING SPECIFIC MEDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials have demonstrated that a number of drugs are efficacious for treating bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/4\">",
"     4",
"    </a>",
"    ]. However, no placebo-controlled, head-to-head trials have been conducted. Based upon efficacy and tolerability, we recommend the selective serotonin reuptake inhibitor (SSRI)",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    as first-line treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/4,5,19,20\">",
"     4,5,19,20",
"    </a>",
"    ]. Second-line options include other SSRIs (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. Third-line options include tricyclics (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"     desipramine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41624?source=see_link\">",
"     imipramine",
"    </a>",
"    ),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    , and monoamine oxidase inhibitors (MAOIs; eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/42/20135?source=see_link\">",
"     phenelzine",
"    </a>",
"    ). Benefits include significant reduction of binges, purges, eating disorder cognitions, and comorbid psychopathology, depending upon the trial.",
"   </p>",
"   <p>",
"    To enhance adherence, patients should be told that side effects may emerge prior to therapeutic effects and that many side effects are transient [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medication combinations have not been studied and should generally be avoided.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28628912\">",
"    <span class=\"h2\">",
"     First-line",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    60 mg once per day as first-line treatment because of its efficacy for the behavioral and cognitive symptoms of bulimia nervosa, as well as its tolerability [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Fluoxetine has been more widely studied for bulimia nervosa than any other medication; among five randomized trials, four reported a significant reduction in the frequency of bingeing and purging with fluoxetine compared with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In addition, the four trials found that fluoxetine significantly improved dietary restraint, food preoccupation, and excessive concern and dissatisfaction with body weight and shape. Some trials found that fluoxetine significantly decreased symptoms of depression, whereas other trials did not.",
"   </p>",
"   <p>",
"    Multiple randomized trials have established that the target dose for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    in bulimia nervosa is 60 mg per day, which is higher than the standard dose for major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/4,5,19,20\">",
"     4,5,19,20",
"    </a>",
"    ]. As an example, one randomized trial compared two doses of fluoxetine with placebo in 387 bulimia nervosa patients for eight weeks, and found that the frequency of vomiting episodes decreased significantly more in patients who received fluoxetine 60 mg per day, compared with either fluoxetine 20 mg or placebo (56 versus 29 and 5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/19\">",
"     19",
"    </a>",
"    ]. The frequency of binge-eating episodes also decreased significantly more with fluoxetine 60 mg (67 versus 45 and 33 percent). Fluoxetine 20 mg per day was significantly superior to placebo for reducing episodes of vomiting, but not binge eating. In addition, adverse events for the two doses of fluoxetine did not differ significantly. &nbsp;",
"   </p>",
"   <p>",
"    Clinicians should prescribe an initial dose of 20 mg once per day and titrate up by increments of 20 mg per day each week, depending upon the therapeutic response, tolerability, and clinical urgency. However, it is feasible to start",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    at a dose of 60 mg per day, rather than escalating the dose [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients not responding adequately to psychotherapy, we suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    as first-line pharmacotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/39\">",
"     39",
"    </a>",
"    ]. Based upon our clinical experience, if psychotherapy provides little or no benefit, it should be discontinued as patients are switched to pharmacotherapy. If psychotherapy provides some benefit, fluoxetine should be added.",
"   </p>",
"   <p>",
"    Additional information about",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H82012154\">",
"    <span class=\"h3\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients receiving SSRIs for bulimia nervosa can expect to encounter the same side effects that commonly occur in general clinical use. To enhance adherence, patients should be told that side effects may emerge prior to therapeutic effects, and that many side effects are transient [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sexual dysfunction is a common side effect of SSRIs [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/40\">",
"     40",
"    </a>",
"    ]. In females, this largely manifests as diminished libido and interference with orgasm, and for males, erectile dysfunction. Maladaptive thoughts about body weight and shape that occur as part of bulimia nervosa can also interfere with sexual functioning. Thus, determining whether sexual dysfunction is an SSRI side effect is facilitated by assessing sexual functioning prior to pharmacotherapy. Based upon our clinical experience, successful treatment of bulimia nervosa often resolves sexual dysfunction that is present at baseline. (See",
"    <a class=\"local\" href=\"#H7762593\">",
"     'Pretreatment assessment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Additional information about the side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link&amp;anchor=H399779851#H399779851\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28628920\">",
"    <span class=\"h2\">",
"     Second-line",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSRIs other than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    are second-line choices because they are better tolerated than third-line treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2\">",
"     2",
"    </a>",
"    ]. Given the experience with fluoxetine, it&rsquo;s reasonable to expect that a better response may be obtained with SSRI doses that are higher than the usual starting dose used to treat major depression. Evidence for the efficacy of SSRIs other than fluoxetine includes randomized trials that found",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/41\">",
"     41",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/42\">",
"     42",
"    </a>",
"    ] were significantly more efficacious than placebo in reducing the number of bingeing and purging episodes.",
"   </p>",
"   <p>",
"    Additional information about SSRIs including side effects is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28628928\">",
"    <span class=\"h2\">",
"     Third-line",
"    </span>",
"    &nbsp;&mdash;&nbsp;Third-line treatment for bulimia nervosa, in order of preference, includes tricyclic antidepressants,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    , and MAOIs. Although randomized trials have demonstrated the efficacy of these drugs, they are generally third-line options because of numerous potential side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/2-6,35,36,43\">",
"     2-6,35,36,43",
"    </a>",
"    ]. In addition, MAOIs require a tyramine-free diet; restricting food is problematic in patients with eating disorders, who typically have extensive, self-imposed dietary rules and restrictions that require treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evidence for the efficacy of third-line options includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial with 78 patients found that episodes of bingeing and purging decreased significantly more with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"       desipramine",
"      </a>",
"      compared with placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A randomized trial with 19 patients found that episodes of bingeing decreased significantly more with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41624?source=see_link\">",
"       imipramine",
"      </a>",
"      compared with placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Two randomized trials with a total of 129 patients found that the frequency of bingeing and purging decreased significantly more with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"       topiramate",
"      </a>",
"      compared with placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/35,36,43\">",
"       35,36,43",
"      </a>",
"      ]. In both trials, body weight decreased significantly more in patients who received topiramate compared with placebo, which is a problem for patients with bulimia nervosa [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H86984773\">",
"       'Weight change as a side effect'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A randomized trial with 42 patients found that episodes of bingeing and purging decreased significantly more with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"       trazodone",
"      </a>",
"      compared with placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/46\">",
"       46",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The dose of tricyclics,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    , and MAOIs to treat bulimia nervosa is usually the same dose that is used in general clinical practice. Bulimia nervosa patients receiving these medications can expect to encounter the same side effects that commonly occur in general clinical use. Additional information about tricyclics, topiramate, trazodone, and MAOIs is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=see_link\">",
"     \"Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link&amp;anchor=H21#H21\">",
"     \"Pharmacology of antiepileptic drugs\", section on 'Topiramate'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=see_link\">",
"     \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7574?source=see_link\">",
"     \"Monoamine oxidase inhibitors (MAOIs) for treating depressed adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although one randomized trial found that the anti-emetic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/2/21544?source=see_link\">",
"     ondansetron",
"    </a>",
"    was efficacious for bulimia nervosa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/62/7145/abstract/47\">",
"     47",
"    </a>",
"    ], it is generally not prescribed for this disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/37/26194?source=see_link\">",
"       \"Patient information: Bulimia nervosa (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86984499\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pharmacotherapy is efficacious for bulimia nervosa and may be included in the initial treatment regimen, along with nutritional rehabilitation and psychotherapy. However, using pharmacotherapy alone is reasonable if specialized nutritional services or psychotherapy are not available. (See",
"      <a class=\"local\" href=\"#H537075322\">",
"       'Overview of treatment efficacy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link\">",
"       \"Eating disorders: Treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pharmacotherapy alone appears to be less efficacious than psychotherapy alone, and combining the two appears to be the best approach. (See",
"      <a class=\"local\" href=\"#H88015905\">",
"       'Pharmacotherapy alone compared with psychotherapy alone'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H88015819\">",
"       'Pharmacotherapy combined with psychotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pharmacotherapy is indicated for treatment of bulimia nervosa and comorbid anxiety and depressive disorders. &nbsp;(See",
"      <a class=\"local\" href=\"#H1600853\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pharmacotherapy generally consists of an antidepressant. For patients with bulimia nervosa, we recommend an antidepressant rather than no treatment (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H88680516\">",
"       'Choosing a drug'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H88013551\">",
"       'Acute pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SSRIs are better tolerated than other medications used for bulimia nervosa. For patients with bulimia nervosa, we recommend an SSRI rather than tricyclics,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"       topiramate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"       trazodone",
"      </a>",
"      , or monoamine oxidase inhibitors (MAOIs) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). SSRIs are prescribed at higher doses for bulimia nervosa than are used to treat major depression. We prefer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      , which is supported by the most evidence; the target dose is 60 mg per day.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"       Bupropion",
"      </a>",
"      is contraindicated. (See",
"      <a class=\"local\" href=\"#H88680516\">",
"       'Choosing a drug'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H28628912\">",
"       'First-line'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H28628920\">",
"       'Second-line'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H28628928\">",
"       'Third-line'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with bulimia nervosa who receive pharmacotherapy can expect to encounter the same side effects that commonly occur in general clinical use. Antidepressants in general may possibly increase the risk of suicidality in young adults, but there is no clear evidence. (See",
"      <a class=\"local\" href=\"#H82012154\">",
"       'Side effects'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H86984566\">",
"       'Serious side effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Relapse occurs frequently. Maintenance treatment prevents relapse, but premature discontinuation is common, probably due to poor tolerability. For bulimia nervosa patients who respond to or remit with pharmacotherapy, we suggest maintenance pharmacotherapy rather than no pharmacotherapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). The duration of maintenance pharmacotherapy will vary for each patient, depending upon several clinical factors. Maintenance pharmacotherapy is typically prescribed for at least 6 to 12 months beyond response or remission. (See",
"      <a class=\"local\" href=\"#H88013694\">",
"       'Maintenance pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/1\">",
"      Crow S, Mussell MP, Peterson C, et al. Prior treatment received by patients with bulimia nervosa. Int J Eat Disord 1999; 25:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/2\">",
"      American Psychiatric Association. Treatment of patients with eating disorders,third edition. American Psychiatric Association. Am J Psychiatry 2006; 163:4.",
"     </a>",
"    </li>",
"    <li>",
"     Eating Disorders: Core Interventions in the Treatment of and Management of Anorexia Nervosa, Bulimia Nervosa and Related Eating Disorders. National Institute for Clinical Excellence, Clinical Guideline 9. file://guidance.nice.org.uk (Accessed on December 22, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/4\">",
"      Shapiro JR, Berkman ND, Brownley KA, et al. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007; 40:321.",
"     </a>",
"    </li>",
"    <li>",
"     Broft A, Berner LA, Walsh BT. Pharmacotherapy for bulimia nervosa. In: The Treatment of Eating Disorders: A Clinical Handbook, Grilo CM, Mitchell JE (Eds), The Guilford Press, New York 2010. p.388.",
"    </li>",
"    <li>",
"     Agras WS. Treatment of eating disorders. In: The American Psychiatric Publishing Textbook of Psychopharmacology, Fourth Edition, Schatzberg AF, Nemeroff CB (Eds), American Psychiatric Publishing, Inc., Washington, DC 2009. p.1231.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/7\">",
"      Bacaltchuk J, Hay P. Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database Syst Rev 2003; :CD003391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/8\">",
"      Nakash-Eisikovits O, Dierberger A, Westen D. A multidimensional meta-analysis of pharmacotherapy for bulimia nervosa: summarizing the range of outcomes in controlled clinical trials. Harv Rev Psychiatry 2002; 10:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/9\">",
"      Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav 2008; 94:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/10\">",
"      Kaye WH, Bailer UF, Frank GK, et al. Brain imaging of serotonin after recovery from anorexia and bulimia nervosa. Physiol Behav 2005; 86:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/11\">",
"      Monteleone P, Santonastaso P, Tortorella A, et al. Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa. Mol Psychiatry 2005; 10:716.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/13\">",
"      Bacaltchuk J, Hay P, Trefiglio R. Antidepressants versus psychological treatments and their combination for bulimia nervosa. Cochrane Database Syst Rev 2001; :CD003385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/14\">",
"      Bacaltchuk J, Trefiglio RP, Oliveira IR, et al. Combination of antidepressants and psychological treatments for bulimia nervosa: a systematic review. Acta Psychiatr Scand 2000; 101:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/15\">",
"      Bacaltchuk J, Trefiglio RP, de Oliveira IR, et al. Antidepressants versus psychotherapy for bulimia nervosa: a systematic review. J Clin Pharm Ther 1999; 24:23.",
"     </a>",
"    </li>",
"    <li>",
"     Wellbutrin (bupropion hydrochloride) Prescribing Information July 2009 file://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103318.htm (Accessed on January 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/17\">",
"      Sysko R, Sha N, Wang Y, et al. Early response to antidepressant treatment in bulimia nervosa. Psychol Med 2010; 40:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/18\">",
"      Keel PK, Mitchell JE. Outcome in bulimia nervosa. Am J Psychiatry 1997; 154:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/19\">",
"      Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. Arch Gen Psychiatry 1992; 49:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/20\">",
"      Goldstein DJ, Wilson MG, Thompson VL, et al. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. Br J Psychiatry 1995; 166:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/21\">",
"      Keel PK, Mitchell JE, Miller KB, et al. Long-term outcome of bulimia nervosa. Arch Gen Psychiatry 1999; 56:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/22\">",
"      Romano SJ, Halmi KA, Sarkar NP, et al. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 2002; 159:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/23\">",
"      Fichter MM, Kr&uuml;ger R, Rief W, et al. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. J Clin Psychopharmacol 1996; 16:9.",
"     </a>",
"    </li>",
"    <li>",
"     Cooper, Z, Fairburn, CG. Cognitive behavior therapy for bulimia nervosa. In: The Treatment of Eating Disorders, Grilo, CM, Mitchell, JE (Eds), The Guilford Press, New York 2010. p.243.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/25\">",
"      Fava M. Weight gain and antidepressants. J Clin Psychiatry 2000; 61 Suppl 11:37.",
"     </a>",
"    </li>",
"    <li>",
"     Labbate, LA, Fava, M, Rosenbaum, JF, et, al. Drugs for the treatment of depression. In: Handbook of Psychiatric Drug Therapy, 6th ed, Lippincott Williams &amp; Wilkins, Philadelphia, PA 2010. p.54.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/27\">",
"      Maina G, Albert U, Salvi V, Bogetto F. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/28\">",
"      Michelson D, Amsterdam JD, Quitkin FM, et al. Changes in weight during a 1-year trial of fluoxetine. Am J Psychiatry 1999; 156:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/29\">",
"      Croft H, Settle E Jr, Houser T, et al. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999; 21:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/30\">",
"      Uher R, Farmer A, Henigsberg N, et al. Adverse reactions to antidepressants. Br J Psychiatry 2009; 195:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/31\">",
"      de Jonghe F, Ravelli DP, Tuynman-Qua H. A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression. Pharmacopsychiatry 1991; 24:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/32\">",
"      Wade A, Michael Lemming O, Bang Hedegaard K. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2002; 17:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/33\">",
"      Lepola UM, Loft H, Reines EH. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003; 18:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/34\">",
"      Fava M, Judge R, Hoog SL, et al. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. J Clin Psychiatry 2000; 61:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/35\">",
"      Hoopes SP, Reimherr FW, Hedges DW, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry 2003; 64:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/36\">",
"      Nickel C, Tritt K, Muehlbacher M, et al. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord 2005; 38:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/37\">",
"      Horne RL, Ferguson JM, Pope HG Jr, et al. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988; 49:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/38\">",
"      Walsh BT, Sysko R, Parides MK. Early response to desipramine among women with bulimia nervosa. Int J Eat Disord 2006; 39:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/39\">",
"      Walsh BT, Agras WS, Devlin MJ, et al. Fluoxetine for bulimia nervosa following poor response to psychotherapy. Am J Psychiatry 2000; 157:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/40\">",
"      Hu XH, Bull SA, Hunkeler EM, et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004; 65:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/41\">",
"      Milano W, Petrella C, Sabatino C, Capasso A. Treatment of bulimia nervosa with sertraline: a randomized controlled trial. Adv Ther 2004; 21:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/42\">",
"      Milano W, Siano C, Putrella C, Capasso A. Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. Adv Ther 2005; 22:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/43\">",
"      Hedges DW, Reimherr FW, Hoopes SP, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. J Clin Psychiatry 2003; 64:1449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/44\">",
"      Walsh BT, Hadigan CM, Devlin MJ, et al. Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 1991; 148:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/45\">",
"      Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 1983; 140:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/46\">",
"      Pope HG Jr, Keck PE Jr, McElroy SL, Hudson JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989; 9:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/62/7145/abstract/47\">",
"      Faris PL, Kim SW, Meller WH, et al. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet 2000; 355:792.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14734 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-1A4E1675F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7145=[""].join("\n");
var outline_f6_62_7145=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H86984499\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1600846\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H537074608\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H537075322\">",
"      OVERVIEW OF TREATMENT EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88015819\">",
"      Pharmacotherapy combined with psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88015891\">",
"      - Compared with psychotherapy alone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88015898\">",
"      - Compared with pharmacotherapy alone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88015905\">",
"      Pharmacotherapy alone compared with psychotherapy alone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1600853\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H88680516\">",
"      CHOOSING A DRUG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H82011921\">",
"      Medication algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H362723321\">",
"      Avoiding bupropion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86984514\">",
"      GENERAL PRINCIPLES AND GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H537075155\">",
"      Goal of treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7762593\">",
"      Pretreatment assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88013551\">",
"      Acute pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88013694\">",
"      Maintenance pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86984773\">",
"      Weight change as a side effect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86984566\">",
"      Serious side effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7761931\">",
"      - Suicidality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H483095\">",
"      Duration of an adequate trial",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28628957\">",
"      USING SPECIFIC MEDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28628912\">",
"      First-line",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H82012154\">",
"      - Side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28628920\">",
"      Second-line",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28628928\">",
"      Third-line",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86984499\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/14734\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/14734|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/46/2796\" title=\"table 1\">",
"      DSM-IV-TR diagnostic criteria for bulimia nervosa",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=related_link\">",
"      Bulimia nervosa and binge eating disorder in adults: Medical complications and their management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33577?source=related_link\">",
"      Bulimia nervosa in adults: Clinical features, diagnosis, and assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7560?source=related_link\">",
"      Bulimia nervosa in adults: Cognitive-behavioral therapy (CBT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28682?source=related_link\">",
"      Depression in pregnant women: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=related_link\">",
"      Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=related_link\">",
"      Eating disorders: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43783?source=related_link\">",
"      Effect of antidepressants on suicide risk in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7574?source=related_link\">",
"      Monoamine oxidase inhibitors (MAOIs) for treating depressed adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/37/26194?source=related_link\">",
"      Patient information: Bulimia nervosa (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=related_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=related_link\">",
"      Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=related_link\">",
"      Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=related_link\">",
"      Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_62_7146="Pathologic skin picking";
var content_f6_62_7146=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F60854%7EDERM%2F72635%7EPC%2F73615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F60854%7EDERM%2F72635%7EPC%2F73615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acne excori&eacute;e",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Excoriated papules with erosions and multiple hyperpigmented macules in a 25-year-old young woman who had developed acne papules a few years before. Chronic picking of papules resulted in erosions, scarring, and postinflammatory hyperpigmentation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Shahbaz A Janjua, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acne excori&eacute;e",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDjY4PlRMZLdSvarMcFvFDjyzuzwd3Woo2KBm3MxI496fGWlcMUIwPpmvFbPSSLdtHGCGhWMSdBkcD3q5HEmdrHzCepIqnHkt/q1RVHANTQzF5H52jpxUt2LSL0OxG2qckdqlA2YDE4ZsZ/pUESrhCAQTyT7U6ZjLIj/Nx2HYUrlpFuN9oZurVJEy+YQSDnkGo4BtwpHzE8E/yoeJs5iGc/w/4Ur3HY0YZFFyA/XZVmJ3M0ueRkAZ9MVh207PM/BDLjOe2PWr01yRIWUH58Bl/qKSYNF0SBjhQrFWIOO1EqM0e+Q8gHCnoKrQmOWX5WKEjPynk0t07wq2+5cR9FyoY1VxWK18wa4jCqGKkMc87j2FQTCWOFpCNjvIC8nTAHYU+2s5Yy8z3J81+dpUEgdsVJciV/JBjSUMfl80kDgelWiGV7a4WCJ5VjD3BQ7QTkAnv+FRPb3C2skvmbtqjfJ/tnqT64HFaMFhLcB1MsSQoMudwBIz2pHjgnmFsjCOwjO+QOzAM/p/Wri+5nJGbZabGX33EivFtCquMnrjP161eltBH88duTEjgxwu3339Seo+lS2tvJqF4z2c2Le3O0St91QP7oPXvWmLa4jjjuZZQcEpEroOnrj+tPmFy3MVIpsuk4FveXAx0wqJnJOantxLc6mltZyA4PlxtHwAD1cnrVuW0uCZJZSHM/GSSMr7+grQ0yCHSrMzwwhHk+UNFJh5D6gY6e9Te5drI6Q2NjocMFnat5skigMq53s3r/AD5NY08TTXkoi2Pcj5EH8EfqffHc1Qubu9ii3RsAGH7yQtlmP9xMdT6mn2cd9bq0dpasLqT52fhiq/y/ChvULaC3RWGSK1hGLlmLGQ9R6nHv6n8KCsUD+TbiSW5c5d8dR9TV6NREozbyG6k4BcZZsdWY/WmSQSRKcvIJHOAduCx7kntgdqlsaRJp0f8ApHnN5UaoNi72/PFaoLSPtV3l7/KhC/iaoWNsIAixQCPC/efkt+JrVjlLxyRzPl2IIHGPpk0XBohlGIkjkBQDoI1A/M5rPlWSQm3s4B5r8NIWyQvrWw7+RGT8pLDbtBB//VVRjFDD5k4RJGYncvzbj6deadxWEtLOXCQQRorj7rDnJ71S1W1n82RIpCbg8nBwI/cnt9KtTXF5INpZ7ZBwTty4H8l/nTonggCx28Z2k5OWJ3t6/WjmDlKttocEUIYjz2f77tyzn1+ntUcdn9kJNv5gfncWbg/T0q3Ldjf+7IVicbDz/OoXuLiRf3sIXB4Ib9cUmxpMz7i6lJPyJv77+/vxVBJzcBkmMMaHIJxjP4H+tbiRrIVcsHbGPmGOfY9qZdWtvKCDJiXGcPghqLthaxhv/oa/KjTwnPAQsV/HuKgksLq8MbmO2A6r8xwv5da6KOzWOMMsiiX6/wAhVSWNo5G8mJtzHLKBwx/oaPUfoYr6XPGU80LubOTGQxP0pWtUiGbl2Q5/1bg5P+P4VorMZWMccLxt6SnkVEbD5mc+XJKTkneSR/hTTXQWvUqGJ7iPaiSFR0APyj8Kh+zxhjsgRj0yDz9farMlkZGO35B1OGPz/QmnNaLEp8geVt5EeetAmZVxZgv80cKEjPyjd09feoZUEA3RjJxy3+FWrhrjl1AQHqoPT86oo7kMzyRFwON7lc/himSUZ5Mn5lw3bAzWbcAOSzpNIx4CgYFaskhAYNaREk9Ukx+PvWRMJAxMaleehY8Vd7EMqXEBaORGi8qP0Cg8/WqktiCgb5enDHrWi1zdKCRLGOxUrUc32mRMtLGD2AFWpGbRz92gICLOfpweapvE8WFYhg3I5rZnhZG3MvQfexiqZWFyVkjJ7g9xWikQ0U540GFMXToSpUGsu6tx5hVTsb0Jq9NBIr7o5XCjoc9KrSKHCxGdH9Cy4I/GtEyLGbLbXSjOMjH51EwuIl4R1J5wRmr+XTK5EijpluQfrTXW5ySGkC4/i/x71SZNjJZZXUlo1Y+mMGqM4jZiHRo29a0rgSDcN2R7iqMirJkHIccbT/SqTGe0DdJmTbtRelWIMFwOdoGSPU1TVjsALZA7VftIz5YZurDOK8ps9FInVGLK3U9DU8MCpOMk7W6+xqaKE7QjY6c1G+ROEyQxPyn1rNloljBe5bBOzt9KtKmPMPaooeGfcMNnAFWYgBMqnJ7nFBRZCiNVV1Ugryc/rTZIXiXOSy9cjqtWkVTuDjcoOB9arzRvGrmJvlxyp5xSuMreVunWTcQ5AO8Dt6H1q2qs5ETbXA6dsVAr4aJ9pVhwzKe3birpUSMxMb5J6oMUAVBG8cpkjLRHkFipZefUU6MOT88icnnIyD+P9KuRySRqQiNIg9eGFSw+VMHwrxv34wfy6GmhEUFtNBG7ZUljymOPwNMt4/tl67lMmNP4m4yTVmMSxAYw6E8BT/MGp90ajzV8pSB82G6/UetNCZDJmyj3hY/Mz8qAZBPsKZIg8lTJveTPygKV3MferNqftTNMoXCjCrnBx9D61O0sTErIdj5ySxxn6VSZLRFa2rp5UUUO7HAXIA+pq6to8oZrlGDkY4+6oHaiKTLKsLl8ckkjila+uQ6rGFRugK/MAPWr0Idwms41ZJruViWHyRs4XPue9VWjubqfZbQyOjdP4S+O3qE/nUwkRGKussk4PzyON3598ewrYsL14CIoraXLnJkcYd/w9KNB2ZTttHn8yNrqYGReQsMYwvsM9MVryQzXSJBamZT90v5p/E4HXFBe8YfPlCx+SNNqs34nPFNgiuWVmOwO3UecQAPQYouLcifSobYbQHJ6tuzx+JPepNK0WNWe7mSOP5iqqzk8evXGfeka1cljKh8sekh5P4mnpawwMN8AUEZBbDk/gTSTHbQZKbcEbXt93fDE/hnP8qY6s7hfLWTj7gUqPbk1pfaQCsbwBUU4ykWCO9Vy4fLiZlOeMrjBpME2VWhlQruaCNMEsoUnB9Mmo0bTIipljiD/AHsb9zHPc9/oKmkhFxta5klI5KruOPxFOiSKIMFgMQbkGMUrjK/mxFd0UEkYPTg4+vFMjuY3Yg32F6hUXA/DIrVYWxI8uWYMM8q+PwxVSa3kiTKqzZHJyM+9P0D1GStazKNxgZu+9vbr0qEmNW2xyBSO6kkD8CKnYOVIDDysDGVzj60GUR/IQTu4BUcGk2NIqSTNDkttduoEeVJ/DGKJLyKYhZ4GMmeBIgH61oRzyMjBbQ7l6HeB+FIVurhcfZAzoPlJPP8A9egDMu7dSgkhs3OzhgCCAfXNNYxzJG4j8l0G04Und+OaluLYM4ZVZH25I4X8qo3NpPbIHiiDBX+8Wyf0NFwsRXlpDLJ80zv3Dcjn+hqCWwkAiaG5jkUjDKRtwf61dXUHKFZEY7yMqv3lx7VWM8ILJJ5xc/d+UjB9aAsUZWuHO1pn3A4YB/ToeagwpOXXcACFYttwa1WWCeBtpjkZuBuGPxwaoz2dydzxpAQo+7uPNAFF5JIdxibcMjqRSSzF0bEashOcDBpsqTI3zW6oMf3iCPfpVJ/tDAsZBHtHUqSD+NCfcTM+8SGR/lQo3oDtxWdcxXEm4rh8cEsRu/8Ar1engdhkTxufXp+hqnIjxsWMzZPYr3q4u2xEkUmjSMjz4yuOpHP41DcpEf8AUzB1/vdD+VWJJS3EjKD/ALXGaozQgEtDlT7c1pcysRSBmYDzJAe3cGqc8VwisQysh9BgirLPKqknZIg6luDURm3j9y4jJ7M2R+FUtBMpsqYPmTKhx0Y5zWXeW8YchWQnr8prUuU83Ky+QrDnjgn8axLtAJD+7O3PBzmtE0ZtFeS1nhJO1T9WFN+2TxoY9yhW6qeh/wADSuoAJVHx71Vkg3sGEYUHrz/StEybDpHBJJfyyR68VDI8O0GYxy+pxg/mKjlTyuGGUHYdRTYUAB8oKSeQp5yPb1q0TY9eWLaiq/U8mtS3+eQEA+oBqo/yyh/bH4VftCC29OUJ4B9K8ls9JIvSvl0UHBHUioVj8x95Oee/apEBd3CrjBxU2wLv4xk1O7NEhsSFBGSC+fzxWjZhd/mRHkHkexqsF4iZAQF61cijbzXkQd8YoYWsTeWUBKAsjdcdR/8AWqIgEYXPIxj0NXLbcMrnjsemB6GoZ7Zchh0PcdqkaIRbtLFlSAMdDT4pJo8o65x1A6/h7U+BZUB5DLjjPBpzOouEaRHVhwMCi47D8SPuCoQvB5IFMEMjAZnAweg4x+PWrfmKTkMMHkZGKV2QqCCD3PFFxWK6rJC21lUA/wAeMj8TWhHFFOuL2BjtwSU5H19cVFHmRSrZwO2OvpU0e+LGHIkAwNx4FVFktXJJbWGTLRTEbSOBwaBEzLzNGVH8MiipYpnyFmhiLHJJ35B96bNbxF8rKFHUqgqrk2GNFLGd7qPKI5kX5v8A9VOWGFoR9ld2LHdmLsfTmlhitRjmTf1yZDjP06VPFaF5GktZyjgDPz4DH3HeqTE0xbbT5LVFdCi55wGyx9cn1+laEbkKcROsp5Z5BuH4etVNhi+W8kjR8/ISh2n/AIEOn0NaMSXAIFukEh9mK/zp3ASFUDsqzIWYfekG3NSq4GRGrkgkmRcHd7Adqci3coUTRDaB0GDUfnMiFFRBnlmAIP6GgBsyxvxKVcgdCc/gKlgWMBcRspxnkfKvpjvmoC8rSoI1CIMjIH6nNKkTMxINyedxJGBjp3pAW4rt4QUDMrdSDg/nSMJFWTzVjlbOFGBgH1p6QM8Ue/yl2naGYjA49qbNbsZMpu24OWBI3f8A6qonS5GbdsZYLJx0VuSabHBCWb94IwG4VuSB6cd6mjiXK7xt6ZfBz7fhUjWoVmKmPC9BjBapHcqxxndho14HJB/zilghK5yc5+bnrVkKsMmSSMg5zmnRR4PfaRg57UWC5XW2XOUUhs5yhByDUyQQyxMJY42AHADYP5U9ooRIvllhnG0gZq5awrJuYRoZR82ANpI+lNE3MprFQiSlmCscE7+tS2tpOkfmWs5c5yFJ6e1W547d41RozG2eDsPzc0+O0jyFQCOUHBy54/zihJDcnYy/sm9mV8vKnzLuPUdwc1QmBQBZYNygcEfeHpmte9ghjmQziVJQSR824Yxxiqt3Bb+Qx8yXzA24NuwcelJ6DWpztwkbkOow55JbjFQzwBSjBdoPBw2QDita4hMe0xtuUg7lbmoJIYljDxnPQsjdPrUbl7GTLDJFGpCrn1JzxVfDgqGRgMZ3K2R+VazgMQ+wBfTHWo5rdovmVl2nkbeOKQzMmZWHl+YxO3jIzxWFIbtMvB5bAE4TOD+XeuhuoFkKuS4VD0J6is6W2UEYfkdSw/qKdxWMOSUI/wDpURjY9nXOfxqncxRyAmEhfpyDW1dQkcsEkB9PSsi4tYCWMalD22nFWmQ0ZL7lBWVdy+uOR71XuFMZ+Qk55wDWjIrFirTBSBgCRcZqhOZotwZY5E6blNaRZm0UJ2JUlQG9VIwfyrKu4/mEgyufX/GtaaBnTcgAHUENyP8ACs5pJkL72WSMdRjoPf1rWOpkyg1zOhyd7x9zQzQTpkH5/SpmkhbmKT7PIekTD5SPas64QxESgFF/vA5wf8KuxNyGeJlOQTsHY1BIpI3ptyPSpmndfmG11PPrUclyjHds2dgccVSJZQlYs53d+tVZo/KO3O6InPuDWoUScHBAccg9j7VTbDZRsYPFaJtEnr8hEnAGQOavKdiRlOQeQPSqQBBYqOCQBWjBGTIBjIA7dq8lnppGjZpGsKbmbe3OP/r1ceMEOB26CqjqVhQqDxyKudVU7uMUirDIlZA4POeoq1p7lYwhO7nrUUakybScEjHSrcULLtERBc9wKTKJlKgqWIODjHtTmjYAlQWXHQ9RShMEg80MWDD5jxxmlsFhu7aqkA1IVD/eXOORS7VDbnBw35VIIw+HDHB49aEJsjWHYe+fQ9qtQhQQGTBIzuxUQWX73yknrVpd2xf3f3T65z70ITG+WWUnaA3ue1R6arWzSedl0c5AIGB6VZWM7+AACf1qdd2D5kZDZPcc1QeQipG6MB8ox3AyM06LiRXaMOikYxjPSkbOCD8o4PXpU8SqBliCQANp7/SquKxUZ1LgxoGb73yj+nrU1vICoDwxrkYJYYP1yBU/k2rPu2bWAyVVaeqwhhgYZR3c8/hTv1DyE8iGQHc6c/wjkke5NMk08wODGW29dhY4P+FWIVSRkxIAcZx1ORVsQZgjMczHcSMA4AprUluxVMsKkb7V4A3Tfl1+gOavLDF5gdV255If19OO1RC3YOVmeUxkDAY9T/KpoLFUUvE7mNODGSSCfT2qkmyXZE0SMzl0VmIHYYFTgB0iRg+EfauW+X/9dNQ7hteI25QYwjHDE+tOFsCnzu4xhlzzjtzinYkXakayRFIyxOMKuWJz61JNsWXDSAHGMFen9abAzIwBjAYYJLrg5z1pZQUmjLqqseWY98+tHQVhJG81FEkoGwkhQpH0FCw7oCXdd4bjntnk1NG6ruLoJcMeQw5OKckbs5QKCpXocH/JoYCPB5ioYQm1QVJI681HsjMjeahA3dU4xS7BEN+NwJIYIR8p6/hUgnURyF1URtwqupzj60tAKskTrHGsTrkMxJyDz/hSwQNJHwf3qjIIOCQT2NTBTJL5iiPp8pxwwHH8qaZGjCjoVb5MDt3/ABo0AfbiSKNVuQWXODk5OM0yWCJJUYblI+Qhj+R+lTQ3G6KRHjLOrblI5GPWnSbowZzEW8s7XJ5wO+R9KYr66mdegMGUZYAlBx09Pw7VkyAD7wDc4IJ6VtRLlAkTbWGVXjk8/wCFY8sQS6Mc6gMCc+pFZT7msOxBNIFJLKrSEAAnnbj29cVVcJIm5DnHPI5B9K0RCSAqsY8993GOuaqTxqzErkgjccCpZSZnlmhy2PlHBI5xUczW7KoVtuc5HSrMqRtjY5YHopHP41Uni8vesikAnhhyKQ9CtJCkmfLbOBwGPSs2aN1ZiijaDyC1X3CYyCemRt4/SqbyiPduVwOvIoAzZSzsSNynHc5qjd/aFUbdrgjGMCtCZVcb4SW74A6VmzfO2xgQexJwDVJsTSMm8SbaUeJjnn5ucVnlflO0Mh7jtW60QjPzs2PrmqF7aLIpaKQZx0xzVqVzOUTGncx8gcA87eap3DwybiuRJjpjr+FXZhcw8Ehu496z7q43fLNHtb3/AKGtosyaMu7QFD8gx6Hn8qz3jaIEKWVSOx4NaM23HJIPvVTzNjmObB9D1BrVMzaMkny2xuYA9RipHt43iOyRinXBPSp7u3VssnXrVCKUwSfMMqa0TuQ1Yi8hVbGWDA5BB4NJdxZ+ZD17dwauukcmSh4PY1TkBQ88rVJiPaoEZ85//VWjaLkEd/51BaqRFjPJFXLVdpbPUjivKvqekkWwu6QLngDpViKPoM8A5GabCAfmACk/pVkRZcAMdwHFS3qWhk4+ddq4PqKsQFkUgHnOQRTVQuF3A7h0qVRjHTikVoSRMSp7HpnNKxUgAn5vp2psK/vOehGQKJQN3CkH2oEPXLIVJPHPtTv9RuCnHP4flUCkoeeR6GpWUOhBPGMj6+lCEWRIdo3IQ3sacHbHybmXNUm3o7YG7kcdquxt8wycE8/jRcdrFmM7lUMCAx+XnpViNM4D5J5wM9TUEUY2HOSQPWrUBHBUlWXj61QvQlRMEphZBjAJ9aT5XUkYLLjlgc5pQdvQkHOQAeKsRyDb8y8DAJz/AEqrkjPJUyFvm2gZO3vUywxkMRvU4yM885/nT2RQS6jkdT/SnlCDx0B3Z7DvimTcieExn902fTtn8amggkVyZi25f4OoH41KiuGVW+cHnAbIFTxx+U6OSAG5Y5OTn0FUkJskjMUcas/zOuStW0DpbL8yBR82Tg1SjGFJVcqg5/E+/SlQqBudgwU8AjO4k46VoiGrk/mCRo9uHBBzGDzgVJBGylSgiVB8xzyCfT1qBZgkyyAjc4+8BgVLFKkj5dR8zcd8Y9KAaHvKPs7LIApXOee3+NOC7xvkjZmXheRz3py+U4kTZnqNzZBOe+abOo8gbyxXO1WP3s0ySPIMqvtY7iSxIzimYRZ2c8Oc7DnADf8A6qWULwiiTYQQe+PepCGWM5BZlB7jioGHmPGEYSbg3JYAcZol3m22ytkM4IyMhienP4UXLeYVQAKx/wBnHOOaXMkRRXQfMo2gfzFDEOicKvmKibk4xnIIz2qO8WOKU4VtrZI9Ae/NO88/ZFKxKTg7cenrUH+sdHd8hh0PJH1FDYLuRus8StueRWH3T6f/AFqcZ3nldTMyMVAkI7gfzpJ4gh4kaQH5WCjGAOlQTMFQKzHBYNuUdBjmpvYpK5C0rK+6AqWU8EngjGBxVS4LTzrIyKmRjHQHHFTqYjvCkFw3G4YyDTZXjMQUDGDjOeKzZoisYmK43Y9jzUSKOUzgOODnvTpWY7Sg56E1Xcy8BXI2fMuR60rlWbIWU4JLAHOOCDUUm4sFYbh2FPkVnU5jUkdSpxzUYleIbTGcjkd8GpGU5FXaylFK5zVCcDOMNx0IOa0bmRNoG0oT3xWbLKj8MBx3BxQJGfNJGMk8MRg5H8qz7p2kQx7hyMDJzWjeYI5ycdM96yZec4wCOxquZoLJmY8c8QIWVioPOeRWdcTOJNm9MjpkEVu5YD5o9y+i1VnWCbKbBkjkEciqTuS1YxWldwEcq2OAD0H0NULqMMdrsDz6dq0L20VCWUfIDgkf1FZt1buqbomYge+TWqZk0ZdzaBVLRyd+oPH5Vl3KFWKyKRxwRWqS6klZMHuCKpzszYWVio9ccVtFmUkZkc2w4c8Hv6UlxiWPoCR39amubUAbgQQepqk7tC2x1+Xsa1TvsZvzKyTGJyrHg9DU7Depz+NRXUeR5iioYpSPp6Ve+pNj36EERj3/AEq0PlIx0qKLAXgdakhzzwfrXkHqI0Yz+6xjtmrW0hI3Oc+tVIf9Xgn6VaDbUKsc4HHvQND3O2RGJ70+NwCQQcdOBmmTLuRTnDHkinxDcuFwWJ5waQyUKVcZyDjGfSnZDEjHIHfvSfOHKNwPXvTkUhgfrnNMQ0ozSDjr2qeKIPlSuR064qJFJJOenIqeNcFh6dgetIVwSMKnCsecYzVgDDAKAw6j2pigEcMakVQFB3EtTAcAOCuVPtU0TuWwMZHYjBNKRv25IHOOOKf5DHBbp2o6gXF4YKCBgdPXvzSxOiv7ng5H51UCkjay8DO2pY154ViPUHiruKxejZNpCPv+boeOPSpVi2BwMnIwPmzk5qoAY33bCeTgjpVmOTK5+cEcgZ796q5LQ4gMQSWBI5HTFSRzbBtUkgHOQcnpUYcvuYtsYdaheNiGwCwXnI61SYWNAyqyPuCKeuM+1UpdUhto2eQq3GWXGDj1NVJzO8J48tcDODnI+tUHSOSPy5VKE4O4d/TIp876FwgupbHiG3aMAIgyMEiTBY564rRtLh3ijubaT93vA2Zztz71zzafG0reTIqIQD+9GckdSfT6VpWcCWluIhKzkt5hKn5QT7djQnJvUuUYpaHRxOzIzxk5yMHOcDNSNcK52E+WWXgE5/zz3rDl1FbaykRvLXIxl2xxisix8RJcaibeWPMrsEjYPn/IzV36GSoykm0dqjMh2+X+8By7ZxUcrFOfvMoHbrVJL0jzGHL4IwfXjJ/nUschfLBnIOBycmpfYycWiw80cjgSsQSMH8utOgkZ5EM8iAbcbumAOwqjBKAzjeA2e5xx60rgZJZsjPXPUH1qbsOXoSKVaXakmWz3+734qQzjnaUk7ZJwwFQwOQpjVwRnGwjg06SRdjuyhgOhGMH8aBWGlklcCTcjdip4PoKqyMd0kbSH0wOh55qRwYolYAlSeCwxke1VGbLIcKRnjPrUPQtIe5AIyqhs4+U1U5yQAQc4wD3H/wBapZ3AXMjAsDgEVXEhEoJHBP51LKQM+IyAQST06H2zUCsxlLncPYU+Ta7f3T6etQNhD1/DPSpuWkJNkgPkKc8nPJNVzJkDJzgdT3okdckrnOOQwqtNIrjAGPUKf5Urhyj/APddc9xnpVS4yBnbuWop5GJwoJwMYPBH41CZ28sgyEY7E8fnRcOUqzMEXIVWU9MdRWbIAxYhVYdTxyKmlYK+VJ56g1Wm2Lhz8hPpQmDRHIsB2ssgDf3cEGsy9TzHba7D61aklIYgFefSq8+5wRuwe4zirUiLGbMZVQgsSR3H9azZd+N8ZP0rSuwyKH7+vrVGQg9OpHStEzNmLdMGLEjJ7giqE65GFORj7ta14odegGOM461i3CkEEE5HQ1pFmbRWGRuUH6qe9V3xIpQ8juDVqRwy4dcGqsyjdkHDdiK3TM2ivnY2xvu9jVKVfLkJ6qT1rRm/eLzw47+tVZUDxkAYPYVrF6kbHv8ACu0DJ5NWUO0j37VVgzjcetWIvvkk15B6RcgbEi9KuqVD4OM1QjxvzirEbbX+YUDJ3A8sjuffrTrYbAc+mPpTIsBgeCO9SLw3HIPNAXJyu7aO2fxp5Geh9iajVhxnr0pzsuMA/WgQ9GwMj1qTdtJA645xUBxjI6E4zSDcpDMeexppAWFyp3LyD296niYOoYngVX69Pu+lLExQkEY+lAImYI2BnIHYcc+tW0kMZG5iRjkZ71UB44APH41Ij5xxkE8ikMuJJknO7JHSpY2YqNuQR29aqKpB4PI55qyjDIIDAk449fSqQF6OXIyyhgTngdKsb127BkYHPPDf4VQ3fMAM7vXHUU7JUlipBJ7DirTI5TSSZDtBViRgbWGMVK7xtluQRypAyCO+faqETEkNgEEYz3BqW3lLMAA3BPbGBVpkuI4BVkjdR8y9RjhlJ71XntoyN6hsNn3xVpYzvXPKY6ZBpyKg+7u2Ag4BxmhIFKxkLApUru6fjirEsRgABIJx8pUfiKuy28O5vLDYJwBu/ipslr5mB+8VQcEYz+NFrF89zG1CVZkGICuR85P8QqhZ21tbOssNqFlUfI+4jafUVtPaNnheoP8AD+FR/ZWjyGBOO5Wobd7msallZBb3BUEMD6nNW7i7wVMbONy5ZumTUaRKDkL1Gef0pTFFksRg5BxnNF2ZO1xEkygXIJHTt+tWPNQAI6ZAPBqvlQQY0fzAc5PSmnKn5g2Cc8ClsJpMuCTzGVwOQfvYx+lNdlVic7s9RjtUaXMbAIkeQvOc4Jp29dgbDCQ8HocU7kWI3kZp1Bz5QPTNMwWduRgHGTSsFbHmNyMkf/XqJWVdvzKecgY/Spt3K9B02+L5JPmP8qrySBlDAbSecjimTPJI5YOQrVXfJHpik2UlYfIdwZeuMZJ7e1V9uRuB4IpxcDvj8cVExX1ZWHr0qCiNjgEElW9M9arybgQAucdT0qVpMEkFc9qjkkGSXH4igCpIAT1wByM1UbdlsDIHXFWpZF24IUE/3uapN8oJycDvQMrsCUbpiqM6bgQSAO2e9XHYA8nANVZjuG1uaBMy3UAY6D0qIxevI+tW3jjHTOfQ02dQYgVXB9OtBLZl3KlVO4kZ7e1ZlxlD8q4x6VsTSMx+7k9KoTgBeK0UiGupkTsGGe+eRis+5jDruHWtadA7c8MO/rWfMmR16VpFmbRjTAgnNQsvHqKv3CbiQw59qqONpwOlbpmbRXCr07dqqzpsYjsauuueaR0V48H8/SrjIho9sjbjao5A59qsR4PB/OqJbjhvoRVmGUZweGA5rz2dyLcb5GQeM9qsZOOnH86qRMAOOtWUO7ANIotIxMnyjauKmhyMnNQxk9AcEcVLnbg4oEThQVO05FEbApiRcAd6Y/BBHAbHSpGORkd+KAFAwnoKdHIWjXO3IPXFQucAE5xT1IKnHrRcCwQXBBGD1yaULwCePeiM8ZPQdD605WBIweKYEhUjHPzetPTOcg4pvAHz9CaeWG0elKwChiMjj25qeJzlTu6HJz0qLIwGGMH9KXd8wAKlT0wKadilsXUkUbiD/D6Yp8c8eVUt90liOx9KorIVU45JHI7UkhXPOQMfL6+1WmHKayyxsFBPBPQ8c1YTLyLtbbjLA+vtXPR3ZSWMSrmMkgn1qK41q1t5JYbh5YwIyY2Az+87A+3vWikuo/ZN6I69njR227iMZI9W9qlQK6CQbco2GXNYOk6pHPZsWlDsx+UjqtSS3wWMlCoYAZzzu9c1pdbmTpSTsa00sZkBjYfNxuIzjnioncvkPyme3YetcwdbWOFpI3icH5cB+ef/ANeK07S7b7Mo+UZJBOcn6YqOYp0XFXL5YDhQQM53dcfX3qRsCNSQTkcfN3qGOVXG2MjGCfmHGaGOVBACkDBGM4qLkWEYDdtRSCe5Ocmh2MjZZk4GPlUcUTuWU7HOeD93o3pSAjILbeR0PrSYgbYhLL8xPpmkxhQoy3QklsYqNmCF8kgDjNICAyktgD35NIYjQoG3Dd5ns3GfpUG8vIzlSAPT+dPJjOcks2eD60HcFZiMA0il5kO87ipbAJzjNDbRke1M3qPlI69Sajkm3vhQcDuetK6HZjmJPQhcGoGZt53HJ7+lMaY7mG0bRVcyHcCPu57VDZSRZdgDnOM+1V5Jcj5jjBwDjrTJpRjjb68+tRCUbAMjnqaAsOkwRkBSB271AxL5UcH2PWnPgqcnofxqtcMob5VOPbrQAycdiQMfr7VUdgGzxjutTPNlPk/HPeqcpO7GB+FAEMxwd2AB/d61DJh13AAe471KzfNg59vemSlWbKH8CKCSmSTwwOPeoZBgFQrKfrmrLKeR1z/CKgmUkfK35mhCZQl/EGqVwQDtcYNXpdxJyM1QlZBJg5+hqkS0UmTBY9f6VQlVd3Ixk1pt970+lVLhRuwRmrTsSZ1xHtwMdeQapSRbs8YFasqEAVEUyv1q4yIaMSWMr9KgbK1rXMPXFZ0iEcEVtF3MpI9ajYDBzVr/AFigqdrDvVCJsgYq3E2M+9cb0OtFyCUM54wR1HpV1WyRzz61loCX3jAYdPf2NXIJBgHv3B7Ggo0Y2HIXrViNiRg9az45Bg8jPrVhGJOQRQBYidj8nftmpQykOD19apIXZ896nGD35HNAFjfnCnnt61JGEAIJ4FVd3pzjnrUhJyGQHHcUgLSkY5I55p/APWq6t8vAI5yec09GAIBJx2p2uBZDdSB7U8EZ5A5HXNRKTnH8PWlHzYL9ulAFjBQEdhSg8cdqh3HjJ+XGOaUOQCF7frSKROGKjr14pxcHIAwcYH4VGsgKDcAvHJH8VKTwUbqSCatDI7vb5ZGF2sM8djmsnVbT7ZJCySADgNnjgdvStS4QsxDDAGfu1EturMNuWzx+NUnc1hLl1K+nWa6fKZCzBf4MNuI9jU2qSNJZzi3fZIyYBJ7d6sR2zOpDoysPWo7u2/dspRgepwe1UlZaDclJ3ZyGjacs0scUl0w4/eIw7Dkc13VjGihcEbRwAB2rnVsWiukliYkADH97P+FbsLDcieZuKjBb1PpU37jqarQ2IZTlEHAPv296czbgfuqDztzxj0qvEzovGOec46ChpPLxkZHoeCaG9NTltqWl+YEHIHbH+elMZlTIXk4/iqusgGAGHI7Hp7U1pcjGefWloTYkdgoOfn9BnvTPODRNl8v3B6moXkOccHA6AUOcgMF+WlcdiVSyITnG4ZAxTDPgfMGyfU1G7beBx371GxRhyST2zSb7DsKZFZ8DrmmFSGxgY71EFVeUOMdABSNvK53bj7VIxsz9t349Qag3jOMHHbFOIKHOCO+cVWlZCxxksevNIpIdIQkZ2nA9xUIO4LgYJ/Wm5+UFjlR681HJJsODwMfnSGExYKeRmoSxYkgY9QKXziRtwMD2qE5JxkUCEmwyjGRjtmqhJ55+gNTupY/MOB3FQMh5Kn5fU0ARjJyAee4qNgOdq9eh9KfJlccZqESELgA4z3oJZEz4+Vhz61DKUbJPBqaTkfMOaqvgigRBNjHyk1QnJJIdePWrb5z3GP1qmx3EgZqkSys429s1CwDdetTM27IGTUTYHarIIZUGCRz7VWKDBJ7dquvgqcj8jUEgBHWmgKM4B5FUbhAeo5rSlUAexqpNnaQa0izNnd27fJz1qzGx3DccelUUAXkZz9asocYOcmsdzYvw8dTkVYwfvpndjkf3qpwPk/MKuIx7UrFXLELho9w79KsxufbiqKDY+QRsPX2PrVpCAxBOTRYaZNubeD3NTKW3DjJHb1qE8EY/A1KhYngZ+lAXJtvyMwbAapYg+7G7jFVtxVsnoeCP61PERtyRigCzEBjaSBmnLyQPSq4OMZOfSnqzAE4H1oEWcErkHBp3zZwfmXGePSoM5H3u1SrIwTgg4pDJMEnAkyOtOzkAHg+vvUZkJKg465BqUnPp6/jQO49MDr1A608E44Ybeg4qKKT5TuKjP5ClyCOAFJHQ1a7DuDDAAdeB02npS79pO0H19CKakw2gycj7hzUbyAAr164I71S0KQXt59mBdnCYGRk1zbeI3NyqzqdrH5ghzxUuu75goX7yksVJ/Dgf0rBns5UkhmjmQkA/JGcEEdiKHLWxvGCtc7y12XLxtuCxOTtx2x2q5aoN2IxntXG6ZcS2rYlO2Rsk8dyeeK6TTr7zJEBcq5/2TQpqWjJnCSWhsK4EY7g/eAFRFdzZGSR0XrxUW4F8g8D0P6VIXxwpolqYWsOLkKAMe2MUnJXcDhfcUw7QR1zTyykDofp3qCXoHYAAkHuaRXVBgKfqDTnbCAbeewzxUHJAGOvah6BuPaQY3MTj+dQFgATnjPWk2hH2t35yaa/zhsADNTuMZIQ3CkkdzTXboCeT6UhYEkYOPyqOeUKOOT34oGE0myJsBSO2Kz3lLNy2Pan3Mwk6AgdDxUaZjIYEZHY80ikgMP8AEWB7+tDyIykYKt065FI0nUA8/TioiR1oshDGPrx6elRu/BPAPYUpbAPzAk1E6gMB3osFxocMuD+Xam7mQHnikdem08io2bkDPI9aQhHYZIyRTHIO0Z7dabIecsuD7Go1Kge/rQIR5doIIznvVRyCxAqaYgg4H5VUkOeQeR60CZHKOnSqssfVkOD6Va2E/MeKry5xxVITKTgKTjIPeomqzIBn3qCRTngVZmQ5OeaZJgnkVIfmx6iopCOnpQBVnX04FU5+Ac1dlbqKoXRA+laRM2dtG2QOeatRAYyck+lUIiTjHSr8C9CazNUWYjkgAVaQHHOarp8q5xU6k5UjIFIZZBGdvtzT4+m3HTv7VAjfMasIMnHfFMq9iwDu6dqlQ4+ZeDUCsRnAwRU6yApkfe9xQBKkm87ePXNSRk/dPX+VRRMRuOBkfqKkySPRh0oFcmY4XpSr9/BxsI696YGO4Z70/aCcdADSGicFRz2FCspIGCDnpmoxwck9O1OU7iTjg88Uxj8EHHTHIp5JIPJphJUgnoB0NBOAOOMcUrDJS+GA28elKSTxjPPNR4zwP/1UpbauTySeDTSKJMc7fb8KrtgE5UgD171KScgZJHr6GmFTgFSd4P5j8Kvca3M7ULcXUK8sZVOQ2eo9Kxo4Ht28yGVYpQpwFXoPfPetLVvOaPdGuzf1ORz+FZwZpISsnUjGCe9Zz0Z1046ak2kgmVzcyO0kmR5hbJBNbU8sdsjSLvdgOXzzisa2gBZJEOG74bk++K1TGZIyFfORyPUe9ON7Cm0mT6bqKzAqqfOuT8x4HvWjFKHxkn6nvWFZ2oiJ8tSPU5zmtiz8xFDOoJHencwqW6F8J3zx9KVnYdgPaoi3UgYyeopCTnGSR3yOaLGA4EY+UZJqIsvAbIA/GiWZBGoGd2e1Vcb26lQKTdhpXJ3lUngNx2Jzioy4wcnB61AVYLwevcioJUZW5JIPAqR2LEsrMnG3PQYPWqvJJ3kgipdrhMNj2OaaBt3Y5HfvSY1oU5Sc5JpglPRuR/OrM0e7sPbjFQ+XtB3DBpWHcY6kAE9+wphGVOfyqQ5YdjjgU0theBk+tMRX2lW68GoZW+cgk/41ZI+U/wBaruQVGDk0rDuQucDk1G+AM459c09kJIJximkY5xx1pCICCcDdn61GTtODxUzZB3YAzUDMS2D07UAREnJ5GTUDDJbPBqWQA5DfmKruDkgnJ9aaIZEzMue9NlVfLUjO4npTiMKcHJ71GTgEGmSyq6nP0qNs4POKmkOOv51Bk8Z69qtEsiPNVpOBzzVuRsZIyD0qpNz9KdhFSbrmqNzypzV6XABrPuTk8VpHczZ3kagYxVuHhgW6VVQYANWk+bAbis2jQvDaxXHSpQPTtUMGMbeOKniAywJ6dqLDHoOfc+lWVGCc8VWVecg8nmp0yepwaEUPGSfSplAKkDjioweRgcDrUu3BABye3pQDHoQwVQAGAx9anPAHGSO4qup+fG0elTZIC59TUgAycgkEZz9KlVmKgEDjv61FyQGU7TnlT3qUSEbSADj0pjRImc96ep+f5eO4pEKMuV6HsaVVKqc9BTsFx5PyrxjmlyAQR06YpuRnOeO9AcEBQVz1xSGOJVccH25pdw6VAxGeTgjrxTgxDEE9vzpopIk3Fs4+636Vn3V2LdjudlIBOB/Op7iQpgrgn3qlqzQ3MKO/leejHIwRlfft+FU3ZXNYLXUxUne4nbzSdvVSeefSryywgKZNu8YCoo+9RYRCNWk2IMNgRnkj6e1P1idmmFztTzJCDkKFBOOwHFZWdrnXzJvlLF1cXB0+FN2ZIySiBBlVJzjP9KTT7qY5D5Cn+I8NmorZjMiO6Mkp6qasoCGwx74xVWs7mLlZWL8bFjgv26VcifI5I249Ko2w3I2S35U/JjUbSfemc8tXYvhw2D/WkaTaCaqq2V55B4BxUifLwzHoeBQyGhXO7DA7cDimktn14pn3uC3yjtQFLAbCcetSApd9xxjk1ErOykcY+nWn4B2+YSATnAFISRnuOwNT6lX7AdwQqpwfU03axXAPPengjbnI5pAOG3Aj3707CIHyDjJWoTkuSRx7VLKhPHODzyaYFGMDoeOKQyNiwxwwY8ZHpUDAjg896sHaRjBVuxqFyOg/Ggm5A56/3ulQFuqkZx04xVibBXkc9KrkcccjNIpET8AAZqIZJ5Iqw4BfKgioipJP9aQEfBORj0+lRsgIO371SMhyVP6VA6FSABj2zQK5XdiDjbgmo2wevapZScYaoHOBjPIpksibqSFxUMuOetPkwFzzmmE5A4AzTIK0oJ56VXPBHrVpuSeRjNQyLWiRJWkOaqyZOcdKsydQe1VZPmbI/KmgKtwSeDVC44bpWhcsC3A6Vn3IySR0rSJmz0CHP19KtDcRyMVBHxirSEbMn8qzsXcnRttWYDnPPPeqsRzgGp4wAc5oGWEx2OBUw4IOciq4PODnFTIc9aBkwOVzj8asdApxnjGarqflqQ5ZQAelFhj06qD1PSrGSO/OenWoMYVSGyRToCHzng9RRYCbIU7mXOaVkB+7yDSoQThse2aWJWTIkPHUUWAE+QYPQDg4qwpOPmPXioMbXzjJaljbqp78CkA7BBGeo9+tNKAngdf0oDkKQQeKczqQMZB+tBSYx3IODkr0yOtKxCqRnNMfG8AdM96axXaTjB9ulBSZFMTjAIx9arEA5DDnpz3qwRuGQc0CHkMVyp71SNFKxSixG3CMijsKg1GddvlEMe4OOFNaJAXIU5phtgED74iD/CetDi2rI0jPW7ILC5MqDapBBw2RjA9q1QAWzjOOmRmqUMZU5XPHGfarS542/Lj1qWn1Ik77Eq4jBy+welODkcAhge9NdQwHCEZ54piRlQdpUDNTr0JJWdyoAUCngkqu5hwM8CmQqGzu5/SpmOBgKcAYzimSxu04GG5zT0O0kCQt64pEBByQ3Hp1pVXPLAgnk8YosIcCNoJ7DjimNswWLHJ7DHFKVCfdU8cGopXXGAuD6nvSYCqS8YyRg8igqygnsfUVGHVWC4603eGfJY+1IY9mJwTn0zTHkG75eR+VLJIznsAO+Kiy3zEKT75xQIY/oze/SoWHIz61NvOcsRkfnUTHcSTwKEBFKoZs96hK7RkDgc/WrJIxjH496hdwBjGRRYEyLcM/Kef5VG2CenzCpTgkEDgfrUbHnkc4pWAgYcZz1NVpAeh6VbdRwR+XpUEmcnngUgKcnOagcEjPb0q3KBkHqB1FV5MehpksqyDBwCcVBISOgq2VzznFVrhWBymOTzmmiSFsYzn8KhcntUsigY5NQSfWtESQuRjH51UkGTxVtqqyjH0polspSjLEk1Ul6kGrsnOc8VUl5zWiIZ3qHnnpU8ZLcAVXiJYjkAVaj+8KixVyaMEnB6ip4gQxB4NRr1yKmU5VTxnviixVyZD19qkwR9PSoA2RnODUgYnkjJosO5ZDE4GMmnqzAgYqsGywGcVOsgyB3oHcs5BGeMinQkBsgcGq3m4B7e1PViM7SBRYLlwHle+T+Rp5bgHPqDmq8bkEA9MYpSVXqfwpBcnGWJHpUmR34NVxgjavIAzkUiybj16HGaBlpm3c5B4wagfIBPQUisNyk9jSyKGI6DJpbghvmYO4cjv7UrHeBkY9COhqIny3Bydp4NDOp6dPekUKSFzxTJHIJIJA9M9adlSTkZFRSkZGPypopEck5Qg7QfrVCxaWGQDcXQtlkfp9atSAtkYz7UxUYMMk475ps0UkkX4WOM8gGpvMyhwDzx+FQRttHWkVsggYz6mkyLlnkR/Mc46YNIGzgjlvr/Ko4i2Dnp6Uq5DAjJbp15FSFyx5jMSNh6c8U9XQMOoHpmmhsKd/p0zmkJDBQF68gAdqYidAG5yTk5PerKuAMAAD1J61Vz1JOMdBwBSSszsNp7dgKNhbkjOj5wDheT70xxu+Y9M496jI5CDPvQXYE8YxSBA5x94Z/pUMrsWxgfhSSybn2A/jmm7SMlSN31osMcNn8QGfapH+Xls7ffrUABAxt+brkGhXkOenTHvQJg2CQU6dM+tMwDgds8e1PXEaYc02R1ZmKgAAfSnYm5DISRkYqBiewFSbi3OetMA2EBjnNKw7iHkD9cUw8tyePSpOOvYcVFJ3OB7UrBcY/rjFVnYg8VO33faqxyGPAOfWlYLkchyOeTVeVecVZc88DtVeRie3FFhMrMOc8GoTlzjFWWGecGoHXJBHXNOwmVp1wTnNVW/L2q5PyOmeegqq6nPpVolsrMDz+lVpBgnI5q47DpnkVUmB5qiGVJB1qrJ7Vck7+tVm6VaJZ2EbFcZq1HKBgdazt/ocVNHKDjH40NCTNVTnv1qZcgADoP1qnAxKggVPEckjvSsWmWkcFuSPoak3446GqoOO2akV/oTRYdyxkA+v0pynIyTz7VX38npk+tOXBzknNOw0ywrkN8xzT1bI6VXUL0xz1zmlWQKMnqOAPWlZjLYbBHzEGkeZmwvAA6ntVZGxnHPfmh33L854PAHrUtDRdguBsx0GOPapY5ANw2gBqzVOOhyBU4lyMHr1wKdgLgfj5SDjtQzhl5yDVMvzkZ57UpcY6mpsMs+bgfMM45qN2DDIGKhV8gr0xQTgUWGmTIxOM4I9KGbBGPXmoQSR2OKbu7UDuTs4JB4zSbg2ABznnFRqSCfSn4xgimFx6lRkGnowB4pmFJwQKHzkYJ+tIL3LCMpfmibCurDAOaqo3bdx1qVWBByBu9c0rDJvtO4dAQPSl5Y8ucEZ4qoW4JGc9MVMjlEG5gQe1FgJtuCgO7PpmnFpEzt3eX9cGoA6gcnkdMUjOR94/rRYVyxISozhgfrmh5C8e3Ax6jtVRndgMNkZp4mCJ7elOwdBxAzyQfT3psm1TkjgVHJMGXHJHsKg8zzJCSwHGMGlYa1LQk2c5/AGneaWGRx61UTd1zTzIduMk0WJZYdiqHj58YzUBXqxYD1BppnGccl/WmvKSgUL1piFyN4JH0HpThyDjketV24IJPPQUoc8bj+VNiJnG1uDzUEuX5IyPSk3YbcxNJuO7rxU2HcRjwAFJ4qBgOw+YdqlLBc/Nk1XLBgWU4oYrkcnHIwDUD8HIPHpT5H3csMioSc8GlYLjcg+tRSgcAZGacR83FNduxzinYCCQdAuKqyA5qzIp57VBIMcVSRLKci85FQSABeTVphUbrxzzTsSyjIOmKrOpB5q9IgBz+lV5F3ZqkSzSSbzG5OfSrUTqG6/UVy1vdSFgxY49q1bO5O4bSCfXOa2cDJSOptHBXIxn0Jq0GJ54965+CcswIPFaUVymMDJPfNZtFKRoNnaNvpQG+YfSoIrhPXPtSvIXPAGKlo0TJt4PU9KVX3Yz0qp5oXA/Op1lG0AUIdywSMd8VEZcAc85pjSnHXAqBm3MeNtDQ0X0mzyMkjqKGbLZ7YrPWVlOA9WInIADHNJjuW0kGAScZ9O1PSQbsE4z3qozDaDznuKVJM47/Xt7UmMuFwFIJ78EU5JAy9s1VUggipBjjFIZOGycdPcUAkj3qEkYxT1cDvSGSJ1x604ggVBuO7INTbunPWmgJN6/wAXBxS7lHVarscEc8Uu/IpgTCTqcA596TzN2cnPt6VXkk+U460xZeoIx70mBYLbRyf8aVZQB8v61WZs8mh3zwOlJajbLRk5z2705ZORg4qoJAF5pnmDOQTg9jTFe5aZjuzknFKJuBuJAPcc1W83IwOnXNKSzD5RikO5dZyUJHIqHzOdvOKhV2jByRkdaPMyDkcVSFcl8zBIzx6U4gE1Vzg8c+5qQSkYyDz6UguTk4PB7UpHqR9aqrKd4BBIzUrEHOO3OKaQrkowMYOaaDuPXnpzVWaQBflBz1zmmJMQfm5FArlrPzkYIUdqJJAR3z61A0p5xzn+8KGPyc/oaBXHO2cY7UwPwQDx7VBLKEQ8EfTvVdrsIP7wotcXMTs5B9j1pXceXkHp6VnvdKSdpwD79Kja7IGCRnpmnyi5izvU7juANMkkXGaoNP8APg80xphgc8dPpRyi5i+rg5z+FNbJJqos21uoPpVtHDAkGlyj5iCRipAPQ1HLgsMCrLruHtVeQckdaLBcgZKic9vSpZG2DmoC3fPWgRBMMfWqrk85xVyYgA8ZFUpehx0qkS2c7bTBT+8AYHuO1XIL1IieW29sVzyTlcEnPtU63JBODtHtXo2OG51NvqrbSIM496euqMrbmbLVyqztwd3FP+1EHK5BqHBMtSZ3NrqiNhXbqM5U1civg7YRztrztJ2GSHYd+KuW9+yrhnOfasnSNFUO8ivFEwUsOematLeqx4wcelcElyHXAcr7jtV23vJUGVcFu49RUOnY0Uzr2ui2MnIqXzAD1rnotQBT5sCrcN0JPlBOfeocS1I0TMu7sB25pUuNpzkmqTe4GaVMk/WpsUmaqzjqRUiScZPU1QTpirUDARg8ZFRsWmWhhsEfjUoJB61VWTpk8ZqfcCMUWGSbg31oGMketQ7gG5pRIM4wc1NhlhM9AcjpUqjg5qsG55604MwOVb65pgWCBjim7wAeD9aaJCRk9PWo9+TjiqsIdJjJx1NReZg4GRkc0jOA30qCRjnOTzUgT+YBnBFNEnQZOarb1GTzkU1pe+76U0guWjLzg0jSnbg4BqmzqeScVE8u1gPlK+op2C5fS5KjackHrTjKQPv49qzTISc7uPSpFmH8RB+tKwNmgZd/Bx9TShgq9SMVS81eCMfhUkcpbOW46VVhXLocEHoT2NOVuPm4GKomdY8fN0/WkN2pG7cAfQClYnmL+9cHaRkdqaJRn/GsqW/AGGAK9iKqPfDOC361XKTzG4Z1D4JH40xpUAIP4VhfbVJOSD7d6a94CMK5BHaqUWJyNj7btbg5HfNOluwx4x0rnDeDBA4cHnNRPfk/d5PfniqVO5LmbjXR5yPzqq02D7n1rM+3bW/ena3ZCetNXUY3ysvy88c0+SxLlcuzyBfvE4Peo/O3AjK+gyetVGlGNgYOnYen41RZwhKtyPQ9PzpqFhcxpfaByhY46EHqtBuWimCyjAb+L1rKF2shxISCOhPXH9acs/BXO9R75/KnyhzGtPMYzhQD3z/hSxXu1uWIJ6j1rEM55CNkdcelPeTegkXqPQ0uQOY6qG6U9R14zTJWUE54xXMR3rgM0bnPdDVhdSMijnPqp7VLplKZsysrKPSqkjAZJqhJdZVQrED09KiN1nvnHepcB85oSSKVx3qjcNxiq5uvm69aRrhGyM5NNRFzHEo4HapPMUdAarA09TXoWOVoseYTTxISRmq+6lDc0rAXQe6kUCSqgJp6mlYaRfimKnjgVdhuQcAk8VkK2OlSo9Q0UnY6G3nC/MvGe3+FX4bkhsjA9Mcg1zEUxU4BrQt7ghlI6ispRNEzrbeVZowy4yOozU0bY598VgwXABDR8E9a07S43Btx75rFqxqmacUm0epqxE/GOKzkmGRVqJ85rNotMth+F4xUqycnmq0fOM9KkHUmpLTJg+fXNKz5IHeo1wRwcUuOMA5NAyUN+dSBjiq6sUOSOM8U/fu74HpQA8senam+YR8ufzppG7B7VCzEN7U0BNv44ODTCfVuaiZ/QY+lJI4xxmkK4r47YBHWoGfceDg9iKN2c4NQMxXNNIlsa7NnB6/Wo3kwh5FIDvJA6VVnlTdsb7qc/jVpCuSpcgthmH+NI2pRpnLc9cVk3MzlAAcL64qvJKmAqDjPPvVqJLkbi6qhPPyk/wB7tSNqaIrEtwO471zz3LY+UtnsOMCqrOF+aVyzZz16VXs0yOex0TasX3MDgehqvJqzY9BWC9wWBC4K561Wkly3Ofzq1SRDqM331XAIBKn19agOoEkt+eKxDLuYbQc01m2k7uD9atQRDmzebUwVHl8t3Bpv2yR33E/N2CnmsNZcdCacsoz8xOD701ETZtNd/PuMh3eg5oN2x6bCT26Vj+ZHswoIbPXNJ5y9MZPaqsTzGtJdFsLJnH5monkK/wCrywPtVIXJUfImcelAuGJyQAaLBctm6KkEq6HsU/wp41Ip97a/sRzVBrqTIG4H0xTZJmfO6L8RSsguWLi5hkB4ZT2qtHcvEwZJDnPQionUk56A+tLhUBO5dw7daLDvcuf2orkeZFg+ooNyHb5Tg+3WqDSBiMoAe5pwKj5grZpWQ7s0WlVyMAqcdfWoxIQ5DkgdmFUhIx56UglJGMnjsaVh3NT7S6EBiGTsw7VE1182NwJqh5h9BTSTnnFLlHdl57jLcZDelNF0M9SD71SLt/8AXozu+8eaOULspPEB0pgQiros5iOEp32Gf+7WvMLlKB4o+lXHtJR1WoWhdeq00xcpEGp4b160wqQDkUh4p7iJ1YHrUqsPWqYbHenq2aloZdDd6nimKkYqij8VKr1LQ0bFvc7SCT+Ga1re54BBrllfHSrcFwV4J4rKUS0zroLoMoyM1fglGPl+lcpbXO0DB4xWxa3Wcc8dDWMo2NUzfibgZParKNkYFZsUof6VbtyAcVm0WmTRszMwKnj0qxEvH1pkbgOSBj3qxuL9wKksaqg53Y4pSoDcjmjawHPI9qa3B56/WgY/cOQBULIDnIqVP9rg0jH8qZJTkBzxUTHAJPSprhexyPeqspwnByaoljGfaeKiMq8ljg+lRytxz161Ukk3A5Jz2poTJJJhHu5+lUGmzG27BZiSxNRyz4J3nOKz57kngcVaiS2FzIZJQobIHOPSqryfiBwKiMu1ie5qJmZu9amZI82DwTmoHlJ5bk00jg01vrVqxLBpMntTBgk5bFFNLAVRNgzijNMLGgcmmFh3WjHvShaNmaBWEVqdvJ7AUoiJ6CpBbue1FxcpF5hHc0m/n/61T/ZZPQ08Wbd1pOSGkVmfLZPBp8d1MucNkHjHrUzWTL1GDUfkvHzii4+UafnyxyuaauFOcA+xp5VnHcAUKBgjH50risJLJuBwiL/u1Bk5Az+VWVjBzlsU1o0HXNO4EIJz1NNZh+NBBB4NRuSTmgpD9wIoLg1FzTicYIp2CwrOc00HNIeTSoMnFAj0AW8RPSn/AGNcggcVlLq0I/i4qwmuQhMnpXN7xroaB05HQfIKqT6ErglRj2psfiSJE+bGKRvFcI421ScuxOhn3OhHBwOaxbrTHjJ4rcuPE6O3CVn3OtRycFOa0i5diG0YMkLIcYqLla0J7yKQ9Kqu0bdDWyb6oWg1H7VMr1XKjsRRyopNJj2LqtUqvVFJcdetTowzUtFXLscpUj0rXs7j5cHOa59H9auW0pVqylEaZ19pckAdxWrDLxkVy9lOCAM/Wty2k3YrmkrM2i7mtBLk8k5q6h4HrWZAfnAxWjESq5C7vpUMtMtx424Yk5p5jBGVAFRwsXwFIx6HrUzAqAuM/jSuUQqgDE9/50yVwVbPBNS7yvG3FVp8MeM5oFuVpjVGUkelXJMcDAFZtyQc9KpEsp3chBwGwPasqe5ZOV6irE5J9RWXdHDHByK0iS2Rz3DOxLHk1VZ6HY5qB2rVIzbHM9MZ6jJpDVWEK70xmpDSEelWKwmfek69acODzTGkGcAZpgPAp2ag3O3AFSx28knU0CHhgOpFTRtHkbjxU1tpe9gWNdFp2iWwYM+0+xqXYTZhwyQddtWUlizgIxJ9q7rT9P0+NtxgjLfw8cVsolmSxFvEjkcEL0otHuLmfY8ta4RCeD9CKYbwYxsxz3rvruytQz4jQs3U7aybjToGBOxRj2qHy9yk7nJS3qsPuk4qo10vPHBrqJtLtmyVUfSsufSI8nqBTTQzFedTwDio2mA6mrd1pgUna1Z89lIg56dq0SRFyTz1xksM00yhu9UZImHUGo/mHIJq1BCuaAPc0Ngn2qiszgc1MkxzyKTg0UmSsuKQqaUNup6jPFK4xqJn1qeGLJ6VJDAWNaVrZk4wPzrOUgSMWThVA9alk+W2yOtFFdHQ5yjLIwUc1HuJFFFC2LYzcSeveoy5JyaKKpEsTcc04dTzRRTEKCQRzU8fI5ooqJbGsRWApVJB4oopdCmWFJxU8ROcdqKKyYzSsWII5rqNPYlcGiiueoaQNe1+9V6MnI5NFFYM2juWom5DYGcVOWJGTRRUljWRWxkVXbkP2x6UUUwKk+MAYHNZNwBmiimiHuZt0AoOKxbvhj9aKK1iQylJ0qtJxRRW0TNjCKAM9aKKoBcDFNYYoooQiIfMealjjX0ooqugmSAAdBQJWU/KaKKQmMa+nRjtfFWU1G5WMMJDmiiqsjNlyDWL0KMSmtKDW73OC4P4UUVlNIuJZGq3JXll59qqz6pclwm4Y+lFFZ2LHRXkpVuR+VQNdytnJHWiiiO4PYpy3DsecflUErcdBRRWq2MzLu2O7oKps3zdBRRW8RCqB6CpABRRQy0TIozV61iVutFFZSKRsWcCZHFa8MSqOBRRXNJmiR//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 13-year-old girl picked the comedones on her forehead, resulting in chronic erosions. Some of the erosions healed with scarring as new lesions appeared.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acne excori&eacute;e des jeunes filles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Multiple excoriations are present on the face.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7146=[""].join("\n");
var outline_f6_62_7146=null;
var title_f6_62_7147="Chronic pelvic pain examination";
var content_f6_62_7147=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75811&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75811&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physical examination in women with chronic pelvic pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pelvic examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tenderness present? Location",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nodularity present? Location",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pelvic mass?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Abdominal examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal distention?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tenderness present?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Straight leg raising test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does leg raising induce pain in the right or left lower quadrant?",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Gambone, JC, Mittman, BS, Munro, MG, et al. Fertil Steril 2002; 78:961.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7147=[""].join("\n");
var outline_f6_62_7147=null;
var title_f6_62_7148="Surgical options for UC";
var content_f6_62_7148=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56142&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56142&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Choice of operation for ulcerative colitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Operation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Advantages",
"       </td>",
"       <td class=\"subtitle1\">",
"        Disadvantages",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Rectal mucosectomy with ileal pouch-anal canal anastomosis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Complete excision of large intestinal disease",
"        <br/>",
"        Transanal defecation and fecal continence preserved",
"        <br/>",
"        No ileostomy",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Two operations required",
"        <br/>",
"        At risk for pouchitis",
"        <br/>",
"        Nocturnal fecal spotting present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Stapled, ileal pouch-distal rectal anastomosis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Transanal defecation and fecal continence preserved",
"        <br/>",
"        No ileostomy",
"        <br/>",
"        Easier technically",
"       </td>",
"       <td>",
"        At risk for pouchitis and cancer from residual rectal mucosa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Continent ileostomy",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Complete excision of large intestinal disease",
"        <br/>",
"        Fecal continence preserved",
"        <br/>",
"        No external appliance",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Stoma present",
"        <br/>",
"        Intubation of pouch required",
"        <br/>",
"        At risk for pouchitis and need for valve revision",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Brooke ileostomy",
"       </td>",
"       <td>",
"        Complete excision of large intestinal disease",
"        <br/>",
"        One operation",
"       </td>",
"       <td>",
"        Stoma present, risk of parastomal hernia",
"        <br/>",
"        Incontinent for feces",
"        <br/>",
"        Need of external appliance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Ileorectal anastomosis",
"       </td>",
"       <td>",
"        Transanal defecation and fecal continence preserved",
"        <br/>",
"        No ileostomy",
"       </td>",
"       <td>",
"        Diseased rectum remains to produce symptoms, require treatment and predispose to cancer",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7148=[""].join("\n");
var outline_f6_62_7148=null;
var title_f6_62_7149="Newer platelet function tests";
var content_f6_62_7149=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F52144&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F52144&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    List of new platelet function tests",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Platelet function test",
"      </td>",
"      <td class=\"subtitle1\">",
"       Aspects of platelet function measured",
"      </td>",
"      <td class=\"subtitle1\">",
"       Advantages",
"      </td>",
"      <td class=\"subtitle1\">",
"       Disadvantages",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Clot Signature Analyser (CSA)",
"      </td>",
"      <td>",
"       Global Haemostasis High Shear platelet function",
"      </td>",
"      <td>",
"       Measures Global Hemostatic Function",
"      </td>",
"      <td>",
"       Cost of cartridges",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cone &amp; Plate Analyser (CPA)",
"      </td>",
"      <td>",
"       High shear platelet adhesion/aggregation",
"      </td>",
"      <td>",
"       Small volume of blood, physiological",
"      </td>",
"      <td>",
"       Requires image analysis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Flow Cytometry",
"      </td>",
"      <td>",
"       Platelet glycoproteins, activation markers, platelet function",
"      </td>",
"      <td>",
"       Whole blood test, flexible, wide variety of tests, powerful",
"      </td>",
"      <td>",
"       Specialized operator, expensive equipment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       ICHOR (Plateletworks)",
"      </td>",
"      <td>",
"       Platelet counting pre- and post platelet activation",
"      </td>",
"      <td>",
"       Simple point of care",
"      </td>",
"      <td>",
"       Preparation of Reagents",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Haemodyne",
"      </td>",
"      <td>",
"       Platelet Contractile force",
"      </td>",
"      <td>",
"       Rapid and Simple",
"      </td>",
"      <td>",
"       Measures clot properties only",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hemostasus Device activity",
"      </td>",
"      <td>",
"       Platelet procoagulant function",
"      </td>",
"      <td>",
"       Simple",
"      </td>",
"      <td>",
"       Insensitive to aspirin and GpIb",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Laser Platelet Aggregometer (PA-200)",
"      </td>",
"      <td>",
"       Platelet micro-aggregates",
"      </td>",
"      <td>",
"       Sensitive, study hyperfunction",
"      </td>",
"      <td>",
"       Little widespread experience",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Platelet Function Analyser (PFA-100)",
"      </td>",
"      <td>",
"       High Shear adhesion/aggregation",
"      </td>",
"      <td>",
"       Rapid and simple screening, In vitro bleeding time, Potential point of care instrument",
"      </td>",
"      <td>",
"       Inflexible",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Thrombotic Status Analyser (TSA)",
"      </td>",
"      <td>",
"       High shear platelet function",
"      </td>",
"      <td>",
"       Simple",
"      </td>",
"      <td>",
"       Little widespread experience",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Thromboelastometry (ROTEM)",
"      </td>",
"      <td>",
"       Measures global hemostasis",
"      </td>",
"      <td>",
"       Can predict bleeding",
"      </td>",
"      <td>",
"       Insensitive to aspirin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Verify Now Test (rapid platelet function analyzer)",
"      </td>",
"      <td>",
"       GP IIb/IIIa dependent aggregation",
"      </td>",
"      <td rowspan=\"3\">",
"       Simple test for monitoring drug effect using three different cartridges",
"      </td>",
"      <td rowspan=\"3\">",
"       Inflexible",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Aspirin effect",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       P2Y12 blockade",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Placor PRT",
"      </td>",
"      <td rowspan=\"2\">",
"       Platelet hyperfunction",
"      </td>",
"      <td rowspan=\"2\">",
"       Rapid point of care test using fingerprick blood",
"      </td>",
"      <td>",
"       Little widespread experience",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Platelets will be activated by finger wound",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Thrombovision T guide",
"      </td>",
"      <td>",
"       Platelet aggregation in response to agonists by light scatter",
"      </td>",
"      <td>",
"       Automated point of care test",
"      </td>",
"      <td>",
"       Little widespread experience",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified and reproduced with permission from: Harrison, P. Progress in the Assessment of Platelet Function. Br J Haematol 2000; 111:733. Copyright &copy;2000 Blackwell Science.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.blackwell-science.com\">",
"      file://www.blackwell-science.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7149=[""].join("\n");
var outline_f6_62_7149=null;
var title_f6_62_7150="ESC 2008 CM familial";
var content_f6_62_7150=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64479%7ECARD%2F74268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64479%7ECARD%2F74268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Familial types of cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        HCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        DCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        ARVC",
"       </td>",
"       <td class=\"subtitle1\">",
"        Arrhythmogenic CM",
"       </td>",
"       <td class=\"subtitle1\">",
"        RCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        Unclassified",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        Sarcomeric protein mutations",
"        <ul>",
"         <li>",
"          &Beta; myosin heavy chain",
"         </li>",
"         <li>",
"          Cardiac myosin binding protein C",
"         </li>",
"         <li>",
"          Cardiac troponin I",
"         </li>",
"         <li>",
"          Troponin-T",
"         </li>",
"         <li>",
"          &alpha;-tropomyosin",
"         </li>",
"         <li>",
"          Essential myosin light chain",
"         </li>",
"         <li>",
"          Regulatory myosin light chain",
"         </li>",
"         <li>",
"          Cardiac actin",
"         </li>",
"         <li>",
"          &alpha;-myosin heavy chain",
"         </li>",
"         <li>",
"          Titin",
"         </li>",
"         <li>",
"          Troponin C",
"         </li>",
"         <li>",
"          Muscle LIM protein",
"         </li>",
"        </ul>",
"        <p>",
"         Glycogen storage disease (eg, Pompe; PRKAG2, Forbes', Danon)",
"        </p>",
"        <p>",
"         Lysosomal storage diseases (eg, Anderson-Fabry, Hurler's)",
"        </p>",
"        <p>",
"         Disorders of fatty acid metabolism",
"        </p>",
"        <p>",
"         Carnitine deficiency",
"        </p>",
"        <p>",
"         Phosphorylase B kinase deficiency",
"        </p>",
"        <p>",
"         Mitochondrial cytopathies",
"        </p>",
"        Syndromic HCM",
"        <ul>",
"         <li>",
"          Noonan's syndrome",
"         </li>",
"         <li>",
"          LEOPARD syndrome",
"         </li>",
"         <li>",
"          Friedreich's ataxia",
"         </li>",
"         <li>",
"          Beckwith-Wiedermann syndrome",
"         </li>",
"         <li>",
"          Swyer's syndrome",
"         </li>",
"        </ul>",
"        Other",
"        <ul>",
"         <li>",
"          Phospholamban promoter",
"         </li>",
"         <li>",
"          Familial amyloid",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        <p>",
"         Sarcomeric protein mutations (see HCM)",
"        </p>",
"        Z-band",
"        <ul>",
"         <li>",
"          Muscle LIM protein",
"         </li>",
"         <li>",
"          TCAP",
"         </li>",
"        </ul>",
"        Cytoskeletal genes",
"        <ul>",
"         <li>",
"          Titin",
"         </li>",
"         <li>",
"          Dystrophin",
"         </li>",
"         <li>",
"          Desmin",
"         </li>",
"         <li>",
"          Metavinculin",
"         </li>",
"         <li>",
"          Sarcoglycan complex",
"         </li>",
"         <li>",
"          CRYAB",
"         </li>",
"         <li>",
"          Epicardin",
"         </li>",
"        </ul>",
"        Nuclear membrane",
"        <ul>",
"         <li>",
"          Lamin A/C",
"         </li>",
"         <li>",
"          Emerin",
"         </li>",
"        </ul>",
"        <p>",
"         Mildly dilated CM",
"        </p>",
"        <p>",
"         Intercalated disc protein mutations (see ARVC)",
"        </p>",
"        Mitochondrial cytopathy",
"       </td>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        Intercalated disc protein mutations",
"        <ul>",
"         <li>",
"          Plakoglobin",
"         </li>",
"         <li>",
"          Desmoplakin",
"         </li>",
"         <li>",
"          Plakophilin 2",
"         </li>",
"         <li>",
"          Desmoglein 2",
"         </li>",
"         <li>",
"          Desmocollin 2",
"         </li>",
"        </ul>",
"        Transforming growth factor-&beta;3 (TGF-&beta;3)",
"       </td>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        <p>",
"         Intercalated disc protein mutations (see ARVC)",
"        </p>",
"        <p>",
"         Lamin A/C",
"        </p>",
"        SCN5A",
"       </td>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        Sarcomeric protein mutations",
"        <ul>",
"         <li>",
"          Troponin I (RCM +/- HCM)",
"         </li>",
"         <li>",
"          Essential light chain of myosin",
"         </li>",
"        </ul>",
"        Familial amyloidosis",
"        <ul>",
"         <li>",
"          Transthyretin (RCM + neuropathy)",
"         </li>",
"         <li>",
"          Apolipoprotein (RCM + nephropathy)",
"         </li>",
"        </ul>",
"        <p>",
"         Desminopathy",
"        </p>",
"        <p>",
"         Pseuxanthoma elasticum",
"        </p>",
"        <p>",
"         Haemochromatosis",
"        </p>",
"        <p>",
"         Anderson-Fabry disease",
"        </p>",
"        Glycogen storage disease",
"       </td>",
"       <td>",
"        Left ventricular non-compaction",
"        <ul>",
"         <li>",
"          Barth syndrome",
"         </li>",
"         <li>",
"          Lamin A/C",
"         </li>",
"         <li>",
"          ZASP",
"         </li>",
"         <li>",
"          &alpha;-dystrobrevin",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ARVC: arrhythmogenic right ventricular cardiomyopathy; DCM: dilated cardiomyopathy; HCM: hypertrophic cardiomyopathy; RCM: restrictive cardiomyopathy.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Elliott P, Anderson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial disease. Eur Heart J 2008; 29:270. Copyright &copy; 2008 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Non-familial types of cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        HCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        DCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        ARVC",
"       </td>",
"       <td class=\"subtitle1\">",
"        RCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        Unclassified",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Obesity",
"        </p>",
"        <p>",
"         Infants of diabetic mothers",
"        </p>",
"        <p>",
"         Athletic training",
"        </p>",
"        Amyloid (AL/prealbumin)",
"       </td>",
"       <td>",
"        <p>",
"         Myocarditis (infective/toxic/immune)",
"        </p>",
"        <p>",
"         Kawasaki disease",
"        </p>",
"        <p>",
"         Eosinophilic (Churg Strauss syndrome)",
"        </p>",
"        <p>",
"         Viral persistence",
"        </p>",
"        <p>",
"         Drugs",
"        </p>",
"        <p>",
"         Pregnancy",
"        </p>",
"        <p>",
"         Endocrine",
"        </p>",
"        <p>",
"         Nutritional - thiamine, carnitine, selenium, hypophosphataemia, hypocalcaemia",
"        </p>",
"        <p>",
"         Alcohol",
"        </p>",
"        Tachycardiomyopathy",
"       </td>",
"       <td>",
"        Inflammation?",
"       </td>",
"       <td>",
"        <p>",
"         Amyloid (AL/prealbumin)",
"        </p>",
"        <p>",
"         Scleroderma",
"        </p>",
"        Endomyocardial fibrosis",
"        <ul>",
"         <li>",
"          Hypereosinophilic syndrome",
"         </li>",
"         <li>",
"          Idiopathic",
"         </li>",
"         <li>",
"          Chromosomal cause",
"         </li>",
"         <li>",
"          Drugs (serotonin, methysergide, ergotamine, mercurial agents, busulfan)",
"         </li>",
"        </ul>",
"        <p>",
"         Carcinoid heart disease",
"        </p>",
"        <p>",
"         Metastatic cancers",
"        </p>",
"        <p>",
"         Radiation",
"        </p>",
"        Drugs (anthracyclines)",
"       </td>",
"       <td>",
"        Tako Tsubo cardiomyopathy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ARVC: arrhythmogenic right ventricular cardiomyopathy; DCM: dilated cardiomyopathy; HCM: hypertrophic cardiomyopathy; RCM: restrictive cardiomyopathy.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Elliott P, Anderson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial disease. Eur Heart J 2008; 29:270. Copyright &copy; 2008 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7150=[""].join("\n");
var outline_f6_62_7150=null;
var title_f6_62_7151="Glomerular permeability";
var content_f6_62_7151=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Size and charge determinants of glomerular permeability",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 269px; height: 198px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fractional clearances (the ratio of the filtration of a substance to that of inulin, which is freely filtered) of anionic, neutral (middle curve), and cationic dextrans as a function of effective molecular radius. Both molecular size and charge are important determinants of filtration, as smaller or cationic dextrans are more easily filtered. As a reference, the effective molecular radius of albumin (which is anionic in the physiologic pH range) is 36 &Aring;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from the American Society for Clinical Investigation Bohrer MP, et al, J Clin Invest 1978; 61:72.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_62_7151=[""].join("\n");
var outline_f6_62_7151=null;
